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Find a tool. 
Find a way. 
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I don’t know 
what is jammed. 
The night does not close, 
The day does not open. 
 
Find a tool. 
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The goal of this research is to create in vitro microenvironments for long term culture of 
hematopoeitic stem cell (HSC) in microfluidic bioreactors. In vivo, HSCs reside in the 
bone marrow osteoblastic and vascular niches in adult mammals. Defining features of 
their in vivo niche include: small number of HSCs, heterogeneous population of bone 
marrow cells that support HSCs, and low oxygen tension. We engineer niche elements in 
microfluidic bioreactors by modulating oxygen tension, optimizing attachment and 
growth of HSC-supporting bone marrow stromal cells, and culturing small numbers of 
HSCs in their physiologically relevant ratios between HSCs and supporting cells.  
 
By using a combination of a mathematical model and quantitative experiments, we have 
created a design tool to manipulate and control oxygen tension for cell culture inside the 
poly(dimethyl siloxane) (PDMS) microbioreactors. Dissolved oxygen concentrations in 
the microbioreactor are quantified in real time using fluorescence lifetime imaging of an 
oxygen sensitive dye. Experimental results are consistent with the mathematical model 
and give insight into operating conditions required for a desired oxygen tension in cell 
culture regions of the microbioreactor.  
 
We used microfluidic perfusion systems to develop nanocoatings made from electrostatic 
self assembly of PDDA (poly(diallyldimethyl ammonium chloride)), clay, type IV 
 xx
collagen and fibronectin to optimize attachment of primary murine bone marrow cells 
(support cells for HSCs) onto PDMS bioreactors. PDDA-topped coatings were found to 
be cytotoxic, while coatings with two or more bilayers of proteins collagen and 
fibronectin were found to optimize spreading, proliferation, and viability as compared to 
other surfaces.  
 
On-chip erythropoiesis was achieved with a 3-D co-culture of HSCs with supporting cells 
in PDMS bioreactors. In addition, an optimal ratio of support cells to HSCs was found to 
maximize self renewal potential of HSCs in vitro. By the combination of hypoxia (which 
simulates in vivo bone marrow oxygen tension), biofunctional surfaces, and 3-D co-
cultures, we are moving towards a ‘microfluidic HSC niche’, in which hypothesis-driven 















Often in our darkness 
we forget to see the light: 
The sun is constant, 
even behind the clouds, 
The river’s current 
washes away the debris. 
Let the wind on your cheeks 
help you remember 
there is more - 
There is more for you. 
-Ruth Gilmore Langs, Ann Arbor Artist, 2006 
 
 
1.1 Specific Aims 
 
In this thesis, we aim to understand and develop various tools to engineer hematopoiesis-
on-a-chip. Efforts to understand and control hematopoietic stem cell (HSC) proliferation 
and differentiation would benefit from development of artificial stem cell niches where a 
single or a few hematopoietic stem cells and primary bone marrow cells can be cultured 
in nanoliter volumes of fluids under investigator defined microenvironments.  This thesis 
describes efforts to accomplish this goal using microfluidic poly(dimethylsiloxane) 
(PDMS) bioreactors.  The nanoliter scale microfluidic bioreactors have an advantage over 
conventional bioreactors or other macroscopic culture systems in that the small volume 
allows even one or a few HSCs to condition the culture environment significantly.  
Additionally microfluidic PDMS bioreactors have the potential to utilize computerized 
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flow control to prepare engineered substrates for cell attachment prior to cell seeding as 
well as to optimize oxygen environments.  This thesis is partly a design-directed 
engineering project to design, fabricate, and characterize microfluidic bioreactors, and 
partly a biological project to study the in vitro self renewal of HSCs in the niche using the 
optimized bioreactor.   
 
The central hypothesis of the research undertaken is that in vitro niches can be created to 
manipulate HSC microenvironments in microfluidic bioreactors to optimize the seld-
renewal of HSCs. Such in vitro models can provide a tool for studying the autocrine, 
paracrine and mitogenic factors regulated by HSCs to exercise control over the niche 
constituent cells. Specifically, with the combined effect of oxygen tension, physical 
attachments between HSC, supporting cells and niche substrate; three dimensional co-
cultures of HSCs and niche constituent cells, the in vitro self renewal of HSCs can be 
improved resulting in undifferentiated multipotent primitive state of HSCs. The labs of 
Drs. Takayama and Linderman were perfectly suited for this thesis as they synergize the 
advantages of microfluidics with those of mathematical models to pre-screen amongst the 
plethora of complex interactions in HSC niche to study important and non-redundant 
crosstalk between HSCs and stromal cells in the bone marrow HSC niche.  The research 
outlined here can ultimately be applied for creation of engineered bony organs, novel 
biosensors and new treatment strategies for hematological diseases such as 
myeloproliferative disorders. 
 
The specific aims for this thesis are as follows: 
 
1) Quantitatively measure and control the oxygen tension inside microbioreactors 
(Chapters 3, 4 and 5) 
 
Oxygen tension in the niche has been directly correlated with fate of stem and tumor cells 
(Csete 2005). Additionally, the most primitive HSCs in the in vivo bone marrow are 
found near low oxygen tensions, while more differentiated progenitors are found near 
comparatively higher oxygen tension (Parmar et al. 2007). Moreover, oxidative stress is a 
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metabolic element which can lead to accumulation of reactive oxygen species (ROS) in 
HSCs and lead to changes in cellular functions (Ito et al. 2004). For the first part of this 
thesis, we develop an optics-based oxygen detection system in PDMS microfluidic 
devices. We also use a nutrient-based quantitative mathematical model (Mehta et al. 
2006) to explain how key parameters control the spatial distribution of oxygen. By 
combining the model and the experiments we create a design tool to enable control of 
oxygen tensions in microfluidic devices for different cell types, including HSCs.  
 
To further lower oxygen tensions in microdevices so that they are suitable for culture of 
primary HSCs and other cells desiring lower oxygen, we fabricate microdevices from 
polymeric materials with lower oxygen and water vapor permeabilities compared to 
PDMS. Such low oxygen tensions are realized in ‘hard top – soft bottom’ 
microbioreactors made from two hybrid bonded materials which are perfused using 
peristaltic Braille pumps and valves. 
 
Another application of the ‘design tool’ that we develop using experimental and 
modeling methods, is in the determination of the intrinsic cell parameters for microfluidic 
cell culture. We use oxygen tension profiles of three different cell types, and evaluate 
Michaelis-Menten rate parameters, Vmax and km, (Vmax is the maximum consumption rate 
(at normoxic conditions) and km is the oxygen concentration at which the oxygen 
consumption rate is half of its maximum rate), for each cell type by utilizing the 
mathematical model.  
 
2) Modify the surface of the microbioreactor to create physiological 
microenvironment for culture of primary bone marrow cells  (Chapter 6) 
 
Primary cells from the bone marrow are not amenable to culture on PDMS surface (Lee 
et al. 2004; Mehta et al. 2007). We aim to make PDMS surface biofunctional by growing 
polyelectrolyte multilayers (PEMs) nanocoatings by layer-by-layer (LbL) self assembly. 
We use microfluidic peristaltic pumps (Braille operated) to make custom nanocoatings of 
polymers and proteins for 2-3 week culture of bone marrow stromal cells (unsorted 
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primary murine whole bone marrow). Such coatings can also be customized for primary 
endothelial cells and other primary cells which are hard to grow for long times on PDMS 
surfaces. 
  
3) Three dimensional co-culture of hematopoeitic and support cells to create an in 
vitro model of HSC niche  (Chapters 7 and 8) 
 
One of the important features of the HSC niche is three dimensional hierarchy and 
arrangement of various cell types in the marrow space. In fact, three dimensional cultures 
of HSCs have been reported to increase the expansion of HSCs in vitro (Banu et al. 2001; 
Kim et al. 2003; Li et al. 2001; Takagi 2005; Tun et al. 2000; Wang et al. 1995). In vivo 
HSCs are surrounded by a heterogeneous population of supporting cells, which provide 
soluble and adhesive signals to HSCs to support the proliferation, survival and self-
renewing capacity of HSCs.  In the third part of this research, three dimensional co-
cultures of hematopoeitic stem and progenitor cells is performed with different support 
cells to test our in vitro microfluidic niches for HSCs. Using 3-D cultures, we create an 
erythropoiesis-on-a-chip model for generating erythrocytes from bone marrow cells for 
up to two weeks. We also use 3-D co-cultures to figure out the physiological ratio of 
HSCs to support cells needed to keep HSCs in a self-renewing state for an extended time 






Figure 1.1: Stem cell niche is regulated by many elements including: constraints of the 
architectural space (structural), physical engagement of the cell membrane with tethering 
molecules on neighboring cells or surfaces, signaling interactions at the interface of stem 
cells and niche or descendent cells, paracrine and endocrine (humoral) signals from local 
or distant sources, input from central nervous system (neural), and metabolic products of 
tissue activity (Scadden 2006). 
 
Our engineered ‘in vitro HSC niche’ will provide a new tool to biologists, a system in 
which they can perform screening assays to find the autocrine and paracrine factors 
secreted by a small number of HSCs and metabolic elements in the niche. Researchers 
working on cell biology have assays to identify the secreted factors (Majka et al. 2001) 
and they also have tools to figure out the signaling regulated by those secreted molecules. 
Our engineered niche would provide them a system in which they can look at miniscule 
amounts of molecules secreted by HSCs. We also propose to work with pure HSCs and 
well-defined microenvironments in order to elucidate the biological processes involved, 
which the current in vivo and in vitro systems are lacking. Thus, with this microbioreactor 
system it will be possible to introduce a new in vitro model of HSC bone marrow niche 
which enables study of key biological behavior as a function of different oxygen tensions, 
flow rates, and surface chemistry. Figure 1.1 summarizes a typical stem cell niche. With 
the tools developed in this thesis, we are creating this functional HSC niche to study how 
HSCs exercise their regulation on the niche.   
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The long term goal of our work is to create biosensors with multiple bone cell types in 
order to engineer a bone marrow. The proposed physiologic biosensor could be used for 
precision sensing of the presence of cytotoxic environmental agents including 
myeloablative radiations or chemicals. Such agents cause tremendous toxic effects to the 
bone marrow, making it more prone than any other organ to cytotoxic environmental 
agents. We also aim to engineer a functional bone marrow, producing different blood 
cells types in the microbioreactor. In this thesis, we describe the crucial first steps in this 
process by recreating physiologically relevant microenvironments in the bioreactor. The 
combination of computerized microfluidics, in situ oxygen sensing, and mathematical 
models opens new windows for microphysiologic studies utilizing different surface 
chemistries, oxygen gradients and low oxygen tension. These results will be significant 
for the development, design, and optimization of novel, more physiological, in vitro 
systems for  cellular studies.  
 
 1.2 Outline of the Thesis 
 
The thesis is arranged as follows: chapter two scrutinizes the literature in the areas of 
microfluidics, microfluidic cell culture, bone marrow biology, in vitro culture of HSCs, 
and in vivo bone marrow niche. The first part of chapter two, which is about biological 
microenvironmental in microfluidic devices, was written as a chapter (Engineering 
Cellular Microenvironments with Microfluidics) for a book titled, “Biological 
Applications of Microfluidics”.  The second part of this chapter focuses on the bone 
marrow biology and HSC background. 
 
Chapter three describes an experimental and modeling method to control dissolved 
oxygen tensions in PDMS microbioreactors, as a part of Aim 1. This work was published 
as an original research article in Biomedical Microdevices.   
 
Chapter four shows how lower oxygen concentrations (hypoxic) can be achieved in 
microbioreactors by making devices from low oxygen permeability materials. This 
chapter is also an extension of Aim 1. 
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Chapter five looks at estimation of cellular characteristic parameters, (Michelis-Menton 
uptake parameters, km and Vmax) in microbioreactors from oxygen measurements for 
three cell lines. The experiments for this chapter were conducted by me; however, the 
modeling part as well the actual estimation of parameters was done by Khamir Mehta. 
This chapter is a part of the Aim 1 and shows an important application of our 
experimental technique. 
 
Chapter six deals with surface modification in PDMS microbioreactors, and demonstrates 
creation of polyelectrolyte multilayers with different compositions made inside the same 
microbioreactors. Primary bone marrow stromal adherent cells are cultures on PEMs of 
30 different compositions for 15 days, and assays for cell spreading, proliferation and 
viability are performed and results compared. This chapter encompasses Aim 2 and was 
published as an article for Advanced Functional Materials. 
 
As a part of Aim 3, chapter seven shows three dimensional in vitro HSC co-culture with 
different support cells. Seven day long in vitro co-cultures are followed by two week long 
colony formation unit (CFU) assays.  
 
Chapter eight demonstrates generation of red blood cells from primary bone marrow 
progenitors for 15 days in microbioreactors, creating a model for ‘erythropoiesis-on-a-
chip’. This chapter is also a part of Aim 3. 
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LITERATURE REVIEW  
 
2.1 Introduction 
In order to create in vitro niche for hematopoietic stem cells, and ultimately, functional 
bony organs on a chip, a comprehensive study of microfluidic microenvironments and 
background of bone marrow stem cell biology is required. In this chapter, the current 
understanding of both these areas is presented. In the first part of this chapter, the 
microenvironments in microfluidic bioreactors are discussed. In the second part, the bone 
marrow biology as well as current knowledge about HSC self-renewal are communicated. 
 
2.1.1 The microenvironment gap 
There are many biomedical applications where it is necessary to manipulate mammalian 
cells outside of the body.  The most common of such applications are: 1.Basic cell 
biological research; 2. Drug testing; 3. Cell-based therapies.  A frequent problem in these 
types of in vitro cell manipulations, which typically occur in culture dishes, is that one 
can study, test, or use the exact same cells, but get very different responses from them 
because the microenvironment they are subjected to in vitro is very different from what 
the cells experience physiologically in vivo.  This “microenvironment gap” may cause the 
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cell biologist to make scientific conclusions about cells that are contrary to their 
physiological behavior, or the drug developer to identify false positives and false 
negatives in drug testing, or the clinician to have to settle for a suboptimal therapeutic 
outcome.  Biologists have identified and made available many bimolecular components 
that comprise the physiologic microenvironment for in vitro culture.  And the list of 
available components continues to increase.  However, the typical culture process of 
adding excessive volumes of culture media that contain a variety of these biomolecules 
together in a dish with a thin layer of cells attached often only goes so far in closing the 
microenvironment gap to elicit physiological cellular responses.  Why is this?  What 
comprises the physiological microenvironment and what are ways in which the 
microenvironment gap between in vivo and in vitro can be narrowed?  This chapter will 
address these questions with a particular focus resolving the microfluidic aspects of this 
problem.   
 
2.1.2 Cellular Microenvironment 
For discussions in this chapter, we define “microenvironment” as a specific set of 
physical, chemical, and biological conditions in the vicinity of cells within a distance 
where those conditions can have an effect on or be sensed by the cells.  The 
microenvironment provides cells with physical architecture, fluid and solid mechanical 
stimulation, adhesive signals, growth factors and cytokines, nutrients, inhibitor 
chemicals, and cell-cell interactions. The in vivo cellular microenvironment is composed 
of an intricate blend of extracellular matrix proteins, immobilized protein factors, 
proteoglycans, mineralized tissue, soluble protein factors, small molecule signals, and 
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various adjacent cell types, which vary in space and time due to material deformation, 
fluid flow, chemical reactions, or cell proliferation, differentiation, death, or migration 
(Adams et al. 2006; Jang et al. 2006; Shim et al. 2003).  Cells continually sense these 
inputs, process the information through signal transduction and genetic regulation, and 
execute a cell behavior or determine a cell fate.  Therefore, to study cell biology under 
well-controlled and versatile yet physiologically relevant conditions in vitro or to 
manipulate cells for clinical applications to elicit their maximum therapeutic potential, it 
is important to not only have the correct mixture of biomolecules but to also recreate the 
physical characteristics of the tissue.  
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Figure 2.1: Physiology is microfluidic.  An example of a microfluidic environment 
presented in human liver. The liver is composed of parenchymal cells, hepatocytes (H) 
(epithelial cells), and at least four major types of nonparenchymal cells (mesenchymal 
cells), Kupffer cells (KC) (resident macrophages), perisinusoidal or stellate cells (SC), 
sinusoidal epithelial cells and large granular lymphocytes (natural killer cells).  Blood 
flows through the sinusoids (S) formed by fenestrated endothelial cells (EC).  Kupffer 
cells and large granular lymphocytes bulge into the sinusoidal lumen from the endothelial 
cells. The space between the endothelial cell lining and the hepatocyte plates is the space 
of Disse (D) in which perisinusoidal or stellate cells and the extracellular matrix are 
located. Adjacent hepatocytes form bile canaliculi with their apical membranes.  
 
2.1.3 Opportunities for microenvironment engineering using microfluidics 
Use of microfluidics makes intuitive sense for cell microenvironment engineering.  The 
physiological microenvironments in living systems are largely microfluidic in nature.  
Just a glance at the vascular network, pulmonary system, liver sinusoids, reproductive 
tracts, other tissues and organs of animals and humans reveals a wealth of physiologic 
microfluidic structures.  The structure is very different from the architecture of the typical 
cell culture dish.  An example of the physiologic microenvironment in the human liver is 
presented in Figure 2.1. 
 
More substantially there are differences in the chemical and mechanical environment 
cells will experience in a microfluidic environment, even if one cultures the exact same 
cells in the exact same medium.  Some of the major microenvironment differences are 
discussed conceptually in the next few paragraphs and examples of how microfluidics 
can be used to engineer more physiologic conditions described in the subsequent section. 
 
2.1.3.1 The fluid volume to cell volume ratios leads to chemical changes   
In a typical culture dish, the volume of culture media is vastly greater compared to the 
volume of cells adhered to the bottom of the dish.  In contrast, physiologically, a majority 
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of the volume within tissues are taken up by cells rather than the fluid surrounding them.  
This difference in fluid volume to cell volume ratio can lead to differences in the 
chemical microenvironment of cells.  Nanoliter scale microfluidic bioreactors have an 
advantage over conventional bioreactors or other macroscopic culture systems in that the 
small volumes allow even one or a few cells to condition the culture environment 
significantly.  By having physiological ratios of cells to liquid volumes, better in vitro 
model systems can be developed in microfluidic devices, in terms of autocrine and 
paracrine signaling, for example, and pave way for biological studies that may otherwise 
not be possible. The small volumes also facilitate formation of significant cell-generated 
chemical gradients because cells can consume and secrete at appreciable levels where 
compounds are depleted or accumulate along the channel length.     
 
2.1.3.2 Flow effects on chemical environment 
Another difference between in vitro and in vivo cellular environments is fluid flow.  The 
dish is static whereas the physiologic environment is dynamic.  In the last 40 years, many 
studies have made it clear that the fluid flow and biology are inextricably intertwined. On 
a macroscopic scale, endocrine effects are exerted through transport by blood flow.  On a 
smaller scale, convection can affect chemical gradients, and how cells sense chemical 
secreted by themselves (autocrine effects) as well as other cells (paracrine effects).  The 
static nature of conventional cell culture also poses limitations for studying the effects of 
steady-state and intermittent stimulation with chemical and mitogenic factors. 
 
 14
In conventional cell cultures, spontaneously occurring spatial variability in temperature, 
solute concentration, or dissolved gas concentration can lead to surface tension 
differences at the gas–solution interface.  These fluctuations cause variable convection 
and mass transfer making precise control of mitogens difficult.  On the other hand, there 
is no defined fluid flow as is present in the blood stream, lymph, liver or other 
physiologic conditions.  Convection is an important aspect of the in vivo 
microenvironment, particularly with respect to autocrine or paracrine signaling, which 
can be recreated to an extent in microfluidic bioreactors with controlled flow.  Generation 
of gradients during perfusion is relevant to a variety of physiological cellular 
microenvironments in developing tissues where morphogenetic gradients are important in 
specifying cell fate, as well as in mature tissue to regulate and maintain function. 
 
2.1.3.3 Flow effects on mechanical stimuli  
Fluid flow also exerts mechanical effects.  Cells in vivo exist in a dynamic environment 
where mechanical forces such as shear stress, tension and compression are important.  In 
fact, cells respond to fluid shear stress through a complex process involving several 
transduction elements and multiple signaling pathways.  For example, fluid shear forces 
acting on endothelial cells produce marked, time-dependent changes in their morphology 
(Dewey et al. 1981, Flaherty et al. 1972).  Fluid-dynamic stresses have been observed to 
influence the adhesion of leukocytes to the endothelium and the tendency of the blood to 
clot.  Cellular level fluid mechanics are complicated by the three-dimensional nature of 
the flow, the compliance of the interacting surfaces, and receptor-ligand dynamics. 
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Mechanical forces are also involved in cell-cell interactions. L-selectin, an adhesion 
molecule, mediates lymphocyte binding to, and rolling on, high endothelial venules.  Puri 
et al manipulated the bond between selectin and mucin-like ligand by selective and 
reversible chemical modification of the ligand to show the effect of mechanical properties 
on the bond strength of interaction between adhesion molecules on two different cells 
(Puri et al. 1998). Additionally, to promote and maintain rolling interactions between 
leukocytes and vascular vessel wall through L-selectin, shear above a critical threshold is 
required but not through E-selectin, P-selectin or VCAM-1. The shear threshold 
requirement for L-selectin may be physiologically important in low shear to prevent 
inappropriate aggregation of leukocytes and interaction with the vessel wall (Finger et al. 
1996, Alon et al. 1995). 
 
It is important to not only have applied forces in cell culture, but also temporal variations 
in the forces applied.  The endothelium has a completely different response to turbulent 
shear stress than to a laminar shear stress of the same time-mean magnitude (Davies et al. 
1984, 1986).  Temporal shear also produces a sustained response in intracellular calcium, 
whereas steady shear leads to an unrepeated single impulse.  Endothelial cells also 
respond to vascular region-specific flow patterns by changing phenotypes as evidenced 
from their differential patterns of gene expression. They have distinct phenotypic 
modulation in response to the wall shear stresses present in prototypic human arterial 
waveforms (atherosclerosis-susceptible vs. atherosclerosis-resistant) (Dai et al. 2004). 
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Comparison of biological responses of human umbilical vein ECs to arterial pulsatile 
flow for 24 hours, at equivalent time-average steady laminar shear stress, and at no flow 
(static) culture conditions showed changes in cell shape and alignment in case of flow 
stimuli. However, different patterns of flow stimuli gave rise to distinct patterns of 
responses in the distribution of actin stress fibers and vinculin-associated adhesion 
complexes, intrinsic migratory characteristics, and the expression of eNOS mRNA and 
protein (Blackman et al. 2002).  Human endothelial cells exposed to two well defined 
biomechanical stimuli --a steady laminar shear stress and a turbulent shear stress of 
equivalent spatial and temporal average intensity-- have the capacity to discriminate 
among these specific biomechanical forces. They even translate these input stimuli into 




Figure 2.2: Cellular microenvironment in a microfluidic culture compared to a 
conventional 2D culture.  a) Cells cultured in a dish grow in a large volume of medium 
under static condition.  Biomolecules secreted from cells are dissipated in bulk medium 
by diffusion and some uncontrolled convection.  b) Cells cultured in a microfluidic 
device grow in small volumes of media under static or dynamic conditions.  Under static 
conditions, biomolecules secreted from cells distribute around cells (autocrine/paracrine) 
and into the surrounding medium by diffusion but in a limited way compared to in a dish.  
Cell consumption and secretion as well as fluid flow can create concentration gradients 
and fluid flow can generate shear stress.  c) Cell culture in a micropipette from a report in 
1948. A = micropipette, B = tube filled with cotton which acts as a bacterial air filter, C = 
rubber tube, D = mouthpiece. 
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2.1.3.4 Opportunities for microfluidics 
Because of the microenvironmental requirements described above, efforts to understand 
and control cellular signaling, proliferation and differentiation would benefit from 
development of artificial cell microenvironment where cells can be cultured in nanoliter 
volumes of fluids under investigator defined conditions.  A summary of the difference 
between conventional 2D cultures and static or dynamic microfluidic cultures are 
depicted in Figure 2.2.   
 
In the first part of this chapter, we give specific examples of how microfluidic cell culture 
aids in each of the three above-mentioned categories. In the first subsection of examples 
of microfluidic cultures, we take a look at the reports of static microfluidic cell culture 
and the knowledge gained from them. In the second subsection, we follow the progress 
made by engineering chemical environments with active fluid flow. In the third 
subsection, we discuss the fluid mechanical effects of microfluidic cell culture. After 
discussing these three topics of how microfluidics can contribute to cellular 
microenvironment engineering, we describe additional useful capabilities that 
microfluidic devices offer including culture of precious cells, integrated biochemical 
analyses and 3-D culture. We end the microfluidic section with future prospects of 
microfluidic cell biological studies.  
 
2.2 Microfluidic Cultures can Simulate In Vivo Microenvironments 
The following are specific examples of how microfluidic cultures can be used to simulate 
in vivo conditions. 
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2.2.1 Use of substantially static microfluidic devices to engineer the chemical 
microenvironment  
Simply culturing cells in small volumes of fluids can be beneficial and more 
physiological.  An early account of “microfluidic” mammalian cell culture is from 1948 
when Sanford et al. described successful growth of isolated cells in a glass pipette that 
did not grow well in the typical culture dish (Sanford et al. 1948). Small number of cells 
grew in the capillary (but not in a dish) due to their ability to self-conditioning the small 
volumes of media surrounding them.  The cells, however, eventually died because of 
nutrient depletion and waste buildup that eventually prevailed, also caused by the small 
volumes of media. Microfluidics has come a long ways since then, thanks to the 
semiconductor industry, and now 60 years later, many sophisticated microfluidic tools 
are being developed with enhanced structures, materials, and flow manipulation to 
manipulate mammalian cells.  There are still many beneficial uses, however, of static 
microfluidic cell cultures. 
 
PDMS microfluidic devices, for example, have been used for static culture of mammalian 
and fruit-fly embryos (Walker et al. 2004, Raty et al. 2004, Walters et al. 2004, Clark et 
al. 2005, Glasgow et al. 2001, Lucchetta et al. 2005).  The diffusion dominant 
microchannel environment has also been characterized by static culture of fall armyworm 
ovarian cells (Sf9) in different sized microchannels (height, width, length) at different 
seeding densities. The cell proliferation was found to be dependent on seeding density 
and channel height (Yu et al. 2005).   
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An alternative to the conventional macroscopic passive gradient generation systems, such 
as the Boyden chamber and Zigmond chamber, has been developed in a microfluidic 
format.  Chemotaxis of neutrophils to gradients of formyl-Met-Leu-Phe (fMLP) was 
shown to cause polarization and migration in six hours in this passive flow microfluidic 
device (Abhyankar et al. 2006).  
 
Substantially static microfluidic devices can be useful for formation of microscale tissue-
like constructs such as spheroids.  Multicellular tumor spheroids, for example, have been 
widely used in 3-D culture methods for solid tumor model.  Tumor spheroids exhibit a 
characteristic in vivo-like morphology and cellular microenvironment that can be used to 
determine gene expression and biological behavior of cells.  A tumor spheroid is 
composed of proliferating, quiescent, and necrotic cells.  Cells located at the periphery of 
the spheroid are actively proliferating, whereas those located in the center are necrotic.  
These characteristics make tumor spheroids a useful tool for a variety of experimental 
studies on radiotherapy, chemotherapy, and photodynamic therapy. A microchip has been 
used to perform long-term culture (2 weeks) of HepG2 and MCF-7 spheroids and to 
evaluate viability and response to different concentrations of the cytotoxic agent sodium 
azide (Torisawa et al. 2007a). 
 
A straightforward method to control the formation of embryoid bodies (EBs) using 
microfluidic techniques has also been recently developed using static culture conditions.  
The device consists of two microchannels separated by a semi-porous membrane treated 
to be resistant to cell adhesion.  Mouse embryonic stem (ES) cells were introduced into 
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the upper channel where they self-aggregate to form uniformly-sized EBs.  The size of 
EBs is regulated by adjusting the cross-sectional size of the microchannels.  The semi-
porous membrane allows subsequent treatment of the non-attached EBs with different 
reagents without the need for EB wash out.  This method is compatible with on-chip EB 
culture, differentiation, and manipulation opening the way for more comprehensive ES 
cell processing on a chip (Torisawa et al. 2007b). 
 
2.2.2 Use of microfluidic devices with active fluid flow to engineer the chemical 
microenvironment   
Active fluid flow and recirculation gives rise to many physiologic chemical phenomena, 
including but not limited to generation of longer range biochemical gradients, formation 
of spatial and temporal heterogeneity, autocrine/paracrine/endocrine effects and 
metabolic interactions between different cells and tissues.  Fluid flow also enables use of 
microfluidic phenomena such as patterned laminar flows not possible in static systems.  
Examples of studies made possible by microfluidic devices with active fluid flow are 
showcased in Figure 2.3.  
 
2.2.2.1 Cell culture with flow    
Cell types vary in their need or tolerance for static or dynamic flow environments. For 
example, Hickman et al. demonstrated that static culture of embryos developing from the 
two-cell to the blastocyst stage produced higher numbers of blastocysts and morulas 
compared to a dynamic flow culture condition at two different flow rates (0.1 and 0.5 
microl/h) (Hickman et al. 2002). Static culture conditions also had lower number of 
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abnormal and eight cell embryos compared to constant flow.  Thus, in this case, static 
culture was better for embryo development compared to dynamic flow conditions.  Allen 
et al. were able to create an in vitro model of liver zonation with three sinusoidal zones 
by forming oxygen gradients along the length of the bioreactor by perfusion (Allan et al. 
2003, 2005).  Here, the oxygen concentration decreased along the length of the channel 
because the oxygen uptake by hepatocytes depleted oxygen in the downstream regions. 
Primary rat hepatocytes and their co-cultures with non-parenchymal fibroblasts showed 
regionally heterogeneous expression of CYP2B and CYP3A proteins in a manner that 
mimics their distribution in the zonated liver in vivo, thus demonstrating the importance 
of perfusion in creating in vitro models of liver physiology.  In another study using 
HFF11 HeLa cells, the signal transduction resulting in the expression of the reporter 
protein Photinus luciferase was shown in microfluidic channels to have no unspecific 
activation which is caused by stress to cells, common in microtiter plate assays (Davidson 
et al. 2004).   
 
For some applications, a delicate balance of substantially static and dynamic environment 
needs to co-exist.  Taylor et al. created microdevices with two larger microfluidic 
compartments that are separated by a physical barrier of very small micron-sized 
grooves. Neurites, but not the cell body can extend from one microfluidic compartment 
across the small grooves into the adjacent microfluidic compartment.  The authors plated 
primary rat E18 cortical neurons into the somal (cell body) compartment, and after 3-4 
days, neurites had extended into the neuritic compartment.  When combined with surface 
micropatterning, neuronal attachment and orientation of neurite outgrowth could be 
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further regulated.  The system opens many opportunities for engineering the neuronal 
microenvironments (Taylor et al. 2003).  For example, the same authors demonstrated the 
ability to perform localized physical or chemical treatment of just the axons or soma 
independently (Taylor et al. 2005). 
 
Whereas many dynamic microfluidic cell culture systems are flow through devices, some 
physiological applications require fluid recirculation.  The Shuler group has developed a 
cell culture analogue reactor (CCA) for culture of mammalian cells together with a 
corresponding physiologic pharmacokinetic model (PBPK) to study drug toxicology.  
The devices have a liver compartment (containing rat H4IIE hepatoma cells), a lung 
compartment (with rat lung L2 cells), and other tissue compartments interconnected to 
each other with fluid recirculating among the compartments with physiologic residence 
times.  The systems have been used, for example, to test the toxicity of naphthalene 
(Ghanem and Shuler 2000a, 2000b) and the bioaccumulation of naphthalene in 
adipocytes (Viravaidya et al. 2002).  They have also used a four chamber CCA device 
(with compartments for lung, liver, fat and other tissue) to screen drugs for colon cancer 
(Viravaidya et al. 2004, Sung et al. 2006). 
 
A challenge for microfluidic recirculation systems where sub-microliter volumes of fluid 
are used is evaporation.  This problem is particularly problematic when using permeable 
polymeric microdevices such as PDMS.  Heo et al. characterized the evaporation-
mediated osmolality shifts of cell culture media through thin PDMS membranes in 
microfluidic devices (Heo et al. 2007). They also demonstrated that a PDMS-parylene-
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PDMS hybrid membrane can slow down evaporation and osmolality shifts for static 
culture of single-cell mouse embryos into blastocysts as well as dynamic culture of 
human endothelial cells with recirculation of submicroliter volumes of media.  
 
Microfluidic architecture can be used to enhance mass transport.  The Fujii lab fabricated 
microfluidic bioreactors by stacking 10 PDMS layers to create four cell culture chambers 
and one chamber for oxygen supply, then used the system to grow large number of 
HepG2 cells at high cell densities (Leclerc et al. 2004a).  Glucose consumption and 
albumin production measures showed that cellular activity gradual increased and 
eventually became saturated.  The authors also cultured rat liver cells within the 
microfluidic bioreactors for 15 day and demonstrated that albumin secretion and 
ammonia removal by these cells was increased by seven times compared to static culture 
(Ostrovidov et al. 2004).  In a more simple device, hepatocytes and 3T3-J2 fibroblasts 
were co-cultured in a microgrooved substrate (Park et al. 2005) where perfusion provided 
oxygen for stable liver-specific function and the grooves protected cells from shear stress 
due to the perfusion.   
 
Recently, a microfluidic device for stem-cell culture with both logarithmically varying 
perfusion rates and concentration gradients has been developed, making it possible to 
explore a wide range of biological perfusion conditions (including effect of shear) 
simultaneously for mouse embryonic stem cells (Kim et al. 2006).  Human Embryonic 
Stem (ES) cells have been co-cultured with a feeder layer of human foreskin fibroblasts 
in microfluidic channels and culture conditions have been established as a function of 
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flow rate (Korin et al. 2007).   
 
In other examples, cell arrays of multiple phenotypes (hepatocytes, fibroblasts, and 
embryonic stem cells,) have been fabricated by sequential delivery of fluids or cells into 
microwells on substrate using reversibly sealable PDMS molds (Khademhosseini et al. 
2005).  Astrocyte and glioblastoma cells have been cultured in PDMS microdevices 
modified with silane coupling agents to study cell adhesion and growth (Cox et al. 2002). 
An integrated microfluidic bioreactor with integrated indium-tin-oxide heater and 
miniature temperature probe and uniform media perfusion system has been developed to 







Figure 2.3: a) A Braille display-based microfluidic cell culture system. (Futai et al. 
2006b) b) Chemotaxis of neutrophils in opposing gradients of IL-8 (0–6 nM) and LTB4 
(0–5.3 nM). A selected frame from the time-lapse images of a representative experiment 




the “right” population polarized to the left (Lin et al. 2005). c) PARTCELL on bovine 
endothelial cells.  A) Area-selective delivery of fluorescently labeled, acetylated, low-
density lipoprotein (DiI Ac-LDL) to a portion of the cell surface. The green dotted line 
indicates the position of the interface between the flows, with and without DiI Ac-LDL. 
B) Intracellular transport of cell-surface glycoproteins labeled with wheat germ 
agglutinin (WGA) conjugated to green (Alexa 488-WGA) and red (TRITC-WGA) 
fluorescent markers. C) Cell after one hour of WGA treatment. (Takayama et al, 2003) 
 
2.2.2.2 Patterned microfluidic flows for spatio-temporal patterning of biochemicals  
The signal transduction in cells occurs through cytoskeleton and various scaffolding 
proteins and other subcellular components.  Such structural elements are not distributed 
randomly in cells, but are present heterogeneously throughout the cell with micron scale 
spatial variations.  The structural order of these components is necessary for the 
propagation and processing of cellular signals.  Taking inspiration from in vivo 
microenvironments where molecular and spatial discrimination can be at the micrometer 
scale, patterned microfluidic flows have been used to perform localized cell and tissue 
stimulation with spatial precision that allows even subcellular biochemical delivery. 
‘Partial treatment of cells using laminar flows’, or PARTCELL uses multiple laminar 
streams in a microfluidic channels to deliver molecules to selected subcellular 
microdomains on the surface or inside single mammalian cells in the case of cell 
permeable molecules.  The low Reynolds number flows in these microfluidic channels 
ensure that there is no turbulent mixing of chemicals between the adjacent laminar 
streams, although diffusive mixing still occurs.  
 
Using this technique, rapidly diffusing, membrane-permeable molecules are directed to 
subcellular regions of a single cell.  Two subcellular processes of mitochondrial 
movement and changes in cytoskeletal structure of bovine capillary endothelial cells were 
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studied by using PARTCELL.  Localization of molecules is achieved by a combination of 
rapid influx and efflux of molecules in distinct regions of the cell, created by using 
multiple laminar streams, and the process is simple and requires no special equipment 
(Takayama et al. 1999, 2001a, 2003). 
  
Using the PARTCELL approach, the Miyawaki lab took a closer look at the epidermal 
growth factor receptor (EGFR) signaling in single live COS cells (a monkey cell line) to 
find if the activation of signaling is localized or propagated over the entire cell. The 
EGFR signaling pathway is one of the most important pathways that regulate growth, 
survival, proliferation, and differentiation in mammalian cells.  The receptor is often 
upregulated in tumor cells and the difference in EGF signaling between normal and 
malignant cells is of great biological and medical interest.  Through the combined use of 
microfluidic subcellular EGF delivery and real-time visualization of intracellular 
signaling based of fluorescent protein reporters, cells were shown to exhibit localized 
activation of receptor phosphorylation and Ras activation or ligand-independent lateral 
propagation of signals depending on the cell surface receptor density and receptor 
internalization.  The results provide unique insights on intracellular events in ways that 
would be very difficult to obtain without use of microfluidics (Sawano et al. 2002). 
 
Using a similar microfluidic approach, embryonic patterning of Drosophila with warm 
(27 oC) and cool (17 oC) media under time specific conditions, showed that anterior and 
posterior halves of the embryo which are exposed to different temperatures, develop at 
different rates (Lucchetta et al. 2005).  In another related use of microfluidics, 
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Tourovskaia et al. performed localized delivery of agrin to myotubes formed inside 
microchannels (Tourovskaia et al. 2005) to induce localized acetylcholine receptor 
clustering in the stimulated portions of the myotubes (Tourovskaia et al. 2006a, 2006b).   
 
Using a different microfluidic approach, Piston’s group developed a microfluidic 
bioreactor capable of partially stimulating islet beta cells to create glucose gradients 
across the islet and observed cellular NAD(P)H and [Ca2+]i responses (Rocheleau et al. 
2004). They demonstrated that extent of Ca2+ propagation across the islet depends on a 
delicate interaction between the degree of metabolic coupling and the extent of ATP-
sensitive K+-channel activation. 
 
2.2.2.3 Biochemical gradients 
The two common methods for using perfused microfluidic systems to create chemical 
gradients are: i) use of patterned laminar flows, where adjacent streams contain different 
concentrations of the chemical of interest, to create chemical gradient in a direction 
lateral to the direction of fluid flow; and ii) use of the ability of cells to secrete and 
consume biochemicals in their vicinity combined with slow perfusion to create gradients 
in a direction parallel to the direction of fluid flow.  
 
A useful category of devices to create lateral gradients of biochemicals is the branched 
network microchannels (Jeon et al. 2002; Lin et al 2004).  Homogenous and 
heterogeneous (hill gradient, cliff gradient) linear gradient, have been generated and used 
to study chemotaxis of human neutrophils towards IL-8 (Jeon et al. 2002).  The 
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chemotaxis behavior of these cells was quantified and important observations regarding 
migration of neutrophils with respect to different profile IL-8 gradients were made.  
 
A microfluidic stem-cell culture platform with a concentration gradient has been used to 
study the effect of growth-factor concentration on human neuronal-stem-cell behavior.  
The observed proliferation rate in the device was proportional to growth-factor 
concentration, whereas differentiation (to astrocytes) was inversely proportional.  In these 
studies, flow in the device minimized autocrine and paracrine signaling (Chung et al. 
2005).  The same group also quantified migration of the MDA-MB-231 human metastatic 
breast cancer cells in various conditions by simultaneously generating multiple growth 
factor (EGF and anti-EGFR) gradients in the microfluidic chemotaxis chamber (Saadi et 
al. 2006).  Microfluidic gradient generator was also utilized to differentiate between 
neutrophil chemotactic response to equal host-derived conflicting gradients of 
chemotactic factors IL-8 and LTB4 (Lin et al., 2005). Chemotaxis of human T cells in 
response to single and competing gradients (spatial and temporal) of chemokine CCL19 
and CXCL12 was studied in ‘Y’ shaped microfluidic bioreactor (Lin and Butcher 2006).  
Concentration gradients over few hundred microns were generated by combination of 
controlled fluid distribution at each intersection of a microfluidic network (due to liquid 
pressure) and subsequent diffusion between streams in the microchannel (Yang et al. 
2002).  
 
Chemical gradients have been created in microfluidic devices by using arrays of 
externally connected, horizontally oriented tubes compatible with commercialized 
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multichannel pipettors.  This Horizontally-Oriented Mini-Reservoirs pumping scheme or 
HOMR pump provides a steady pulse-free flow by keeping a constant hydraulic pressure 
drop across a microchannel; thus the pump overcomes the problem of decreasing flow 
rate typical for gravity driven pumps.  The HOMR pump does not require any external 
power connection, is compact in size, and was compatible with generation of multiple 
laminar streams (up to 8 in this example) of alternating liquids, smooth gradients of 
various concentration profiles, as well as a step gradient of biochemicals which can be 
used for microfluidic drug assays (Zhu et al. 2004).  
 
Apart from generation of lateral chemical gradients, microfluidic systems with slow 
perfusion can take advantage of cellular consumption or production of biochemicals to 
generate gradients along the length of a channel.  For example, changes in oxygen 
concentration have been detected in a continuously perfused PDMS microfluidic 
bioreactor for cell culture (Park et al. 2006, Szita et al. 2005, Zanzotto et al. 2004).  Steep 
oxygen gradients caused by uptake by cells have been observed along the length of a 
mammalian cell culture channel in continuously perfused microfluidic bioreactors (Allen 
and Bhatia 2003, Allen et al. 2005, Mehta et al. 2007). 
 
The area of microfluidic gradient generation is a very active and fruitful area.  
Considering that in vivo microenvironments have more complex gradients such as pulsed 
gradients, exponential gradients or other non-linear gradients (Katz and Lasek, 1980) of 
multiple factors simultaneously, one can expect many more enhancements and 
innovations in this area. 
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2.2.2.4 Paracrine effects 
Active perfusion allows control of directionality in terms of intracellular chemical 
communications.  For example, interactions between macrophages and osteoblasts were 
studied while the cells remained physically separated in different parts of a microfluidic 
bioreactor. The cytokines released upstream by macrophages (IL-1 and TNF-), 
flowed through the device in linear gradients and induce downstream osteoblasts to 
secrete prostaglandin E2 (PGE2) (Wei et al. 2006). 
 
2.2.2.5 Perfusion culture of three-dimensional cell aggregates 
Spherical cell aggregates of hepatocyte spheroids retain the 3-D architecture and cell-cell 
contacts required for maintenance of many liver-specific functions (N Koide et al. 1990).  
Spheroids are generated when their cellular adhesion sites to a substrate are blocked, 
thereby forcing the cells to adhere to each other.  Recently, microscale technologies have 
been applied to spheroid culture for development of alternative tools for cellular biology. 
Co-culture spheroid arrays have been developed using micropatterning techniques (H 
Otsuka et al. 2004, Fukuda et al. 2006).  Hepatocytes spheroids co-cultured with 
endothelial cells or fibroblasts maintain their liver-specific functions for at least one 
month.  Such 3-D cell cultures have been combined with microfluidic systems.  3-D 
culture inside PDMS microfluidic bioreactors (with uniform and non-uniform flow) was 
achieved by stacking two pieces of PDMS containing 3-D features. The culture of HepG2 
cells was demonstrated in this bioreactor and metrics of cell functionality (albumin 
production, glucose consumption) were evaluated (Leclerc et al. 2003).  Kojima et al. 
created agar microstructures with cell-culture holes to culture primary neonatal rat 
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cardiac myocytes and observed synchronized beating in them 90 min after they had made 
physical contact (Kojima et al. 2003). 
 
2.2.2.6 Microarrayed bioreactors  
A number of interesting microfluidic array systems have been developed, some of which 
are outlined below: 
  
A 10 x 10 microfluidic cell culture array for long term monitoring of HeLa cells was 
developed by Hung et al (Hung et al. 2005a, 2005b).  By continuous perfusion, it was 
possible to passage confluent cells within the microfluidic chambers, thereby creating a 
stable culture environment. 
 
A bioreactor array (8 x 8) with culture regions disjoint from flow channels to create low 
shear spaces for cells and convective flow for transport of fluids was made for continuous 
flow in multiplexed environment (Lee et al. 2006).  The device enabled uniform cell 
loading, low shear for cell culture units, and low pressure stresses on cultured cells for 
culture of HeLa, NIH 3T3 fibroblasts, primary bovine endothelial cells, HepG2 
hepatocytes, human SY5Y neuroblastoma cells. 
 
A 64 (8 x 8) array of microfluidic wells connected with two microfluidic perfusion 
networks  for culture medium and oxygen was fabricated to support micropatterned 
coculture of primary rat hepatocytes and 3T3-J2 fibroblasts (Kane et al. 2006).  The 
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hepatocytes cultures in the array were able to continuously generate albumin synthesis 
and urea production in a steady-state. 
Chueh et al. have recently reported fabrication of 8 x 12 criss-crossing microfluidic 
channel array by overlaying polyester and polycarbonate membranes over PDMS 
structures (Chueh et al. 2007).  
 
2.2.2.7 Use of microfluidic flow for creating layered structures 
Defined 3-D microsctructural multilayered arrangements of live cells have been created 
by photopatterning of 3-D hydrogel (Liu and Bhatia 2002) to culture different cell types.  
3-D layers of extracellular matrix biopolymers (collagen, chitosan, fibronectin) have been 
micropatterned on PDMS substrates for culture of human umbilical vascular endothelial 
cells (HUVECs) and fibroblasts (Tan and Desai 2003).  Microfluidic layer-by-layer 3-D 
biomimetic structures were also created using collagen, chitosan, matrigel, and fibrin to 
culture human lung fibroblasts (IMR-90), human umbilical vein smooth muscle cells 
(HUVSMC), human umbilical vein endothelial cells (HUVECs) for 5 days (Tan and 
Desai 2004). 
 
Microfluidic channels were utilized to create polyelectrolyte multilayers of 
poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonic acid) (PSS) on PDMS 
substrate in order to culture neuron-like cells (NLCs) derived from pluripotent embryonal 
carcinoma P19cells (Forry et al. 2006). Additionally, primary murine bone marrow 
stromal cells were grown on nanocomposite coatings deposited onto PDMS using layer-
by-layer assembly in microfluidic bioreactors (Mehta et al. in revision).  The cells 
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attached, spread, and proliferated well on the nanocomposite coatings whereas the cells 
detached, rounded, and died on native PDMS even when coated with cell adhesive 
proteins. 
 
2.2.2.8 Long term culture 
Using microfluidic bioreactors, long term culture of cells can be easily carried out in 
controlled environments for many physiological functional assays which take place over 
time in range of few weeks.  For example, differentiation of alveolar epithelial cells takes 
two weeks to complete (Huh et al. 2004; Huh et al. in revision) and finding the frequency 
of long term culture initiating hematopoeitic cells takes over 3 weeks to complete (Bock 
1997).  Long-term culture combined with imaging of cells has always been one of the 
important goals of microfluidic cell culture labs.  Although still somewhat low resolution 
in terms of cell imaging, a recently developed microfluidic recirculation system with 
built-in transparent heater when used with customized media allowed time lapse imaging 
of proliferation of C2C12 myoblasts and MC3T3-E1 osteoblasts for over 2 weeks in 
ambient atmosphere without medium exchange (Futai et al. 2006a). 
 
2.2.3 Use of microfluidic devices with active fluid flow to engineer the fluid 
mechanical microenvironment 
 
The most well known and important example of the influence of fluid mechanical forces 
in physiology is that of endothelial cells. Vascular endothelial cells are located at the 
innermost layer of the blood vessel wall and are always exposed to three different 
mechanical forces: shear stress due to blood flow, hydrostatic pressure due to blood 
pressure and cyclic stretch due to vessel deformation. It is well known that endothelial 
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cells respond to these mechanical forces and change their shapes, cytoskeletal structures 
and functions. After applying fluid shear stress, cultured endothelial cells show marked 
elongation and orientation in the flow direction. In addition, thick stress fibers of actin 
filaments appear and align along the cell long axis. Thus, endothelial cell morphology is 
closely related to the cytoskeletal structure. (Sato and Ohashi 2005) 
 
When endothelial cells are exposed to hydrostatic pressure, they exhibited a marked 
elongation and orientation in a random direction, together with development of centrally 
located, thick stress fibers. Pressured endothelial cells also exhibited a multilayered 
structure with less expression of VE-cadherin unlike under control conditions. 
Simultaneous loading of hydrostatic pressure and shear stress inhibited endothelial cell 
multilayering and induced elongation and orientation of endothelial cells with well-
developed VE-cadherin in a monolayer. 
 
Wall shear stress also regulates adaptive vessel growth and angiogenesis, and might be a 
local risk factor in the pathogenesis of atherosclerosis. Shear stress also modulates the 
production of vasoactive substances such as endothelium-derived relaxing factor, 
prostacyclin, histamine and endothelin, and regulates macromolecule permeability and 
endocytosis. More recent studies have shown that shear stress exerts an influence on the 




Additionally, different flow patterns elicit distinct responses of Kruppel-like factor-2 
(KLF2) in endothelial cells (ECs) in vitro and in vivo. The pulsatile flow with a 
significant forward direction induces sustained expression of KLF2 in cultured ECs, but 
oscillatory flow with little forward direction causes prolonged suppression after a 
transient induction. The KLF2 protein levels ECs at arterial branch points are related to 
local hemodynamics (Wang et al. 2006). 
 
2.2.3.1 Two phase flows 
Gas-liquid two-phase flow configurations have been used to study alveolar epithelial 
cells and also for microfluidic flow cytometer (Huh et al. 2003).  To expose pulmonary 
epithelial cells to various fluid flows, Huh et al. developed a compartmentalized 
microfluidic bioreactor that mimics in vivo microenvironment with different flows under 
normal and pathological pulmonary conditions (Huh et al. 2004; Huh et al. in revision).  
 
2.2.3.2 Shear stress in microfluidic bioreactors  
Exposure of cultured endothelial cells to controlled levels of shear stress is possible in 
microfluidic culture systems using computer controlled pulsatile fluid flows, as 
represented in Figure 2.4.  The high-velocity flows created by these microfluidic 
bioreactors generated shear stress levels capable of fluid mechanical regulation of 
vascular endothelial cells (Song et al. 2005). 
 
A variable height flow cell has been developed to create an increasing stronger laminar 
shear stress along a flow path.  Flow rates of 5-105 ml/min created a wide range of shear 
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stress to study adhesion characteristics of neuroblastoma X glioma cells, NG108-15, on 
different self assembled monolayers of organosilicates (Schneider et al. 2001). 
 
By culture of endothelial cells in microfluidic channels of different widths and subjecting 
them to steady state shear stress levels, shape and function effects were quantified (Gray 
et al. 2002). Narrow channels had more elongated bovine aortic endothelial cells, 
however if channel width was 200 µm or larger, the elongation was similar to that in 
plastic dishes. 
 
Culture of osteoblasts requires shear stress for enhanced differentiation and expression of 
alkaline phosphatase and osteocalcin. The ALP expression has been shown to increase 
three times (even with no flow, due to a 3D environment) and 7.5 times (with low flow, 
due to simulating shear stress and 3D environment) in a bioreactor made of 3D network 
of microstructures, compared to a conventional dish culture (Leclerc et al. 2006).  
 
Shear stress has also been shown to induce embryonic stem cell differentiation.  F1k-1-
positive mouse ES cells subjected to shear stress selectively differentiated into vascular 
endothelial cell.  The shear stressed F1k-1-positive ES cells formed tube-like structures 
and developed an extensive tubular networks significantly faster than the static controls 
(2005 Yamamoto et al. 2005).  
 
By creating a microfluidic bioreactor with channels whose width narrows uniformly, just 
as in vivo microcirculation, release of ATP from erythrocytes was found to be 
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proportional to channel cross sectional area (Price et al. 2006). While Weinberg et al. 
developed three-dimensional microfluidic constructs for tissue engineering which have 
uniform wall shear stress throughout the network (Weinberg et al. 2004).  
 
Hang et al. used microfluidic devices to quantify cell adhesion as a function of shear 
stress by manipulating the geometry and surface chemistry (Lu et al. 2004).  The 
adhesion of fibroblasts to fibronectin-coated substrates was evaluated as a function of 
shear stress or fibronectin concentration in channels.  They also confirmed that the 
fibroblasts cultured in the perfusion-shear device reduced their adhesion strength to the 
substrate in response to epidermal growth factor stimulation. 
 
Griffith’s group has presented a bioreactor that enables morphogenesis of 3-D tissue 
structures under continuous perfusion (Power et al. 2002a).  Three-dimensional scaffolds 
were created by deep reactive ion etching of silicon wafers to create an array of channels 
(through hole) with cell-adhesive walls. Scaffolds were combined with a cell-retaining 
filter and support across the top of the array and through the 3D tissue mass in each 
channel.   Reactor dimensions were constructed so that media flow rates meet estimated 
value of cellular oxygen demands while providing fluid shear stress at or below a 
physiological range (<2 dyne cm2).  Primary rat hepatocytes seeded in the bioreactor 
rearranged to form tissue like structures reminiscent of liver cords.  The aggregates 
formed bile canaliculi and tight junctions and maintained viability at least 2 weeks 
(Power et al. 2002b). 
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The embryonic flow-structure interactions influence whether development will proceed 
normally or become pathogenic. Genetic, pharmacological, or surgical manipulations that 
alter the flow environment can thus profoundly influence morphologic and functional 
cardiovascular phenotypes (Hove 2006). 
 
To get a better understanding of fluid dynamics in microchannels, a three-dimensional 
numerical flow-model incorporating mass transport has been recently developed to 
compute substrate concentrations and shear stresses in the fluid environment of the 
microfluidic bioreactors (Zeng et al. 2006). 
 
 
Figure 2.4:  Study of effects of shear stress on microvascular endothelial cells inside 
a continuously perfused microfluidic bioreactor (Song et al. 2005). Time lapse images 
of ECs comparing changes in their elongation and alignment in response to varying levels 
of shear stress. 
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2.2.3.3 Squeezing cells through microchannels 
Microchannels have also been used to observe healthy and malaria (Plasmodium 
falciparum) infected red blood cells (Shelby et al. 2003). The normal erythrocytes were 
very elastic and passed through channels of varying widths (2-8 m) and squeezed 
through blockages readily, while the infected cells in different stages of the disease could 
not do so.  
 
2.2.3.4 Osmotic Loading 
Chao et al. developed a microfluidic device to apply hydrostatic pressure-driven dynamic 
osmotic loading to observe dynamic changes in cell sizes of cultured bovine articular 
chondrocytes (Chao et al. 2005).  The cells showed a trend of increasing changes in cell 
size with decreasing loading frequency (for a given osmotic loading magnitude), with 
significant differences from isotonic control at 0.0125 Hz. 
 
2.3 Other Useful Capabilities of Microfluidic Cell Culture Devices 
2.3.1 Efficient manipulation of precious cells or cells available in only small numbers  
Some of cell types are so precious and rare or hard to isolate --for example, primary cells 
like neurons, hematopoeitic stem cells, and human embryos for clinical treatment-- that 
any study or handling involving them has to be done with great care. Moreover, the 
biochemical responses of such a small population of cells in culture are difficult to 
observe because of the dilution effects in the large pool of media surrounding them. 
Biological studies with such small number of precious cells would greatly benefit from 
the use of microfluidic culture systems integrated with microanalysis capabilities where 
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even miniscule quantities of secreted and soluble products can be assayed with accuracy. 
One example of rare cell culture is shown in Figure 2.5, where murine embryos are 
grown in a microfluidic device for in vitro fertilization. 
 
Stem cell biology in microfluidic bioreactors has focused on two key aspects of 
differentiation and self renewal of the cells. Recently, attempt has been made to expose 
primary human neural precursor cells in a parallel manner to various ECM signals and 
perform a quantitative, multi-parameter analysis of cellular responses.  The ECM arrays 
of signals provided to cells were composed of mixtures of extracellular matrix 
components, morphogens, and other signaling proteins. The signals affecting 
developmental decisions on the differentiation of these precursor cells were quantified. 
Wnt and Notch co-stimulation maintained the cells in an undifferentiated-like, 
proliferative state, whereas bone morphogenetic protein 4 induced an 'indeterminate' 
differentiation phenotype characterized by simultaneous expression of glial and neuronal 
markers (Soen et al. 2006).  
 
ES cell differentiation is often initiated by generation of embryoid bodies (EBs), which 
are three-dimensional cell aggregate formed by culturing ES cells on a non-adherent 
substrate (Desbaillets et al. 2000). EB differentiation has been shown to recapitulate 
many aspects of early embryogenesis, resulting in the generation of a wide variety of cell 
type within EBs (Choi et al. 2005). Regulating the size of EBs is crucial for controlling 
the differentiation of ES cells.  Recently, several approaches, including 
microtechnological approaches, have developed to control EB size. There have been 
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reports of regulating EB size by using microwells to produce ES colonies of defined size 
and then forming EBs from those colonies (Khademhosseini et al. 2006, Mohr et al. 
2006). Uniformly-sized EBs were formed in microfluidic device with semi-porous 
membrane between two microchannels. This method is compatible with on-chip EB 
culture and differentiation, opening the way for more comprehensive ES cell processing 
on a chip (Torisawa et al. 2007b). 
 
Figure 2.5: A PDMS/borosilicate device for embryo culture: a) side view, and b) 
schematic cross-section of the PDMS/borosilicate device. The basic structure of the 
device is a PDMS bottom covered with a borosilicate slide that forms the top of the 





2.3.2 Integrated assays   
Rather than monitoring only simple phenotypic changes, integrated microfluidic 
bioreactors can gather precise biochemical and mechanistic data from cells and tissues, as 
in shown in Figure 2.6, in which secretion of a soluble factor by living cells is 
continuously monitored over time. The rationales for integration of sensing and analysis 
in the microdevice include greater accuracy and reproducibility, smaller sample sizes, 
and higher throughput (Park et al. 2003). 
 
Controlled perturbations followed by monitoring cellular responses can provide insight 
into cellular pathways that govern phenotype and behavior. Thus, a fundamental study of 
biochemical pathways, cell-fate decisions and tissue morphogenesis is underway in 
microfluidic bioreactors. These “integrated microfluidic bioreactors” are capable of fast 
and reproducible measurements with as little as femtomolar sample concentrations and 
nanoliter volumes. Combining these aspects with the integration of sample preparation 
and separation steps on the same microfluidic bioreactor has resulted in these systems 
finding considerable commercial applications in the fields of genomics and proteomics 
(Clayton 2005). 
 
Immunoassays can be readily analyzed by absorption techniques and fluorescent markers. 
Quantitative protein analysis and detection can be performed with antibody capture in 
microdevices as they have high selectivity and affinity of antibody–antigen binding to 
achieve specificity in analysis. Enzyme-linked immunosorbent assays (ELISA) that 
amplify the signal from each labeled molecule are now routinely used to detect analytes 
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with high sensitivity in microfluidic bioreactors (Weigl and Bardell 2004, Rossier and 
Girault 2001, Roberts and Durst 1995, Diamandis 1996, Hatch et al. 2001, Bernard et al. 
2001, Schweitzer et al. 2000, 2002, Carroll et al. 2003, Hayes et al. 2001, Roos and 
Skinner 2003, von Heeren et al. 1996, Koutny et al. 1996, German and Kennedy 2000, 
Chiem and Harrison 1997, Jiang et al. 2003). 
 
Microfluidic bioreactors that can continuously monitor insulin secretion from islets of 
Langerhans with four integrated electrophoresis-based immunoassay channels have been 
recently developed. The detection limit of the bioassay was 10 nM insulin and insulin 
release was evaluated every 6.25 s from four islets. (Dishinger and Kennedy 2007).  A 
microfluidic bioreactor with an on-line electrophoresis immunoassay and continuous 
perfusion was developed by same group to monitor insulin levels in live islet culture.  
The detection limit of the assay was 0.8 nM and it allowed quantitative monitoring of 
classical biphasic and oscillatory insulin secretion with 6 s sampling frequency following 
step changes in glucose from 3 to 11 mM (Shackman et al. 2005).  Electrophoretic 
separation of anti-insulin antibody (Ab), fluorescein isothiocyanate-labeled insulin 
(FITC-insulin), and insulin from different reservoirs was also carried out in a 
microfluidic bioreactor. The detection limits for insulin were 3 nM and assays could be 
collected at 15-s intervals with continuous sampling (Roper et al. 2003).  
 
In a glass microdevice with integrated cell culture, chemical and enzymatic reactions, and 
detection capabilities, nitric oxide released from macrophage-like cells stimulated by 
lipopolysaccharide was successfully monitored. The micro-immunoassay was much 
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faster (assay time 4 h compared to 24 h), detection limit of NO was improved (from 
1x10-6 to 7x10-8 M) and the system was also able to monitor a time course of the release 
(Goto et al. 2005).  Moreover, microfluidic bioreactors with an integrated assay modality 
was able to test potency of different concentrations of 5-Fluorouracil (in gradients) as a 
cancer drug against live stomach cancer cells (Fujii et al. 2006). 
 
Real-time characterization of gene expression in living hepatocytes in a device has been 
carried out by King et al. (King et al. 2007).  High density matrixes of stimulus-response 
experiments were performed with help of microvalve arrays (control row-seeding and 
column-stimulation) in 256 nanoliter-scale bioreactors to obtain quantitative live cell 
imaging of fluorescent protein transcriptional reporters. Weider et al. fabricated a 
microfluidic device to monitor GFP-based gene expression in a high-throughput manner, 
and found that transcription factor NF-kappa B response of live reporter cells on 
stimulation TNF-alpha shows the same fluorescence kinetics as observed in standard 
tissue culture (Weider et al. 2005).  In another report of on-chip immunoassay, Matsubara 
et al. fabricated a microfluidic device for on-chip detection of allergic response of rat 
basophilic leukemia cell line RBL-2H3 to antigen stimulus by fluorescence (Matsubara et 
al. 2004). 
 
Impedance sensors which monitor morphological changes and motility of adherent cells 
(Giaever and Keese 1993) and pH sensors which evaluate functional responses of cells 
upon receptor stimulation by measuring the extracellular H+ have also been developed in 
microfluidic  bioreactors (Park and Shuler 2003). There are also various reports of 
 47
measuring oxygen concentrations inside microfluidic devices using optical as well as 
polarographic measurements (Benninger et al. 2005; Chang-Yen et al. 2003; Mitrovski et 
al. 2005; Park et al. 2006; Sin et al. 2004; Szita et al. 2005; Vollmer et al. 2005). A 
PDMS bioreactor coupled with pH and glucose sensors has also been developed to 
characterize culture of fibroblast cell line, CHO cells, hepatocytes and hybridoma cell 
lines (Prokop et al. 2004).  
 
Figure 2.6: Integration of cell culture and analysis in a single microfluidic 
bioreactor.  (Dishinger and Kennedy 2007). a) Channel layout of a microfluidic device 
for monitoring insulin secretion from four islets of Langerhans. b) Averaged detected 
insulin secretion from four islets on a single chip. 
 
2.3.3 Three-dimensional culture 
There are many cells where 3-D culture would be more physiological compared to 
attachment on a 2-D surface.  There are many accounts of microfluidic cell culture with 
defined three dimensional cellular matrices (Liu et al. 2002, Leclerc et al. 2003, Kojima 
et al. 2003, Power et al. 2002).  Some examples are discussed below.  
a) b)
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2.3.3.1 Cells in hydrogels inside microfluidic devices  
Cells have been cultured in hydrogels inside the microfluidic devices.  For example, 
macrophages and 3T3 fibroblasts were encapsulated in poly(ethylene glycol)(PEG) 
hydrogel microstructures created by photolithographic polymerization inside PDMS 
microdevices (Koh and Pishko 2006).  HepG2 cells immobilized in channels by 
hydrodynamic focusing of biocompatible self-assembling peptide hydrogel have been 
cultured with linear concentration gradients by injecting different reagents on the sides of 
the scaffold (Kim et al. 2007).  Primary rat hepatocytes were immobilized in situ in a 
localized matrix of methylated collagen and a HEMA-MMA-MAA in a microfluidic 
bioreactor (Toh et al. 2005).  Cells have also been grown in 3-D layers of extracellular 
matrix biopolymers (collagen, chitosan, fibronectin, matrigel, and fibrin) which were 
micropatterned in PDMS devices (Tan and Desai 2003, 2004).  Anticancer drug 
sensitivity test was performed using PDMS microfluidic devices in which collagen gel-
embedded cells were entrapped.  The proliferation rate of collagen gel-embedded cells 
was close to that in vivo and their drug sensitivity was less than that of 2-D cells, 
suggesting that the 3-D culture conditions provide a more in vivo-like environment 
(Torisawa et al. 2005).  
 
2.3.3.2 Cells in gel channels 
Microfluidic devices were even made by molding gelatin to produce microchannels for 
culture of adherent epithelial cells (Paguirigan and Beebe 2006).  Microfluidic 
bioreactors have also been fabricated from biocompatible photopolymerized 
poly(ethylene) glycol diacrylate (PEGDA) (Butterworth et al., 2004).  Recently, Leclerc 
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et al. used a photosensitive biodegradable polymer (pCLLA acrylate) to create single and 
multistep microstructures, as well as microstructure with simple fluidic channels. These 
microstructures are able to support culture of mammalian cells to grow and spread on it.  
With Hep G2 cells, human umbilical blood vessel endothelial cells (HUVEC), 3T3-L1 
mouse fibroblasts (Leclerc et al. 2004b). 
 
2.4 Microfluidic Devices Useful for Cell Applications Other than Culture 
Microfluidic devices are useful for more than cell culture.  Devices have been used in cell 
sorting, for example, in separations of non-motile and motile cells such as sperm. (Cho et 
al. 2003), in separation of the contents of single cells (McClain et al. 2003), separations 
coupled to mass spectroscopy (Vilkner et al. 2004), high-throughput screening in drug 
development (Lion et al. 2003, Andersson and van den Berg 2003), bioanalyses (Sia and 
Whitesides 2003), and examination and manipulation of samples consisting of a single 
cell (Verpoorte 2002) or a single molecule (Helmke and Minerick 2006, Stavis et al. 
2005).  
 
Microfluidic devices have been used to isolate small numbers of target cells (or even 
single cells) from a large population of cells on the basis of physical and chemical 
properties such as electrical characteristics, chromatography or fluorescent markers 
(Brehm-Stecher and Johnson 2004, Becker et al. 1995, Hu et al. 2005, Huang et al. 2002, 
Fu et al. 2002, Chang et al. 2005, Revzin et al. 2005). A comprehensive review of recent 
developments in microfabricated flow cytometers and related microfluidic devices that 
can detect, analyze, and sort cells or particles is provided by Huh et al. (Huh et al. 2005). 
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2.5 Future Prospects for Biological Studies in Microfluidic Bioreactors 
One of the useful applications of microfluidics is the culture of cells under engineered 
physiologic conditions. In microfluidic bioreactors, well-defined physiologically-relevant 
chemical and fluid mechanical microenvironments can be created for answering 
fundamental questions in cell biology. These in vitro microenvironments can be powerful 
tools for studying disease mechanisms, testing drug safety and efficacy, engineering 
microscale tissues, and developing cell-based biosensors. In these systems, one can 
systematically perturb cell culture conditions for specific experiments, test many different 
conditions on the same or different cells or even different parts of the same cell. On-chip 
integration of quantitative analysis and sensing greatly expands the biological 
applications of these devices. 
 
Just as the electronic industry has integrated more and more components onto smaller and 
smaller an area, the trend in the bioMEMS community is to integrate more and more 
types of cells and analysis capabilities on a chip, with a possible eventual establishment 
of an animal-on-a-chip or a human-on-a-chip. Having all tissues growing in one single 
device could be a great boon to drug screening and clinical research. However, in order to 
achieve an organotypic culture of such complexity, we must first be able to engineer the 
microenvironment of each cell type with high quality and precision in terms of 
recapitulating physiologic conditions. This type of research requires in depth knowledge 
of not only microfluidic engineering and materials science but also the underlying 
biology.  Collaborations between bioengineers and biologists or clinicians need to be 
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further enhanced to unleash the true potential of microfluidics for the study of cell 
biology and application to the clinic.  
 
2.6 In Vivo Bone Marrow Biology 
Bone marrow is the primary niche of HSCs in adult mammals. The features of an HSC 
niche include: a small number of HSCs surrounded by supporting cells, low oxygen 
tension, close proximity of HSCs to sinusoidal endothelial cells as well as to osteoblasts 
on the endosteum, and adhesive and soluble signals between HSCs and surrounding cells. 
Osteoblasts and other stromal supporting cells (including endothelial cells, 
megakaryocytes, adipocytes, and fibroblasts) play a central role in hematopoiesis, and 
produce many factors essential for the survival, renewal and maturation of hematopoeitic 
stem cells (Scadden 2006).  Some of the features of in vivo bone marrow are represented 
in Figure 2.7, where a single HSC (stained in red) is in close contact with numerous 
supporting cells (in green and yellow), and sits very close to a sinusoidal blood vessel.  
These key features can be recreated in microfluidic bioreactors, as shown in Figure 2.2; 
however, conventional culture does not recapitulate these important features (as seen in 
upper panel of Figure 2.2). 
 
The in vivo HSC niche is composed of an intricate blend of extracellular matrix proteins, 
soluble protein factors, immobilized protein factors, proteoglycans, small molecule 
signals, mineralized tissue, and numerous adjacent cell types, which vary in space and 
time. Thus, these components present the HSCs with biochemical signals, and the HSCs 
are continually faced with the sensing these inputs, processing the signals through signal 
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transduction and gene regulation networks, and executing cell behavioral or fate choices 
(Adams & Scadden 2006; Jang & Schaffer 2006; Shim et al. 2003). As depicted in Figure 
1.1, two of the most important niche components are the oxygen tension, niche substrate 
and 3-D architecture. We focus on these three parameters in this thesis. 
 
 
Figure 2.7: In normal bone marrow, HSCs (CD150+CD48−CD41−Lineage−) represent 
0.0067% ± 0.0016% of cells in tissue sections shown here. Some of the HSCs are closely 
associated with endosteum, and most of them contact sinusoidal endothelium (C, arrow). 
A large megakaryocyte is also seen associated with the sinusoid (C, arrowhead). These 
images each represent a single optical section (Kiel et al. 2005). 
 
Hematopoeitic stem cells (HSCs) are defined as cells that retain the capacities for both 
self-renewal and multilineage differentiation, and can give rise to all blood cell types (see 
Figure 2.8). In adult mouse BM, CD34low/–c-Kit+Sca-1+Lin– (CD34–KSL) cells, which 
constitute 0.004% of BM cells, represent HSCs with long-term repopulating (LTR) 
ability, whereas CD34+KSL cells are progenitors with short-term repopulating capacity 
(Kiel et al. 2005a; Kiel et al. 2005b). In normal bone marrow, 0.0067% ± 0.0016% of 
cells in sections are CD150+CD48−CD41−Lineage− (or pure HSCs). Some of these cells 
are closely associated with endosteum, sinusoidal endothelium and megakaryocytes. 
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Understanding the molecular mechanisms underlying these cell–cell interactions 
(mediated by cell-surface or secreted molecules) holds the key for HSC biology and is of 
biological and clinical interest.   
Figure 2.8: General model of hematopoiesis and hematopoietic stem cell lineages 
 
HSCs can renew themselves, differentiate into all types of blood cells, mobilize out of 
bone marrow and undergo apoptosis. The bone marrow is the classic source of HSCs, 
along with fetal liver, umbilical cord, aorta-gonad-mesopherous region and peripheral 
blood.  About 1 in every 100,000 cells in the marrow is a long-term, blood-forming stem 
cell; other cells present include stromal cells, stromal stem cells, blood progenitor cells, 
and mature and maturing white and red blood cells (as seen in Figure 2.9).  Long-term 
replicating HSCs renew themselves throughout the lifespan of the organism; therefore, 
they are very important for developing HSC-based cell therapies. Unfortunately, to date, 
researchers cannot distinguish with 100% accuracy the long-term from the short-term 
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Figure 2.9: Hematopoietic and Stromal Stem Cell Differentiation (www.nih.gov) 
cells when they are removed from the bloodstream or bone marrow. A small number of 
stem and progenitor cells circulate in the bloodstream. HSCs that have been mobilized 
into peripheral circulation are mostly non-dividing cells. HSCs taken from tissues at 
earlier developmental stages have a greater ability to self-replicate, show different 
homing and surface characteristics, and are less likely to be rejected by the immune 
system (nih.gov). 
HSCs live in intimate connection with the stroma of bone marrow in adults. Adhesion 
molecules in the stroma play a role in mobilization, attachment to the stroma, and in 
transmitting signals that regulate HSC self-renewal and progenitor differentiation. 















2.6.1 Bone Marrow Stromal Cells (BMSCs) 
In bone marrow, hematopoiesis occurs in close contact with the stromal 
microenvironment; the bone marrow stromal cells support hematopoietic stem cell 
growth and differentiation. As shown in Figure 2.10, the bone marrow stroma is 
composed of a variety of different cell types that provide structural and functional 
support for hematopoiesis. Stromal cells, in addition to providing the physical 
environment in which HSCs differentiate, generate cartilage, bone, and fat. They support 
hematopoiesis; differentiate towards osteogenic, chondrogenic and adipogenic lineages; 
and form a bone structure complete of hematopoietic marrow.  
 
Bone marrow stromal cells (BMSCs) are isolated from the iliac crest bone marrow 
aspirates in humans or femurs and tibias in mice. A bone marrow sample provides a low 
frequency of BMSCs derived from mesoderm tissue. For gene therapies, BMSCs must be 
able to provide long-term proliferation. Cell therapy of bone lesions by ex vivo expanded 
osteogenic progenitor been developed to repair bone via local delivery of cells within a 
scaffold. The possibility of using mesenchymal progenitors in the therapy of genetic bone 
diseases via systemic infusion is very appealing. Experimental evidence suggests that 
mesenchymal progenitors delivered by this route engraft with very low efficiency and 
does not produce relevant and durable clinical effects.  
 
Although BMSC multi-lineage differentiation potential is supported by substantial 
experimental evidence, a better understanding of the mechanisms controlling their 
differentiation is required to exploit them for therapy of human diseases.  Furthermore, a 
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deeper understanding of their engraftment mechanisms will extend the field of 
therapeutic applications of mesenchymal progenitors. The BMSC interactions with HSCs 
that induce HSC commitment, differentiation, and proliferation need to be exploited to 
treat numerous autoimmune diseases. 
 
Figure 2.10: BMSC differentiation into various cell types (www.nih.gov) 
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2.6.2 HSC-BMSC Cell-Cell interaction in stem cell niche 
Regulation of HSC fate involves multiple highly orchestrated pathways that determine 
the cell cycle status, and gene expression profile. HSCs do not grow as independent 
autonomous units; instead, they are completely surrounded by the marrow micro-
environment, which is defined by cell-cell interactions, cell-ECM interactions, and 
exposure to variable concentrations and combinations of soluble factors including 
cytokines. The bone marrow microenvironment is comprised of stromal cells, a diverse 
population consisting of fibroblasts, smooth muscle cells, endothelial cells and others. 
These cells not only provide a scaffold to the developing stem cells and progenitor cells, 
but also produce transmembrane ligands, extracellular matrix components, and soluble 
proteins. HSCs are exposed in situ to many different growth factors, some soluble, some 
bound to ECM, and some bound to adjacent cells, some of which are outlined in Figure 
2.11.  Frequent cell-cell signaling occur when HSCs are in cell-cell contact with stromal 
cells, committed hematopoietic progenitor cells, and other HSCs. ECM of bone marrow 
acts in concert with cell-cell interactions and soluble factors to regulate the HSC. 
Adhesion of hematopoietic stem and progenitor cells to the marrow ECM inhibits cellular 
proliferation and prevents apoptosis, both of which leads to long term survival of 
quiescent hematopoietic stem cells.  Numerous molecules within the HSC membranes 
mediate signals from the ECM including integrins, immunoglobulin-like molecules, 
cadherins, selectins, and mucins (Morrison et al. 2008; Taichman 2005; Taichman et al. 





Figure 2.11: A Model of Secreted and Cell-Associated Factors Produced by 
Osteoblasts that Influence HSC. Stem cell fate is influenced by specialized 
microenvironments that remain poorly defined. Osteoblast production of soluble 
hematopoietic-supportive secreted and cell-associated factors work in concert so that 
hematopoietic stem cells derive regulatory information from bone, accounting for the 
localization of hematopoiesis in bone marrow. Abbreviations; alkaline phosphatase (Alk 
P04), bone morphogenic factors (BMPs), byglycan (BG), collagen type I (ColI), 
fibroblast growth factors (FGFs), Flt ligand (FL), fibronectin (FN), fibromodulin (FM), 
granulocyte colony stimulating factor (G-CSF), granulocyte macrophage colony 
stimulating factor (GM-CSF), hepatocyte Growth Factor (HGF), heparin sulfate 
protyoglycan (HS), insulin like growth factors (IGFs),interferon (IFN),interleukin (IL), 
leukemia inhibitory factor (LIF), macrophage colony stimulating factor (M-CSF), 
macrophage inhibitory factor (MIP), monocyte chemotactic protein (MCP)-1/JE (JE), 
matrix Gla protein (MGP), oncostatin-M (ONC-M), osteocalcin (OC), osteonectin (ON), 
osteopontin (OP) osteoprotogerin (OPG), platelet derived growth factor (PDGF), platelet 
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factor 4 (PF4), receptor activator of NF-kappaB ligand (RANKL), tyrosine kinase 
receptors (RTK), serine/threonine kinase receptors (RSTK), regulated on activation, 
normal T-cell expressed and secreted (RANTES), stromal derived factor -1 (SDF-1), 
transforming growth factor (TGF), thrombospondin (TP), tumor necrosis factor (TNF). 
(Taichman 2005) 
 
HSCs are clinically useful for leukemia and lymphoma (such as acute lymphoblastic 
leukemia, acute myeloblastic leukemia, chronic myelogenous leukemia, Hodgkin's 
disease, multiple myeloma, and non-Hodgkin's lymphoma), inherited blood disorders 
(such as aplastic anemia, beta-thalassemia, Blackfan-Diamond syndrome, globoid cell 
leukodystrophy, sickle-cell anemia, severe combined immunodeficiency, X-linked 
lymphoproliferative syndrome, and Wiskott-Aldrich syndrome. Inborn errors of 
metabolism that are treated with bone marrow transplants include: Hunter's syndrome, 
Hurler's syndrome, Lesch Nyhan syndrome, and osteopetrosis), and as rescue in cancer 
chemotherapy as rapidly dividing marrow cells are often target of such treatments in 
addition to the cancer cells. Additionally HSCs are used in other diseases, primarily 
autoimmune diseases, such as diabetes, rheumatoid arthritis, and system lupus 
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CONTROL OF OXYGEN 
LEVELS IN MICROFLUIDIC 
POLY(DIMETHYLSILOXANE) 






To study cells under simulated physiological microenvironments ex vivo (e.g. three-
dimensional cell cultures and development of so-called “animals-on-a-chip”) (Park et al. 
2003), it is necessary to develop tools to enable quantitative real-time control of 
microenvironment  of cell culture in microbioreactors. This approach requires three main 
components:  (i) the ability to actuate the spatio-temporal distribution of nutrients, 
growth factors, and adhesive signals in the cellular microenvironments, (ii) the ability to 
sense/measure nutrients, metabolites, growth factors, cytokines, and other cell-secreted 
products, and (iii) the ability to quantitatively model the relationship between various 
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design and operating parameters to enable control and operation of the bioreactor. Our 
previous studies with development of highly versatile computerized microfluidic 
bioreactor arrays (Gu et al. 2004) are hence still incomplete in that they lack integration 
of chemical sensors and quantitative understanding of the bioreactions involved through 
modeling. This paper specifically addresses these issues for a crucial cell substrate, 
oxygen, by developing an optics-based method to quantify dissolved oxygen in PDMS 
microbioreactors and by applying a quantitative mathematical model to explain how key 
parameters control the spatial distribution of oxygen inside them.  
 
Oxygen is a very important nutrient for cell culture, and its lower solubility in culture 
media (less than 7 mg/L at 37 oC) makes it imperative that it is constantly monitored and 
supplied (Fleischaker et al. 1981).   One of the reasons PDMS microbioreactors are 
advantageous for cell-based studies is due to high diffusivity (D= 4.1 X 10-5 cm2/sec) 
(Charati et al. 1998) and solubility (0.18 cm3 (STP)/cm3 atm) (Merkel et al. 2000) of 
oxygen in PDMS  compared to other polymers and materials used for bioreactor and 
microfluidic device fabrication. Because of these properties of PDMS, passive 
permeation of oxygen through PDMS is generally assumed to be sufficient for supplying 
necessary amounts of oxygen for insect and mammalian cell cultures, which do not have 
very high oxygen uptake rates, and investigators do not typically quantify actual in-
channel oxygen concentrations during microfluidic cell culture (Leclerc et al. 2006; 
Leclerc et al. 2003; Leclerc et al. 2004; Walker et al. 2002). Even within the range of 
oxygen concentrations sufficient for cell survival, the concentration of oxygen has a 
profound influence on cell signaling, growth factor production, growth, and 
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differentiation (Muschler et al. 2004). Different types of cells require different oxygen 
concentrations for optimal physiological function. Human embryonic stem cells benefit 
from low oxygen concentration (below 5%) in order to maintain their pluripotency, and 
transient changes in oxygen levels can change gene transcription and affect fate of stem 
cells in culture conditions (Ezashi et al. 2005). Hematopoeitic stem cells (HSC) self-
renew and maintain pluripotency better at lower oxygen tension (lower than 5% in vitro), 
and at higher oxygen levels in vitro, HSCs differentiate, and undergo apoptosis (Csete 
2005). Hence, there is considerable interest in the design of poly(dimethylsiloxane) 
(PDMS) microbioreactors conducive for culture of different types of cells, particularly 
cells requiring low oxygen tension.   
 
There are various reports of measuring oxygen concentrations inside microfluidic devices 
using optical as well as polarographic measurements (Benninger et al. 2005; Chang-Yen 
et al. 2003; Mitrovski et al. 2005; Park et al. 2006; Sin et al. 2004; Szita et al. 2005; 
Vollmer et al. 2005). Typically, electrode or fluorescence-based sensors are used to 
monitor dissolved oxygen content in cell cultures (Andreescu et al. 2004; Deshpande and 
Heinzle 2004; Gerritsen et al. 1997a; Helmlinger et al. 2000; Hwang et al. 2004; John et 
al. 2003; Malda et al. 2004; Sud et al. 2006b; Sweet et al. 2002; Tolosa et al. 2002; 
Urayama et al. 2003; Zhong et al. 2003). Polarographic oxygen sensors based on Clark 
electrodes have been widely used for monitoring oxygen in cell cultures. However, they 
suffer from disadvantages including: consumption of oxygen; long-term instability; 
sterilization problems; sensor drift; difficulty of adaptation to continuous monitoring, 
automation, and high-throughput measurement; flow dependence; and susceptibility to 
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electrical interferences (Andreescu et al. 2004; Malda et al. 2004; Sweet et al. 2002). 
Most of these drawbacks are overcome by using optical oxygen sensors based on 
quenching of fluorescence by oxygen (Deshpande et al. 2004; Hwang et al. 2004; John et 
al. 2003; Tolosa et al. 2002). Fluorescence is attenuated in the presence of oxygen in a 
linearly dependent manner. Optical sensing is performed either through steady-state 
intensity based or lifetime based methods (Gerritsen et al. 1997a; Gerritsen et al. 1997b; 
Sud et al. 2006b; Urayama et al. 2003; Zhong et al. 2003). 
 
Previous efforts on modeling oxygen transport in microchannels have shown that the 
spatial distribution of oxygen concentration is a function of operating velocities and the 
channel geometry and significant gradients in oxygen concentrations can exist in the 
bioreactor especially at low flow rates (Mehta et al. 2006; Roy et al. 2001). Theoretical 
studies of transport of oxygen have shown the possibility of axial concentration gradients 
in PDMS devices without any cells (Vollmer et al. 2005). Application of such 
mathematical models to real devices, however, requires validation with actual 
measurements. Some experimental studies have detected changes in oxygen 
concentration in a continuously perfused PDMS microbioreactor for cell culture (Park et 
al. 2006; Szita et al. 2005). While steep gradients (greater than 50% change in oxygen 
tension within 1 cm along the length of the bioreactor) have been observed in bacterial 
cultures in PDMS microbioreactors (Park et al. 2006; Szita et al. 2005; Zanzotto et al. 
2004), no studies have reported such steep gradients in oxygen concentrations for 
mammalian cell culture in continuously perfused PDMS microbioreactors. Yet such steep 
gradients could clearly facilitate the function of those mammalian cells that need low 
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oxygen tension, as in the studies of tissue zonation in perfused sinusoids due to oxygen 
gradients. When cells are cultured in a non-gas-permeable microbioreactor, it is well 
known that uptake by cells can reduce oxygen levels, leading to the formation of 
gradients of oxygen concentration along the length of the cell culture channel (Allen et al. 
2003; Allen et al. 2005).  Native PDMS is highly oxygen permeable, but the permeability 
is subject to change when proteins are adsorbed on it or when the surface is modified by 
plasma oxidation as is common in construction of microbioreactors (Shiku et al. 2006). 
Shiku et al. (Shiku et al. 2006) demonstrated that the mass-transfer coefficient of oxygen 
through PDMS is reduced 1000-fold after a 5 minute plasma oxidation, and reduced by 5 
times after 20 minute incubation with bovine serum albumin.  Furthermore, the use of 
parylene C coating in the PDMS devices can add additional diffusive resistance to the 
oxygen transfer from the ambient air owing to the lowered permeability of the composite 
layer. Thus, it is crucial to confirm theoretical models with experimental measures for 
each type of device where the plasma oxidation conditions, protein coating methods, and 
other culture device fabrication and preparation methods vary, even when the devices are 
all made of “PDMS”. Indeed, oxygen gradients in PDMS microbioreactors may be 
significantly steeper than expected if the oxygen permeability of device material is low. 
 
Here, we quantitatively measure extracellular oxygen concentration in the microfluidic 
channels inside PDMS bioreactors containing living cells by using fluorescence intensity 
and lifetime studies. Fluorescence lifetime imaging microscopy (FLIM) bases image 
contrast on lifetime variations, which reflect local biochemistry but are oblivious of 
intensity based artifacts such as scattering, photobleaching and concentration variation of 
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fluorophore. Calibration of ruthenium tris(2,2’-dipyridyl) dichloride hexahydrate (RTDP) 
lifetime on a wide-field, time domain FLIM system was employed to calculate dissolved 
oxygen concentrations via fluorescence intensity studies (Sud et al. 2006a; Sud et al. 
2006b; Urayama et al. 2003; Zhong et al. 2003). Optical sensors for oxygen estimation 
are beneficial since they are suited for small volumes, are minimally perturbing, and do 
not consume oxygen during the measurement. This technique may be used for time-lapse 
studies (hours or days) without disturbing the set-up, and for imaging of spatial oxygen 
distributions.   
 
Using a mathematical model we have previously shown that the concentration of soluble 
nutrients can be manipulated by controlling operating conditions and by using channels 
of appropriate geometry (Mehta & Linderman 2006).  We utilize this mathematical 
model that describes oxygen diffusion, convection, and uptake by cells within the device 
to draw comparisons between the model and the experimental results, and to determine 
the contribution of oxygen flux through PDMS to overall oxygen delivery to cells.  
 
In this work, we show that by manipulating the operating variables, e.g. media flow rates, 
one can effectively achieve the desired oxygen tensions inside the bioreactor.   We also 
see that the relative supply of oxygen via diffusion through PDMS can also be altered 
using the media flow, as per the model predictions. Additionally, we show that oxygen 
diffusion through PDMS is not always sufficient to avoid oxygen concentration gradients 
along the length of the bioreactor even in culture of mammalian cells that have much 
lower oxygen uptake rates compared to bacterial cells. The validation of the model 
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predictions also enables its use in controlling the oxygen levels inside the reactor.  This 
combined capability to experimentally measure in-channel oxygen concentration gradient 
and to fit device-specific parameters to mathematical models ultimately propels us 
towards our goal of producing well-defined and controlled oxygen tensions inside PDMS 
microbioreactors. 
 
3.2 Materials and Methods 
 
3.2.1 Cell Culture  
C2C12 cells (mouse myoblasts, ATCC, CRL-1772) were cultured in a media comprising 
Dulbecco’s Modified Eagle’s Medium (DMEM, 11960, Gibco), 15% Fetal bovine serum 
(FBS, 10082, Gibco), 1%v/v antibiotic–antimicotic (15240, Gibco) and 1%v/v 
GlutaMAX2-I Supplement (35050, Gibco). The 100 mm2 culture dishes were placed in a 
humidified 5% CO2 cell culture incubator. At 70-80 % confluence, the cells were 
passaged by washing in PBS, and incubating with 0.25% Trypsin/EDTA (Invitrogen, 
Carlsbad, CA). The Trypsin solution was neutralized with 15% FBS in DMEM and spun 
down with a centrifuge (ThermoForma, Marietta, OH) for 2 minutes at  25 oC and 1000 
RPM. The supernatant was removed and the pellet was resuspended in DMEM media. 
The pellet was reconstituted in 4 ml of DMEM media, and 1 ml of this suspension was 
used for creating a new plate of C2C12. The cells were passaged every third day.  When 
the cells were to be cultured in the PDMS microbioreactor, the pellet was reconstituted in 
70-100 μL of DMEM media and then injected into the seeding ports of the chip. 
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Figure 3.1: Microfluidic device design and set up.  A) The top layer of the microfluidic 
device is a reservoir layer, connected to the channel layer with punched holes (pink holes 
in channel layer connected to the reservoir layer with a dashed blue line). A “horizontal” 
pump (yellow pins) drives cell culture media from top left to bottom right, all other 
channels are valved closed (blue pins are raised to close channels by deformation), and 
rest of the pins are in valve open position (white pins are down). The cells are attached in 
a part of the X-shaped channel region, between top left and bottom right. B) Optical 
photomicrograph of a complete device with green food dye to showcase channel design, 
placed with a quarter for scale, C) Top view of channel layer showing the positions of the 
pin driven pumps and valves when the device is used for continuous perfusion 
experiments. The flow direction (black arrows), areas of cell growth (green with green 
arrows), and, upstream and downstream positions (blue rectangles) where images were 
taken are shown in the figure. The flow in some of the channels is stopped by valves 
(grey with dark black borders), while flow is allowed in the desired channels by use of 
pumps (grey with no border).   
 
3.2.2 Preparation of the microfluidic bioreactor chip 
The chip consisted of three components: reservoir top layer, channel middle layer and 
membrane bottom layer, as seen in Figure 3.1A. The chips were formed from pre-
polymer (Sylgard 184, Dow Corning) at a ratio of 1:10 base to curing agent. The top 
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layer contained fluid reservoirs and was cured overnight at 60 oC. The middle layer was 
formed using a glass wafer mold (soft lithography) (Duffy et al. 1998) to form a layer 
with negative relief channel features ~30 μm in height and 300 μm in width. The positive 
relief features of the mold were composed of SU-8 (Microchem, Newton, MA) formed 
on a thin glass slide (200 μm thick) using backside diffused-light photolithography (Futai 
et al. 2006). The glass slide was silanized with tridecafluoro-(1,1,2,2-tetrahydrooctyl)-1-
trichlorosilane (United Chemical Technologies Inc., Bristol, PA). The middle layer was 
also cured overnight at 60 oC and holes were punched (Dermal biopsy puncher, Miltex 
Inc., York, PA) in the channel and reservoir layer to connect channel features to the 
culture media reservoir. The thickness of PDMS above the channel feature was 6±2 mm. 
The bottom layer was a thin sandwich of PDMS (100 μm)-parylene C (2.5 μm)-PDMS 
(100 μm) prepared by spin coating (Cee 100 Spin Coater, Brewer Science Inc., Rolla, 
MO) PDMS and vapor deposition of parylene C (PDS 2010 labcoater; Specialty Coating 
Systems) and curing PDMS at each step in an oven at 60 oC overnight (Heo et al. 2006). 
The hybrid membrane was oxidized in oxygen plasma (SPI Supplies, West Chester, PA) 
for 30 seconds thereby making the PDMS surfaces hydrophilic. The layers were sealed 
irreversibly, the flat surfaces were pressed together, and the entire chip was placed in an 
oven at 60 oC for 5-10 minutes.  The oxygen permeability (a crucial transport property 
which incorporates diffusivity and solubility) of parylene C is 3.24 X 10-10 (cm3 (STP) 
cm)/(cm2 sec atm)  (Yeh et al. 1990), while that of PDMS is 6.0800 ± 0.1519 X 10-6 (cm3 
(STP)  cm)/(cm2 sec  atm) (Merkel et al. 2000). The bottom hybrid membrane hence, has 
lower oxygen permeability due to the parylene layer, despite being much thinner (~8 mm 
PDMS vs 0.2 mm PDMS plus 0.0025 mm parylene) than the upper all-PDMS layer. Such 
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low diffusivity and solubility of the parylene layer hence ensures that there is minimal 
diffusion of oxygen from the bottom layer of the device. 
 
Fibronectin (100 mg/μl, F2006, Sigma) was injected (30-gauge hypodermic needles) in 
the cell culture channels to maintain the hydrophilic nature of the channels and to 
promote cell attachment (see Figure H1). This absorption was carried out for 30 minutes, 
following which DI water was introduced. The chips were then sterilized by placing 
under UV light for ~30 minutes. After sterilization, water was replaced with DMEM 
media in the reservoir, and the chip was placed on an array of pin actuators adapted from 
Braille displays for at least one hour to peristaltically pump fluid through the channels 
(Futai et al. 2006; Heo et al. 2006; Song et al. 2005). C2C12 cells were then seeded into 
the chip. We were able to manipulate the cells to attach only in the area of the bioreactor 
in between the upstream and downstream channel regions by use of valves (pin actuators 
pushing up and deforming channels closed) during cell seeding (see Figure H2). The cells 
were given 1-2 hours to attach under no flow (pins up and channels valved closed) 
condition in a dry heat incubator (Forma 310 Series Direct Heat CO2 Incubator, Thermo 
electron Corporation, Marietta, OH) maintained at 37 oC and 5% CO2. Pumping was 
started after cells became adherent and the chip was perfused for 12-14 hours. 0.2 ml of 
the oxygen sensitive dye, ruthenium tris(2,2’-dipyridyl) dichloride hexahydrate (RTDP) 
(93307, Fluka) (5 mg/ml in DPBS (14190250, Invitrogen); final concentration is 1 mg/ml 
because of dilution) was then introduced into the reservoir of the chip, and pumping was 
continued for three more hours. The setup comprised of a microfluidic chip attached to 
the pin actuator array module was then taken to the microscope and intensity or lifetime 
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measurements performed at room temperature.  Cell densities in the cell culture channels 
in the microbioreactor chips were determined by counting the number of cells present in 
10 microscope brightfield images taken at different positions along the length of the cell 
culture channel.  
 
3.2.3 Fluid Actuation  
An array of 48 pin actuators adapted from a Braille display module (SC9, KGS, Saitama, 
Japan) was used for fluid actuation (Futai et al. 2006). The pin actuator module was 
controlled with a computer via Universal Serial Bus (USB) through a finger-sized stand 
alone custom controller circuit board (Olimex, Plovdiv, Bulgaria) (Futai et al. 2006; Heo 
et al. 2006). The microfluidic bioreactor chip interfaces with the pin actuator module by 
simply holding the chip in place such that the channels align with the pins which push 
upward closing the channel, as seen in Figure 3.1 A and C.  
 
The pin movements for valving and pumping were controlled with a custom computer 
program written in C #.  The software program provides effective control of the Braille 
hardware setup and is flexible, enabling one to define new behaviors of pumping, 
blocking or opening channel paths, and controlling timing and flow rates for short and 
long-term automated control of microfluidic devices. This software can run on PCs and 
control specific custom Braille hardware through a USB connection, and it acts as an 
interpreter enabling us to write complex sequences of actions in a shorthand text form. 
Multiple threads of execution within the program handle the exact timing and order of 
events within a main execution loop. The shorthand description form allows us to create 
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any number of pumps (3-4 Braille pins) and valves (1 Braille pin) on the 'grid' of braille 
pins (up to 16 columns and 4 rows for our setup, see Figure 3.1A). We specify the 
position for each of the pumps or valves (which will have a different effect on flow 
depending on the overlayed channel design), and in the case of pumps also their 
alignment (horizontal or vertical), direction of pumping flow (positive or negative), and 
relative speed. We also specify time intervals on an execution time axis for each of these 
objects, which allows us to describe more complex sequences of events, e.g. pump1 starts 
at 0s and stops at 30s, then valve2 closes from 30s to 50s, and pump3 and pump1 turn on 
from 31 to 40 seconds. Figure 3.1C shows the valves and pumps used for the continuous 
perfusion experiment. The software also has a user interface that allows starting, pausing, 
stopping, and even rewinding the execution of any loaded shorthand program of pumps 
and valves, and also has an independent speed control that allows running essentially the 
same program and sequence of actions but with different flow rates and faster or slower 
execution. 
 
The average flow rate was controlled by changing the time delay between pin motions. 
Fluid flow was characterized by tracking 6 μm diameter fluorescent beads (Carnine, 
polystyrene microspheres, Molecular Probes, Eugene, OR) using a digital CCD camera 
(Orca-ER, Hamamatsu Photonics, Japan) and a fluorescence stereomicroscope (Nikon 
SMZ1500). The image sequences were acquired at ~13 frames/sec to determine the 
velocity of the microspheres, which are representative of the fluid velocity, and were 
used to determine the average fluid flow rate. An entire pumping cycle was used to 
measure each flow rate in order to compensate for backflow during certain steps of a 
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pumping cycle. The average flow rates used for these experiments were in the range of 
0.0005 μl/sec to 0.22 μl/sec, and the flow rates were relatively linear with frequency. 
This was observed from the motion of polystyrene microspheres, and is outlined in Table 
3.1.   




Average Flow rate 
(x103 μl/sec) 
0.01 0.50 ± 0.02 
0.02 1.40 ± 0.40 
0.04 3.00 ± 1.00 
0.10 6.00 ± 2.00 
0.20 12.4 ± 4.00 
1.00 83.0 ± 23.0 
5.00 220 ± 30.0 
 
3.2.4 Intensity measurement 
We used a Nikon TS100-F inverted microscope with Epi-Fluorescence using a 10x CFI 
Achromat ADL Ph1 objective (n.a. 0.25, w.d. 6.20mm), TRITC HY-Q Filter Cube, and 
an X-CITE 120 PC Fluor illumination system to measure intensity of the RTDP dye in 
the microbioreactor. The pictures were recorded using the Coolsnap CF2 12 bit Firewire 
Monochrome Camera with MetaVue Software. Intensity measurements were taken at 
upstream and downstream locations of the perfused microbioreactor at different flow 
rates, and at different cell densities. The fluorescent images were taken at an exposure 
time of 0.6 seconds for each observation, and each area was sampled three times. In total, 
six data-sets were created by repeating the experiments at all flow rates. The relationship 
between fluorescence intensity (or lifetime) and dissolved oxygen concentration is 
described by the Stern–Volmer equation (Gerritsen et al. 1997b; Sud et al. 2006b; 
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Urayama et al. 2003; Zhong et al. 2003): Io/ I = 1 +  Kq[O2]  or τo/τ=1 +  Kq[O2] , where 
Io or τo = uninhibited sensor dye intensity or lifetime (i.e. 0% oxygen), I or τ = sensor dye 
intensity or lifetime at oxygen level [O2] and Kq is the Stern-Volmer quenching constant.  
 
For fluorescence lifetime studies, a time-domain FLIM system with a tunable, pulsed 
excitation source covering the UV-vis-NIR spectrum (337–960 nm) and an intensified, 
gated (min. 200 ps) CCD camera (Picostar, LaVision) to record images was used 
(Urayama et al. 2003). Lifetimes could be measured in the range of 750 ps - ∞ with a 
discrimination of 50 ps, and an axial resolution of 1.4 μm. RTDP fluorescence from 
microbioreactor compartments were collected at 600 nm via 460 nm excitation at gates of 
40, 140, 240, 340, and 440 ns, with the intensifier gate width set to 100 ns. A lifetime 
macro implementing the rapid lifetime determination (RLD) algorithm was used to 
generate lifetime images on a per pixel basis from gated intensity images (Urayama et al. 
2003; Zhong et al. 2003). Oxygen levels were ascertained by fitting the Stern-Volmer 
equation to calculated lifetimes. The data were analyzed statistically by ANOVA, 
Tukey’s test and Student’s t test at a 95 percent confidence level assuming unequal 
variances. 
 
3.2.5 Mathematical Modeling 
We adapted our previously published model of transport of soluble nutrient/growth 
factors inside a microchannel bioreactor for the current study (Mehta & Linderman 
2006). Briefly, partial differential equations were written to describe the spatial 
distribution of oxygen inside the bioreactor in the presence of the convective transport 
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associated with media flow, diffusive flux through PDMS, and cellular consumption and 
were solved using FEMLAB®. We used a steady state model with constant cell density, 
as the experimental time scales are small compared to the doubling times of cells. The 
model assumes uniformly distributed cell density along the bioreactor, which is 
reasonable as the cells are seeded using a suspension, and as visualized from microscope 
images.  We also assume that the cells are adherent to the channel walls and are 
preferentially located at the bottom floor of the channel. Further, the model assumes a 
laminar flow profile, Michaelis-Menten rate of uptake of oxygen by all cells, and a 
constant overall mass-transfer coefficient to describe the flux of oxygen through PDMS. 
We assume there is no flux of oxygen from the bottom because the thin bottom 
membrane contains a parylene film which has low diffusivity and permeability to oxygen 
relative to PDMS, as described in the preparation of the microfluidic bioreactor chip in 
the methods section and because we also placed a glass cover slide underneath this 
membrane in the cell observation region (flux from the top of the bioreactor is much 
more than that from bottom for modeling purposes).  A brief description of model 
equations, geometry and the associated variables is shown in Figure 3.2. 
 
Analysis of the model equations in dimensionless form gives us information on the three 
key dimensionless groups important in determining the concentration distribution of 
oxygen inside the bioreactor:  Pe/α = <u>H2/(DeL);  Da = VmaxφH/Decin;  Sh=klaH/De.  
The dimensionless group Pe signifies the Peclet number (Pe=<u>H/De), the ratio of 
convective transfer of species in the axial direction to the diffusive flux within the 
channel directed toward the lower end of the channel (i.e. toward the cell domain); α is 
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the geometric aspect ratio for the bioreactor, L/H.  The Damkohler number (Da) is a 
measure of relative rates of total cellular uptake and diffusive flux from the bulk media. 
The magnitude of diffusive flux from PDMS is governed by the value of the Sherwood 
number (Sh), defined as the ratio of the diffusive transfer rate through the PDMS top 
surface to the diffusion rate in the media.  
 
Key parameters of the model include the Michaelis-Menten uptake rate parameters (Vmax 
and Km) and the overall mass transfer coefficient (kla). For the current study, the these 
parameters were estimated from a single data set from our microbioreactor 
(corresponding to the cell density of 5.1x 108 cells/m2), with initial estimates based on 
physiologically relevant values, (Allen & Bhatia 2003) and then used to compare the 
model predictions with the remaining data.   Calculations were made for several values of 
kla for comparison with the experimental data.   
 
3.3 Results and Discussion 
3.3.1 Device Description 
Figure 3.1 A, B, and C show the design and set up of the microfluidic bioreactor chip and 
its alignment with the pin actuator module (Futai et al. 2006).  Three pin actuators act as 
a peristaltic pump pushing cell culture media through the microfluidic channels. The cells 
are seeded only in the area between the top left to bottom right of the X-shaped channel 
crossing region (shaded green in Figure 3.1 C). The bottom layer of the microfluidic 
bioreactor chip is a thin flexible membrane composed of PDMS and parylene C and has 
low oxygen permeability. During cell culture, the media is perfused (flow direction 
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shown with black arrows in Figure 3.2 C) from top left to bottom right of the 
microbioreactor chip by pin actuators acting as pumps (yellow pins shown in Figure 3.2 
A), while all other channels are valved-off (blue raised pins). Within the parameters of 
the current experiments, this microfluidic bioreactor is a flow-through, rather than a 
recirculating, perfusion system.  A part of the device (the X-shaped channel region) is 
viewable on an inverted microscope. 
 
Figure 3.2: Modeling oxygen transport in the microfluidic channel bioreactor. 
Assuming constant cell density and idealized rectangular geometry with cells 
preferentially located at the channel bottom, oxygen transport can be modeled using the 
partial differential equations shown. The boundary conditions in the y dimension are 
given by diffusive flux from PDMS at the top (y = 0) and by cellular uptake at bottom (y 
= H). The diffusive flux from PDMS can be estimated using an overall mass transfer 
coefficient kla based on the solubility and diffusivity of oxygen in PDMS, while the 
uptake of oxygen by the cells is modeled as Michaelis-Menten kinetics with parameters 
Vmax and Km. Refer to Mehta & Linderman (2006)8 for further details on solution 
techniques and parameters . co2 : oxygen concentration, u : velocity profile, De : effective 
diffusivity of oxygen in the media ( = 2.1 x10-9 m2/s), H : height of the microchannel ( 40 
µm), L : length of the microchannel ( 0.01 m), φ : cell density, and velocity profile u = 
6<u> (y/H- (y/H)2) where <u> is the average velocity. 
 
3.3.2 Local oxygen content measured by fluorescence intensity 
We used different concentrations of the RTDP (in PBS) ranging from 0.1 mg/ ml to 1.0 
mg/ml, and found that dye signal was best at 1.0 mg/ml for both intensity and lifetime-
based fluorescent imaging. Thereafter, 1.0 mg/ml of RTDP in culture media was used for 














































all cell experiments. RTDP quenching by oxygen is a collisional process described by the 
Stern-Volmer equation. We employed Kq =  2.7 X 10-3 μM-1 for our measurements,  as 
reported (Gerritsen et al. 1997b) and verified via FLIM (Sud et al. 2006b). 
 
Our negative control comprised of microfluidic chips containing only DMEM media and 
RTDP and no cells. We used the intensity and lifetime observed in this control device for 
calculating the intensity at zero oxygen content. We observed that the average intensity of 
RTDP over different flow rates at upstream and downstream positions was 327 ± 7 AU, 
while, the average RTDP lifetime over different flow rates at upstream and downstream 
positions was 307 ± 7 nanoseconds. This corresponds to 8.2 mg/l of dissolved oxygen in 
media in the microbioreactor in the absence of any cells, while the saturation dissolved 
oxygen content in an aqueous solution is 8.5 mg/l at 25 oC (Fleischaker & Sinskey 1981). 
Thus, intensity at no oxygen was calculated using the Stern-Volmer equation, and found 
to be 550 AU. The Stern-Volmer equation describes the relationship between (I/Io -1) and 
dissolved oxygen to be linear, as was seen in our calibration (data not shown). Thus, the 
intensity values obtained from the microbioreactor culture could be translated into local 



























0.22 μl/sec 0.083 μl/sec 0.0124 μl/sec 0.006 μl/sec
0.003 μl/sec 0.0014 μl/sec 0.0005 μl/sec Upstream
 
Figure 3.3: Upstream and downstream extracellular oxygen in the microbioreactor 
at different flow rates and cell densities. The horizontal line depicts the upstream 
oxygen content of 8.20 ± 0.20 mg/L. The downstream oxygen concentrations are shown 
as a function of six different cell densities (from 1.92 x 108 cells/m2 to 8.01 x 108 
cells/m2) at each at seven different flow rates, from fastest flow rate (0. 22 μl/sec) to 
slowest (0.0005 μl/sec).   
 
3.3.3 Observed oxygen gradients are a function of flow rate and cell density 
We measured oxygen concentration at the upstream and downstream regions of the cell 
culture channel (see Fig. 1C) in our perfused bioreactor culturing C2C12 cells and found 
gradients that depend on both cell density and flow rate. The distance between each 
observation point and cell culture region was essentially the same. The relationship 
between flow rate and oxygen content at six cell densities, ranging from 1.92 x 108 
cells/m2 to 8.01 x 108 cells/m2, is depicted in Figure 3.3. The figure shows the upstream 
and downstream oxygen content for all cell densities and at seven different flow rates, 
ranging from 0.0005 μl/sec to 0.22 μl/sec. 
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Upstream oxygen concentrations remained steady at 8.2 ± 0.2 mg/l (corresponding to an 
oxygen partial pressure of 154 mm Hg, 20.7 % oxygen in air, or 97 % saturation) for all 
flow rates. Downstream oxygen concentrations varied with cell density and flow rate.  
The lowest value of dissolved oxygen content observed was 1.76 mg/L, which 
corresponds to the lowest flow rate of 0.5 nL/sec and the highest cell density (8.01 x 108 
cells/m2) tested. In contrast, the downstream dissolved oxygen content observed at low 
cell densities and the highest flow rates was nearly identical to the upstream 
concentration.   
 
As shown in Figure 3.3 and for each cell density, as the flow rate decreased the difference 
between upstream and downstream dissolved oxygen content increased. The 
concentration of oxygen decreases down the cell culture channel axis because the cells 
present along the axis consume oxygen. At slower flow rates the amount of oxygen-laden 
media coming into the culture channel is smaller, leading to a steeper concentration 
gradient. We also observed that for a constant flow rate, increasing cell density inside the 
culture channel caused oxygen content to decrease measured at the downstream region 
(Figure 3.3).  
 
The downstream (see Figure 3.1C) oxygen levels at each flow rate (corresponding to a 
particular cell density) were statistically different from one another with a p value of less 
than 0.0001 (ANOVA). When comparing downstream oxygen tension data at each flow 
rate (at a particular cell density) with all other datasets using Tukey’s test, differences 
were found to be statistically significant (α=0.05) for all comparisons. The downstream 
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oxygen levels at each cell density (corresponding to a particular flow rate) were 
statistically different from one another with a p value of less than 0.0001 (ANOVA). 
When comparing downstream oxygen tension data at each cell density (at a particular 
flow rate) with all other datasets using Tukey’s test, differences were also found to be 
statistically significant at α=0.05. The oxygen concentration values observed at different 
flow rates as well as different cell densities were statistically significant (t-test, p<0.01) 
between the upstream and downstream regions (see Figure 3.1 C) of the cell culture 
channel. Comparison of the upstream oxygen tensions with those downstream for all cell 
densities and flow rates, using ANOVA gave p value of 0.024, which is statistically 
significant at α =0.05.  
 
The oxygen tensions observed here are similar to those seen by Allen and Bhatia (Allen 
& Bhatia 2003) with hepatocyte culture in a perfused polycarbonate microbioreactor. 
They observed oxygen partial pressure differences of 23 to 133 mm Hg (1.2 to 7.1 mg/l) 
between the inlet and outlet of when perfusing a 55 mm long polycarbonate 
microbioreactor at flow rate of 0.4 ml/min to 3.0 ml/min (inlet pressure: 158 mm Hg), 
suggesting that there are axial gradients (0-0.107 (mg/l) mm) of oxygen within their 
device.  
 
Oxygen gradients have been observed in physiological systems (Tsai et al. 2003). In 
microcirculation, there are radial and longitudinal gradients as oxygen exits through the 
vessel walls, which are related to the level of metabolic activity of the tissue. In vivo 
oxygen tensions range from 20 mm Hg to 100 mm Hg (1-8 mg/L in vessels of diameters 
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of 20-300 microns) in different parts of the tissues of animal models (Duling 1972; 
Pittman et al. 1975; Seiyama et al. 1996; Swain et al. 1989; Tsai et al. 2003). Thus, the 
downstream oxygen levels observed in our microbioreactor are comparable to 
physiological values for mammalian cells.  
 
We used a high concentration (1 mg/ml) of RTDP to get good fluorescence signals at low 
exposure times. However, there are some studies suggesting that RTDP might have 
cytotoxic as well as phototoxic effects on mammalian cells (Dobrucki 2001). For the 
scope of this study we confirmed that the presence of dye in the media contributed 
minimally (less than 10%) to cell death within the timeframe of the oxygen concentration 
measurement period (up to 5 hours after dye injection) and the photoexcitation and 
measurements were performed in regions on the microfluidic bioreactor where cells were 
not present to avoid phototoxic damage to cells. We did observe that when cells were 
incubated with RTDP over long periods of time (24 -72 hrs) their viability decreased with 
time. The actual rate of oxygen consumption without added RTDP may thus be higher 
than what we measured since any toxicity would most likely reduce respiration.  
 
The presence of a gradient is not necessarily indicative of insufficient oxygen transport to 
the cells.  But it is crucial to understand and characterize the gradients generated to be 
able to understand and regulate cellular responses in microfluidic bioreactors.  The ability 
to generate and regulate oxygen concentration gradients may actually be beneficial for 
recreating physiologic gradients as is observed, for example, in liver sinusoids (Tsai et al. 
2003).  We note that steep oxygen gradients of the type we describe (up to 79 % decrease 
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in oxygen tension within 1 cm along the length of the bioreactor) have not previously 
been demonstrated for mammalian cultures in continuously perfused PDMS 
microdevices. 
 
Our finding of a significant oxygen gradient may provide one plausible explanation for 
the gradient of cell proliferation previously observed in PDMS perfusion reactors (Futai 
et al. 2006; Gu et al. 2004). Specifically, they observed higher cell densities of cells at the 
inlet of the device relative to the regions near the exit, presumably in response to a 
nutrient concentration gradient along the length of the channel. The range of oxygen 
concentrations we observed is within a range where no adverse effects on viability or 
marked differences in differentiation patterns is expected for C2C12 cells, as under in 
vitro culture at low oxygen tensions (5 % oxygen or 2.0 mg/L) the C2C12 cells are at 
similar stages of differentiation (from myoblasts to myotubes) during the hypoxic and 
normoxic (21% oxygen) exposure periods (Yun et al. 2005). However, the C2C12 cells 
may have migrated upstream or otherwise functioned differently along the length of the 
perfusion channel (Gu et al. 2004) because the cells were exposed to a relatively steep 




Figure 3.4: a) Model predictions vs. Experimental data. The model predictions are 
compared with experimental data on the oxygen concentration at the outlet.  The oxygen 
concentration is non-dimensionalized using the inlet oxygen concentrations. The line y=x 
is shown as reference. The model was simulated based on the average values of cell 
density and operating flow rates as measured, with microbioreactor geometry parameters 
as described in Figure 3.2.  The parameters for uptake rates and mass transfer are: Vmax = 
2.06 e -16, mol/cell/s, Km = 0.005 mol/m3, and kla = 9e-7 m/s. b) Effect of diffusion of 
oxygen through PDMS on dimensionless outlet concentration, C.  The value of mass-
transfer coefficient kla was varied to understand the contribution of oxygen diffusion from 
PDMS when φ = 5.12e8 cells/m2. Solid line shows model prediction for kla = 9e-7 m/s. 
Experimental data for the same conditions (solid circles) are shown as reference. The 

































3.3.4 The experimental data are consistent with the mathematical model  
The observed trends in the experimental data are consistent with the results of our 
mathematical modeling. Figure 3.4A shows the comparison of model predictions and 
experimental data on downstream oxygen concentrations for media flow rates and cell 
densities tested. The agreement between model and experiment suggests that the model 
captures the essential transport processes occurring in the microfluidic bioreactor. 
Analysis of model equations shows that when velocity is decreased relative to diffusion 
(low Pe/α) and for higher rates of uptake of oxygen inside the microfluidic cell cultures 
(high Da), the outlet concentration of oxygen decreases.  
 
The model predicts generation of oxygen concentration gradient within PDMS channels. 
The relative magnitude of diffusion and convective transport are characterized by the 
overall mass-transfer coefficient and the media velocity in the model, and we use the 
model to investigate the relative contribution of diffusion through PDMS for various 
geometries and thicknesses of PDMS layers by varying the numerical value of the mass-
transfer coefficient kla. 
 
We observed the effect of changing the overall mass-transfer co-efficient on the outlet 
concentration of oxygen in the microbioreactor (Figure 3.4 B).   At low flow rates, higher 
values of kla (higher Sh) lead to higher values of the oxygen concentration at the outlet.  
At these low flow rates, oxygen delivery to cells via diffusion through PDMS is a 
significant source of oxygen.  It should be noted that at high flow rates, oxygen delivery 
occurs primarily via perfusion and is sufficient to eliminate axial gradients in the cell 
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culture channel, and hence the value of kla (Sh) does not affect the concentration of 
oxygen at outlet.  Our data is best fit by a kla = 9 x 10-7 m/s.  Our value of the mass-
transfer coefficient is lower than that mentioned by other researchers, (e.g ~ 10-4 m/s, 
Vollmer et al. 2005). The reduced oxygen permeability of our device is likely due to 
various coatings and pre-treatments, i.e. plasma oxidation and protein coating.  
 
Using the measured experimental data from oxygen concentration at the outlet, we can 
estimate the cellular uptake rates of oxygen. This opens up the possibility of using these 
microfluidic bioreactors for quantitative evaluation of cell properties. However, we note 
that for successful parameter inference we will require more experimental data to cover a 
wider range of oxygen concentrations. For example, we could not see a sensitivity of 
model predictions on the uptake parameter Km for the current experimental data, as most 
of the experiments were performed at concentrations of oxygen well above Km. 
Nevertheless, using similar experimental protocols, and careful experimentation coupled 
with the mathematical model, one could infer quantitative information on the cellular 
oxygen uptake rates for wide variety of cell types. 
 
3.3.5 Mathematical model and microfluidic PDMS bioreactor provide tools for 
spatio-temporal regulation of oxygen microenvironments  
The results presented here demonstrate that we can understand and predict oxygen 
gradients in a perfused PDMS microfluidic bioreactor as a function of media flow rate 
and cell density. Significant axial (along the length of the bioreactor) gradients in oxygen 
concentration can exist for lower flow rates (low Pe/α), even with significant diffusion of 
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oxygen through PDMS (high Sh). Axial concentration gradients also increase with 
increased cell density. These spatial gradients in oxygen concentrations could be a 
primary cause of spatial heterogeneity in cell density inside microfluidic bioreactors as 
observed in our previous experiments (Gu et al. 2004). Our modeling studies indicate that 
for a particular cell density the depletion in oxygen can be controlled by regulating flow 
velocity. Additionally, complementing perfusion with media recirculation would offer an 
additional means of lowering the concentration of oxygen inside the reactor to a desired 
level at all the stages of the cell culture. Modified channel geometries may also be used to 
engineer the concentration distribution of oxygen inside the reactor at desired levels 
(Mehta & Linderman 2006).  
 
The combined use of models together with experimental measurements and computerized 
fluid actuation enable powerful experimental systems in which cell responses to various 
oxygen gradients can be efficiently and systematically analyzed or an optimal oxygen 
environment can be dialed in for better cell function. When used at relatively slow flow 
rates and high cell density, this microbioreactor creates oxygen limited physiology 
(Duling 1972; Pittman & Duling 1975; Seiyama et al. 1996; Swain & Pittman 1989; Tsai 
et al. 2003), which is known to be beneficial for a variety of applications, including 
maintaining the pluripotency of embryonic stem cells (Ezashi et al. 2005) and inducing 
the growth of erythroid colonies from bone marrow progenitors (Van Merris et al. 2001). 
Our device is capable of generating such conditions in ambient atmosphere without need 
of hypoxic chambers by simply taking advantage of cell respiration and the small volume 
of media in microfluidic systems. It has also been observed that even transient changes in 
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oxygen levels can change gene transcription, thus affecting the fate of stem cells in 
culture conditions (Pfau et al. 2004).  Our system provides convenient dynamic control of 
the oxygen environment by computer programmed temporal changes in the perfusion 
rates.  Our experiments and analysis do indicate that manipulating the media flow rates is 
not always sufficient to achieve very low oxygen tensions inside the PDMS bioreactor. In 
order to obtain pathologic hypoxic conditions such as 0.01% oxygen (0.004 mg/l), 
alternative techniques would have to be used. We envision this biomedical microdevice 
to be useful in conducting key biological studies pertaining to the effect of physiologic 
oxygen microenvironments on cell behavior.  In addition to the ability to regulate oxygen 
microenvironments, this bioreactor reaps benefits of a typical PDMS device; including 
rapid prototyping, ease of fabrication, low cost, optical transparency, durability, 
disposability, and biological inertness.  
 
3.4 Conclusion 
 We developed a method to measure dissolved oxygen content in real time in microfluidic 
PDMS perfusion systems using fluorescence intensity and lifetime imaging.  Cell 
respiration created an axial oxygen gradient in the reactor along the length of a cell 
culture channel even though the device was mainly fabricated using highly gas-
permeable PDMS.  The downstream oxygen concentration decreased with increasing cell 
density and decreasing perfusion velocities.  The measurements agree with a 
mathematical model which describes the spatial distribution of oxygen along the length 
of a microfluidic cell culture channel inside the bioreactor and enabled the estimation of 
oxygen transfer coefficients through the materials comprising our PDMS device.  
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These results are important not only for characterization of the specific device we 
describe in this report but also for formulating general guidelines for designing PDMS 
devices in regards to their oxygen microenvironment for mammalian cell culture.  The 
relationship that describes the minimum convective flow rate that will offset specific 
oxygen consumption rates, as is described in this report, will be useful to the 
microfluidics community for designing devices and experimental conditions for 
microfluidic cell culture.  In order to achieve oxygen gradients or hypoxic conditions in 
PDMS microbioreactors, researchers should plan experiments at low Sh, and low Pe/.  
Our results also underscore the importance of characterizing the oxygen transfer rate of 
each type of PDMS device made under different conditions such as plasma oxidation and 
protein coating to explain cell behaviors observed as the oxygen permeability of a given 
device cannot always be predicted by simply using the permeability values of native bulk 
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FROM HYBRID BONDED 
MATERIALS FOR CELL 







Microfluidic devices are useful for myriad applications, including but not limited to: 
biotechnology, nanotechnology, biological and chemical processing, analytical 
technologies (electrophoretic separation, mass spectroscopy, radionucleotide labeling), 
hydraulic actuation, heat transfer, and power generation (Beebe  et al. 2002; Makamba et 
al. 2003; Weibel et al. 2006; Whitesides et al. 2001). They have been popular due to 
economical and efficient synthesis of chemicals, low consumption of expensive reagents, 
ease in performing combinatorial chemistry, ability to carry out biological and clinical 
analyses such as immunoassays, capacity to run a large number of analyses 
simultaneously, and integration of full-scale rapid analyses from sample introduction to 
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chemical separation and detection on single, miniaturized μTAS device (Beebe  et al. 
2002; Dittrich et al. 2006; El-Ali et al. 2007; Makamba et al. 2003; Weibel & Whitesides 
2006; Whitesides et al. 2001). 
 
Different materials are used for fabrication of microfluidic devices. Polymers are 
advantageous for microfabrication as they are available in large varieties and favorable 
prices; moreover, they can be prototyped rapidly using replication techniques such as hot 
embossing, injection molding, micromilling, wire imprinting, in situ polymerization, soft 
lithography and laser ablation. Poly(dimethyl siloxane) (PDMS) is one of the most 
popular starting materials due to its low cost, inertness, gas permeability, elastomeric 
nature, and rapid prototyping (Makamba et al. 2003; Shim et al. 2003). Other polymers 
also used for making microfluidic devices include polystyrene (PS), polycarbonate (PC), 
poly(methyl methacrylate) (PMMA), glycol-modified polyethylene terephthalate 
(PETG), poly(ethylene terephthalate) (PET), polyurethane (PU), cyclo olefin copolymer 
(COC) and many others. Each material has its own characteristic properties and 
advantages.  
 
Due to their intrinsic characteristics, microfluidic devices fabricated using these materials 
can have issues such as evaporation of liquids from the channels, high permeability of 
oxygen leading to non-hypoxic oxygen tensions (which lead to decrease in stem cell self-
renewal), or inability to integrate with popular channel deformation-based valving and 
pumping techniques. Such issues motivate examination and assessment of other polymers 




Fabrication of microfluidic devices with hybrid materials would synergize useful 
properties of different polymers, namely, the rigid ‘hard top’ (from PETG, COC, PS) 
which provides excellent barrier properties to the microdevice, and the ‘soft bottom’ 
(from PU or PDMS) which is deflectable. All-COC, PS, PMMA, PETG, and all- PDMS 
microdevices are fairly common in literature (Lin et al. 2005; Nielsen et al. 2004; Steigert 
et al. 2007; Tsao et al. 2007). However, there are few or no reports of PETG-PDMS, 
PETG-PU, PS-PDMS, PS-PU, COC-PDMS or COC-PU devices.  Bonding hard top and 
elastomeric bottom has been shown in literature for bonding glass, quartz, SiO2 coated 
materials to elastomeric PDMS, PMMA and perfluoropolyethers  (Osterfeld et al. 2006). 
PDMS and PMMA have also been bonded together to create a laminated microfluidic 
device for immunosensing (Ko et al. 2003). Such bonding of rigid materials with 
elastomeric materials has not been shown for PETG-PU, COC-PU, PS-PU or PETG-
PDMS, COC-PDMS, and PS-PDMS. The bonding between the rigid polymer with 
channel features and elastomeric membrane, which would allow fluid actuation, although 
difficult to achieve, is demonstrated in this chapter. 
 
Although our lab has established the control of fluid flow in PDMS microdevices using 
Braille tactile array (Futai et al. 2006; Gu et al. 2004; Heo et al. 2007; Song et al. 2005), 
application of the same perfusion system to devices made with thermoplastic materials 
has not been reported. Braille arrays are beneficial because they allow non linear and 
multidirectional perfusion, portability of microbioreactors, compartmentalization of 
channels within a single device, dynamic pumping and valving, and easy automatic 
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programming of fluid flow through different channels of a device. In this report, we bond 
thermoplastic channels with elastomeric (deflectable) membranes (either PDMS – 
parylene C - PDMS or PU), and demonstrate actuation, pumping and valving in a hard 
top-soft bottom chip using Braille array.  
 
Evaporation of liquids through microfluidic devices is a recognized problem which arises 
due to high surface to volume ratios encountered at the microscale (Heo et al. 2007; 
Walker et al. 2004). Evaporation of water from the microchannels often leads to changes 
in the concentration and osmolality of the solutions, and is harmful to cells under culture 
as well as confounding for assays under scrutiny. Thermoplastic polymers such as PETG, 
COC, and PS have significantly lesser water vapor transmission rates compared to PDMS 
(as seen in Table 4.1), which makes the microfluidic devices fabricated using these 
materials less susceptible to evaporation of aqueous phases as compared to all-PDMS 
devices.  
Table 4.1: Oxygen permeability values (in cm3-mm/m2-day-atm) for materials used in 
this report for fabricating and assembling microfluidic devices with hard tops and soft 
bottoms (Massey 2003). 
 
Material Oxygen gas permeability 
(cm3-mm/m2-day-atm) 
Water Vapor Transmission  
Rate (g-mm/m2-day) 
PDMS 52531 125 
PS 145 3.4-6 
PU 78.7 0.9-3.43 
COC 63.5 0.75 
PETG 10.0 1.6 
Parylene C 2.8 1.68 
 
 
In our previous work, we have shown the modulation of oxygen tension in PDMS 
microbioreactors and found that dissolved oxygen can be regulated from 20% to 4.3% 
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level by operating the device at different cell densities and perfusion velocities (Mehta et 
al. 2007). However, it was difficult to get very low oxygen tensions, of the order of 1-2% 
in a microfluidic device made of gas permeable PDMS. Such low oxygen environments 
are needed for the biological studies of embryonic, adult stem cells as well as for studies 
of the diseases of the circulatory system and bone tissue engineering.  Even though glass 
channels perfused with syringe pumps could be used for lowering oxygen concentration 
and increasing barrier to evaporation in microdevices, it would not be possible to have 
dynamic pumping and valving in different parts of the same microdevice, thus creating 
separate compartments of different flow rates and oxygen tension inside the microdevice 
or for performing fluid recirculation on chip. With channel deformation-based fluid 
actuation such as using pin actuator on refreshable Braille displays programmable 
deformation-based microfluidic actuation and hence control of oxygen to have different 
value in different parts of the same microdevice would become possible. We therefore 
embarked on fabricating microdevices with materials that have low oxygen 
permeabilities as compared to PDMS. Table 4.1 lists the permeabilities of all materials 
that we have used in this report. PDMS allows most oxygen transport in this comparison, 
followed by PS. PU and COC have similar oxygen transport properties, and PETG and 
Parylene C allow least oxygen diffusion through them. 
 
Here we report microfluidic devices made using thermoplastic and elastomeric 
components that offer: 1) lower evaporation of aqueous solutions from the 
microchannels, 2) significantly lower oxygen tensions in microchannels compared to 
PDMS microdevices, and  3) peristaltic Braille actuation for pumping and valving in hard 
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top-soft bottom materials,. The new microfluidic devices are made up of two 
components: a rigid channel layer fabricated using PETG, COC or PS; and an elastomeric 
membrane of PU or PDMS to seal the channels. Bonding between dissimilar hard top and 
soft bottom was achieved by exposing substrates to oxygen and argon plasma. We also 
report the performance of the device for culture of cells and lowest oxyen tension 
possible in the devices with 3 different cell lines. These devices can have multiple 
applications in understanding fundamental biology (such as observing the effects of 
pliable and stiff surfaces on cellular behavior, studying cells under hypoxic 
environments), biochemical analysis, and analysis of cellular activities, as well as 
integrated devices which can perform all these functions at the same time. 
 
4.2 Experimental Methods 
4.2.1 Materials 
For hot embossing, the following three polymers were obtained: Cyclic Olefin 
Copolymer (COC) (Zeonor 1060R and 1020 R), Zeon Chemicals L.P., Louisville, KY), 
Glycol-modified polyethylene terephthalate (PETG) (12” X 12” X 0.25”) (McMaster 
Carr, Robbinsville, NJ), and Polystyrene (PS) – obtained from Fisherbrand 100 x 15 mm 
Fisherbrand Petri dishes (sterile) (Cat. 0875712 – 2071). For making elastomeric PU 
membranes, medical-grade aliphatic thermoplastic PU were used (Tecoflex®SG93A and 
SG80A, Thermedics Incorporated, Woburn, Massachusetts) in as a 5% solution by 
weight in 95% chloroform (Sigma). Epoxy molds were made using high temperature 
epoxy (Epoxy Cytec Industries Inc., Conapoxy FR-180, Parts A and B). PDMS was used 
as 10:1 base: curing agent (Dow Corning Sylgard 184). Tridecafluoro-(1,1,2,2-
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tetrahydrooctyl)-1-trichlorosilane was purchased from United Chemical Technologies 
Inc., Bristol, PA. 
 
4.2.2 Fabrication of the mold 
Fabrication of Glass Wafer Mold 
Briefly, a glass wafer mold was fabricated using backside diffused-light photolithography 
to form positive relief features made of SU-8 onto a thin glass wafer (200μm thick).  The 
resulting glass wafer mold was taped to a single glass slide (75 x 50 mm) using double-
sided tape and silanized with tridecafluoro-(1,1,2,2-tetrahydrooctyl)-1-trichlorosilane. 
This silanized glass wafer mold was then used to create a PDMS master.   
 
Fabrication of PDMS Master (Using Soft Lithography) 
The glass wafer mold supported on a glass slide was stacked on six additional glass slides 
(also 75 x 50 mm) using double-sided tape between each slide.  The resulting ‘block’ was 
approximately 7.5 mm tall, with the channel features on the ‘top’ face.  This block was 
then placed in a square Petri dish, covered with PDMS pre-polymer (10:1 base to curing 
agent (by mass) and degassed in a vacuum chamber), and then cured overnight at room 
temperature on a level surface.  It is critical that the PDMS cures on a level surface.  Any 
deviations from levelness will be transferred to the subsequent epoxy mold and result in 
uneven embossing.  The levelness of the surface was easily verified using a simple, 
liquid/air-bubble leveling device.  The resulting PDMS master had the channel features 
set into the bottom of a ‘dish’, and allowed the master to be used as a molding pattern for 
the subsequent epoxy mold.  The final PDMS master was checked for levelness using a 
simple, liquid/air-bubble leveling device. Critical Dimensions used were: total height of 
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PDMS master: 11 mm, depth of the ‘dish’: 7.5 mm and PDMS height above glass wafer 
mold: 3.5 mm. 
 
Fabrication of Epoxy Mold 
High temperature epoxy (83:100, hardener: epoxy by mass) was poured into the PDMS 
master ‘dish’.  The PDMS master (with epoxy) was then placed onto a level surface in a 
120oC oven.  The levelness of the surface was verified using a simple, liquid/air-bubble 
leveling device.  As in the fabrication of the PDMS master, the levelness of the surface is 
critical to creating a useable mold.  After about 5-10 minutes, the PDMS master was 
briefly removed from the oven, and a pipette tip was used to agitate the epoxy and 
remove all air bubbles trapped in the epoxy near the channel features (the epoxy is 
considerably less viscous after 5-10 minutes in oven, making removal of the air bubbles 
fairly easy).  The PDMS master was then placed back into the oven for ten more minutes, 
after which it was checked again and any remaining air bubbles removed in the same way 
described above.  The PDMS master was then placed back into the oven, and allowed to 
cure undisturbed for approximately 4 hours.     
After the curing the epoxy and cooling it for approximately 1 hour, the hardened epoxy 
was carefully removed from the PDMS master.  The resulting epoxy mold was checked 
for levelness using a simple, liquid/air-bubble leveling device. 
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4.2.3 Hot embossing 
A 12 ton hot press with a platen size of 9 x 12" with mold area of 8 x 10" and a manual 
hydraulic press was used for embossing channels (model 912, maximum sustained 
temperature 177 C, Jackson Marking Products Co., Inc., Mt. Vernon, Illinois).  
 
Before embossing a material, we had to find the appropriate embossing temperature that 
would allow imprinting of channel features on the substrates. In order to find this optimal 
embossing temperature (Temboss), qualitative investigation with the polymers was 
performed by subjecting the materials to contact with epoxy mold at different 
temperature and same pressure. The Temboss of polymers used in this report are: COC 
(Zeonor 1060R) Temboss = 150 oC, PS Temboss = 125 oC, and PETG Temboss = 140 oC.  The 
Tg of these polymers are: COC (Zeonor 1060R) Tg = 102 oC, PS Tg = 95 oC, and PETG 
Tg = 105 oC.   
 
A silanized glass plate was centered on the metal tray with the silanized surface facing 
up, and loaded into the press.  The temperature of the press to Temboss, when the press 
temperature has stabilized at Temboss, the tray was removed from the press and un-
embossed material was placed in the center of the silanized glass plate.  The tray was 
loaded back into the press and the lower platen was raised until the un-embossed material 
was a few millimeters away from the top platen.  This insures quick and even heating of 
the un-embossed material.  After 4-5 minutes, the tray was quickly removed from the 
press and the material was probed to verify that it was soft enough (or reached the glass 
transition temperature) for embossing (it deforms easily when gently poked with a 
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wooden pick).  The epoxy mold was placed face-down on the softened material and the 
tray was load back into the press. The bottom platen of the press was raised slowly until 
the pressure gauze indicated the desired pressure.  The pressure decreased to 0 as the 
material flowed around the epoxy mold.  This procedure constitutes one “press.”  Two-
four “presses” were performed to correct for any unevenness in the epoxy mold and 
obtain the desired thickness.  When the embossed material flows up and around the edges 
of the epoxy mold, enough “presses” have been made.  The number of “presses” will 
vary according to the thickness and type of material, as well as the levelness of the epoxy 
mold.    
 
After embossing, the glass plate, the embossed material and the epoxy mold were 
removed off the tray and placed onto a cooling rack for 10-15 minutes after adding some 
weights on top to prevent the embossed material from warping as it cools. The embossed 
material was then separated from the epoxy mold, cut to rectangular shape using an 
electric saw. The holes for liquid inlet and outlet, as well as cell seeding ports were made 
on the embossed material using a drill press (Figure 4.1A). 
 
To make PS embossed channels, a 2 mm thick PS sheet was made first from 4 layers of 
edge-cut petri dishes (Fisherbrand, 100 x 15 mm, sterile). The sheets were melted 
together at 125oC using the press to make a thicker PS sheet. 
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4.2.4 Device assembly 
In order to assemble a device, the hole punched hot embossed hot top needed to be 
bonded to an elastomeric soft bottom (Figure 4.1B). To make 200 um membranes from 
PU, 8 ml of the PU-chloroform solution (5% PU by weight) was placed in glass molds 
and left covered to evaporate overnight. The membranes were cut out of the glass mold 
next day and placed on silanized glass slides.  PDMS – parylene C - PDMS membranes 
were fabricated as described earlier (Heo et al. 2007; Mehta et al. 2007). 
 
The hard top and soft bottom were bonded using an Expanded Plasma Cleaner & 
PlasmaFlo™ (PDC-001 (115V), 200 W input, Harrick Plasma, Ithaca, NY) with argon 
and oxygen gases. The ratio of argon to oxygen inside the plasma chamber was 2:1. The 
channel piece and membrane were plasma oxidized for 1 minute at 400 mTorr. After 
removal from the plasma etcher, they were placed on top of each other, any remaining air 
bubbles were removed, and then the bonded devices were left in a 60 C oven with some 
weights on top until the next day.   
 
When ready to be used, the devices were made hydrophilic again by plasma oxidation for 
one minute, and sterile DPBS was introduced into the channels. These devices were then 
sterilized by placing under a UV-C light for ~30 minutes. 
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4.2.5 Braille actuation 
An array of 48 pin actuators adapted from a Braille display module (SC9, KGS, Saitama, 
Japan) was used for fluid actuation (Futai et al. 2006). The pin actuator module was 
controlled with a computer via Universal Serial Bus (USB) through a finger-sized stand 
alone custom controller circuit board (Olimex, Plovdiv, Bulgaria) (Futai et al. 2006; Heo 
et al. 2006). The microfluidic bioreactor chip interfaces with the pin actuator module by 
simply holding the chip in place such that the channels align with the pins which push 
upward closing the channel, as seen in Figure 4.1 C. The pin movements for valving and 




Figure 4.1: The microfluidic device used for hot embossing. a) Hot embossed COC 
device, b) overall schematic of the device showing two components: channel layer and 
membrane layer, c) an actual hard top-soft bottom device with green food dye, and d) 






Pictures of the devices and channel cross sections were taken using an inverted phase 
contrast microscope (Nikon TE 300) and a digital CCD camera (Hamamatsu) at different 
magnifications. Scanning electron microscope (SEM) was used for imaging the cross 
sections of the embossed channels.  In order to prepare the samples for imaging, the 
channels were coated with carbon (SPI Supplies, Module Carbon Coater) for two 
minutes. 
 
4.2.7 Fluid flow simulation 
In order to investigate the valving behaviors of the fabricated microfluidic devices, we 
performed simulations using finite element analysis (FEA) software, ANSYS 10.0 
(ANSYS Inc., Southpointe, PA).  To reduce the computational time, a three-dimensional 
(3-D) model of the half of the device with a symmetric boundary condition was 
constructed as shown in Figure 4.2 A.  Figure 4.2 B shows the cross-sectional view of the 
constructed model from the symmetry plane.  The model was composed of a microfluidic 
channel with a bell-shape cross-section, which is measured experimentally, bonded with 
a flat membrane, and a Braille pin structure.  Two sets of contact analysis were 
performed to simulate the interactions between the Braille pin and the membrane; the 
channel and the membrane respectively.  The 3-D contact and target elements, 
CONTA173 and TARGE170, were employed in contact analysis, and the deformation of 
the structure was simulated using 10-node tetrahedral 3-D solid element, SOLID92.  The 
force boundary condition was assigned to the Braille pin to simulate its actuation motion.  
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To simulate the large deformation of the structure, non-linear, large deformation static 
analysis was performed. 
 
 
Figure 4.2: Simulation of the fluid flow inside the device with Braille actuation: a) 
schematic drawing of the three-dimensional (3-D) model constructed for finite element 
analysis (FEA) to simulate valving behaviors for various microfluidic channels using 
Braille display actuation,  b) The cross-sectional view from symmetry plan of the 
constructed model in FEA software, ANSYS (ANSYS Inc., PA).  
 
4.2.8 Cell culture 
HepG2 cells (human hepatocellular carcinoma, ATCC, HB-8065) and C2C12 cells 
(mouse myoblasts, ATCC,  CRL- 1772) were cultured in a media comprising Dulbecco’s 
Modified Eagle’s Medium (DMEM, 11960, Gibco), 15% Fetal bovine serum (FBS, 
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10082, Gibco), 1%v/v antibiotic–antimicotic (15240, Gibco) and 1%v/v GlutaMAX2-I 
Supplement (35050, Gibco). MC3T3-E1 cells (mouse preosteoblast, ATCC, MC3T3-E1 
subclone 4, CRL-2593) were cultured in ascorbic acid free alpha-MEM media (Minimal 
Essential Alpha Medium, 0010083DJ, Gibco)  supplemented with 10% Fetal bovine 
serum, 1%v/v antibiotic–antimicotic  and 1%v/v GlutaMAX2-I. Primary human dermal 
microvascular endothelial cells (HDMECs) were cultured in EGM-2MV (EGM-2MV 
Microvascular Endothelial Cell Medium, CC-3202, Lonza) media supplemented with 
1%v/v antibiotic–antimicotic. 
 
The T-25 culture flasks were placed in a humidified 5% CO2 cell culture incubator. At 
70-80 % confluence, the cells were passaged by washing in PBS, and incubating with 
0.25% Trypsin/EDTA (Invitrogen, Carlsbad, CA). The Trypsin solution was neutralized 
with 15% FBS in DMEM and spun down with a centrifuge (ThermoForma, Marietta, 
OH) for 2 minutes at  4 oC and 1000 RPM. The supernatant was removed and the pellet 
was resuspended in DMEM media. The pellet was reconstituted in 4 ml of DMEM 
media, and 1 ml of this suspension was used for creating a new plate of HepG2, C2C12, 
MC3T3-E1, and HDMECs. The cells were passaged every third day.  When the cells 
were to be cultured in the PDMS microbioreactor, the pellet was reconstituted in 70-100 
μL of DMEM media and then injected into the seeding ports of the chip. 
 
4.2.9 Cell seeding in devices 
Fibronectin (100 mg/μl, F2006, Sigma) was pipetted into the microdevices to help with 
cell attachment. This absorption was carried out for 30 minutes, following which media 
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(specific to the cells being seeded) was introduced in the device and the chip was placed 
on an array of pin actuators adapted from Braille displays for at least one hour to 
peristaltically pump fluid through the channels. Cells (HDMECs, HepG2, MC3T3E1, 
C2C12) were seeded into the chip through the cell seeding ports. The cells were directed 
into the desired location inside the microdevice by using Braille pumping and valving. 
The cells were given 2-4 hours to attach under no flow (pins up and channels valved 
closed) condition in a dry heat incubator (Forma 310 Series Direct Heat CO2 Incubator, 
Thermo electron Corporation, Marietta, OH) maintained at 37 oC and 5% CO2. Pumping 
was started after cells became adherent and the chip was perfused for 12-14 hours.  
 
4.2.10 Oxygen measurement 
0.2 ml of the oxygen sensitive dye, ruthenium tris(2,2’-dipyridyl) dichloride hexahydrate 
(RTDP) (93307, Fluka) (5 mg/ml in DPBS (14190250, Invitrogen); final concentration is 
1 mg/ml because of dilution) was introduced into the inlet of the device, and pumping 
was continued for three more hours. The setup comprised of a microfluidic chip attached 
to the pin actuator array module was then taken to the microscope where lifetime 
measurements performed at room temperature.  Cell densities in the cell culture channels 
in the microbioreactor chips were determined by counting the number of cells present in 
brightfield images taken at different positions along the length of the cell culture channel.  
The oxygen measurement system consisted of Nikon TS-100F microscope with 
fluorescence attachment, LED light source (default is blue light with central wavelength 
of 470nm (LXHL-MB1D Blue Luxeon, Lumileds Lighting, LLC, CA), lock-in amplifier 
(SR830, Stanford Research System, Inc., CA), function generator (33220A, Agilent 
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Technology, Inc., CA), and silicon PIN photodiode with preamplifier (PDA36A, 
Thorlabs, Inc., NJ).  The system is controlled by a personal computer with LabVIEW 
graphic user interface program for operation and data acquisition through GPIB interface 
(GPIB-USB-HS, National Instruments, Co., TX).  Figure 4.3 shows the schematic of the 
Nikon TS-100F Microscope Fluorescence Intensity Detection System (FIDS).  The 
numerical data from LabVIEW was saved in a .txt file containing values of time (in sec), 
intensity signal (in μV), and phase (in degree).  
 
The relationship between fluorescence intensity (or lifetime) and dissolved oxygen 
concentration is described by the Stern–Volmer equation (Gerritsen et al. 1997; Sud et al. 
2006; Urayama et al. 2003; Zhong et al. 2003): Io/ I = 1 +  Kq[O2]  or τo/τ=1 +  Kq[O2] , 
where Io or τo = uninhibited sensor dye intensity or lifetime (i.e. 0% oxygen), I or τ = 
sensor dye intensity or lifetime at oxygen level [O2] and Kq is the Stern-Volmer 
quenching constant. The system was calibrated by testing devices with just the dye and 
no cells and no oxygen for uninhibited sensor lifetime. The oxygen was removed by 




Figure 4.3:  Schematic of the Nikon TS-100F Microscope Fluorescence Intensity 
Detection System (FIDS). 
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4.3 Results and Discussions 
4.3.1 Hot Embossing of Hard Top Devices 
Embossing temperature varies with material and is a temperature at which material flow 
balances with material stability.  If the temperature is too low, the material will not be 
soft enough to flow and might result in the destruction of raised features (such as the ‘X’ 
region in our design which is 200 μm high, compared to rest of channels which are 30 
μm high) on the epoxy mold as it is pressed against the relatively hard material.   The 
destruction of these features results in an imperfect replica of the desired features.  On the 
other hand, if the temperature is too high, the material can degrade.   
 
In general, the optimal embossing temperature is 30-50oC above the Tg (Cameron et al. 
2006; Fredrickson et al. 2006; Steigert et al. 2007).  For our work, we used Temboss equal 
to 150 oC for COC, 140 oC for PETG, and 125 oC for PS.  A representative image of the 
hot embossed COC is observed in Figure 4.1 A, which shows imprinted channel features 
on COC surface after de-embossing. Thus, channel features were replicated onto the 
PETG, COC and PS ‘hard tops’ with good reproducibility for channels with different 
heights and shapes. All channels except ‘X’ region were bell shaped, while the ‘X’ region 
was rectangular; likewise, all other channels except ‘X’ were 30 μm high while X was 
200 μm high.  
 
In order to investigate the geometry of the microfluidic channels made by various 
materials using soft lithography and hot embossing, we performed scanning electron 
microscope (SEM) imaging for the fabricated devices.  Prior to imaging, the microfluidic 
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channels were coated with carbon (SPI Supplies, Module Carbon Coater) for two 
minutes.  Figure 4.4 shows the SEM images of the top and cross-sectional views of the 
fabricated microfluidic channels.  The imaging results demonstrate the excellent 
geometry transferring through the fabrication processes, and showcases that the surfaces 
of the devices are microscopically smooth.  Moreover, the bell-shape cross-sectional 
geometries can be well transferred into the devices, which facilitate the microfluidic 
actuation using Braille displays. 
 
Figure 4.4: Scanning Electron Microscopy images of the cross sections of the 
channel features fabricated using: a) PDMS by soft lithography replica molding, and 
b) COC, c) PETG, and d) PS microfluidic channels made by hot embossing. Scale bars 
are 100 microns. 
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4.3.2 Bonding of Hard Top Devices with Soft Elastomeric Membranes 
We tried various ways to bond hard tops (COC, PETG, PS) to PU or PDMS-parylene C-
PDMS membranes. Methods that resulted in an unstable bond between hard top and soft 
bottom included oxygen plasma treatment, chemical grafting on hard top, UV 
polymerization between hard and soft components, and thermal sealing.  
 
We were able to successfully bond devices by surface treatment of all components with 
one minute of oxygen and argon plasma, with a ratio of argon to oxygen flow rate of 2:1. 
After plasma treatment, the surfaces were brought together, hermetically sealed and 
placed in a 60 oC oven with small weights (less than 1 lb) for an overnight heat treatment.  
To make the devices hydrophilic, the microfluidic channels were plasma oxidized or 
corona treated as a complete device for 2 minutes. Devices sealed in this way had stable 
bond strength at room temperatures for up to several months.   At high humidity (for 
example as in the humidified incubators), the device bonding lifetime is limited to about 
seven days due to delamination of the bottom elastomeric membrane from the hard top.  
 
Bonding monolithic devices made of just COC, PETG, PS or PDMS is well established 
and relatively simple and long lasting (Bhattacharyya et al. 2007; Lin & Burns 2005; 
Mair et al. 2007; Mizuno et al. 2005; Nielsen et al. 2004; Pal et al. 2006; Tsao et al. 
2007). The techniques employed in this report for bonding dissimilar materials result in 
devices that may have bond strength inferior to thermally bonded monolith devices 
because of the varied intrinsic characteristics of the materials that we bond together. The 
hard tops (PETG, COC and PS) all have saturated hydrocarbons in their polymeric 
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backbones which results in difficulty in introducing any suitable functional groups on the 
surface.  However, in literature (Bhattacharyya & Klapperich 2007; Makamba et al. 
2003; Mizuno et al. 2005), the plasma oxidation with Ar and O2 has been reported to 
produce lower molecular weight polymer fragments on the surface which leads to 
reduction in Tg and furthermore crosslinking of activated surface groups on substrates, 
giving rise to a stable bond. Such explanations are often ascribed to similar surface 
treatments of polymers.  
 
4.3.3 Braille Actuation and Perfusion in Hard Top Soft Bottom Devices 
The analysis of fluid flow with Braille peristaltic pumping and valving was performed to 
confirm and validate perfusion in hard top-soft bottom devices. The bonded and 
hydrophilyzed devices were filled with green food dye, place on top of Braille array with 
channels aligned with respect to Braille pins, and the pumping and valving motion of the 
channels was documented (as seen in Figure 4.1 C and  4.1 D).  
 
Figure 4.5 shows a representative picture of hard tops pumping and valving in 4.5 A and 
4.5 B, while all-PDMS channels are depicted in 4.5 C and 4.5 D for comparison.  As can 
be seen from the images, the Braille array can successfully pump and valve though a 
device made of a rigid top later and elastic bottom layer and there are no leaks observed 
with repeated pumping and valving action.  
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Figure 4.5: Braille actuation in hard top soft bottom devices (a and b) as compared 
to all PDMS device (c and d).  
 
When comparing hard top-soft bottom channel valving to that in the all-PDMS channels, 
the extent of channel closure and deformation is higher in PDMS channels. This is 
expected because PDMS had a much higher bending strength and modulus than either 
PETG, COC or PS. However, it should be noted that when valving in hard top soft 
bottom devices, the channel does completely close under the weight of the Braille pin and 
there are no leaks of liquid around the bonded interface. 
 
While PDMS is an elastomeric polymer; COC, PS, PETG are thermoplastic hard 
polymers, and thermoplastic PU used in this report is also flexible and elastomeric. The 
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control of fluid motion in hard top-soft bottom devices as compared to all-PDMS devices 
is also explored using a two dimensional model of pressure distribution inside the device 
as the Braille pin pushes up. The extent of channel closure and the strain produced is 
observed. The fluid flow in hard top soft bottom channels was further compared to a 
device made of all PDMS channels by flow simulations of Braille pumping and valving 
in microfluidic devices. Two dimensional finite element model of Braille pin pushing on 





Figure 4.6: FEA simulated horizontal displacement (y-direction) results of a) PDMS-
PDMS microfluidic channel, and b) hard top COC-PDMS microfluidic channel with the 
0% and 10% channel width misalignment of the Braille pin.  
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Figure 4.6 shows the simulation results for PDMS-PDMS and hardtop COC-PDMS 
microfluidic channels.  As can be seen in the figure, in the PDMS-PDMS microfluidic 
channel, both the channel and the membrane will be deformed to seal the channel, while 
in the COC-PDMS microfluidic channel, only the membrane will be deformed.  
Moreover, due to the higher Young’s modulus of the COC, the Braille pin causes less 
displacement in hardtop channel (c.a. 55 μm) compared to the PDMS channel (c.a. 90 
μm).  The smaller displacement makes the alignment between the device and the Braille 
pin more critical.  For instance, when the Braille pin is aligned 10% off center along the 
channel width, the PDMS-PDMS channel can still be sealed by Braille pin actuation for 
complete valving as shown in Figure 4.6 A.  However, in COC-PDMS channel, the 
corner of the channel will not be contacted with the membrane as shown in Figure 4.6 B, 
which leads to a non-complete valving. For studies in which isolation of cells or analytes 
in particular compartments is essential, or when it is necessary to know the flow rates in 
microchannels with precision, accurate alignment will be essential. If the alignment is 
offset even by 10%, in case of hard top soft bottom devices, the microchannels will not 
close completely when valved, resulting in leaky valving and pumping.  
 
4.3.4 Cell Culture in Recirculation Loop in Hard Top Soft Bottom Devices 
We show culture of primary human dermal microvascular cells  
(HDMECs) in a very small amount of media inside a recirculation loop in the hard top-
soft bottom device for 12 hours outside the incubator. This is a significant improvement 
over previous work from our lab where because of evaporation we could only perform 
the outside culture of HDMECs in PDMS devices for less than 2 hours in a device 
 128
fabricated of only PDMS. This result is also comparable to the HDMEC culture 
performed in a PDMS device bonded with PDMS - parylene C - PDMS membrane, 
where ~70% of cells were alive after 12 hours of outside incubator culture (Heo et al. 
2007).  
 
Cell survival when recirculating very small amount of media (~1 μL) in channels with 
reservoirs valved off for duration of 12-24 hours outside incubator is ~100% and the cell 
morphology after such culture is healthy, as seen in Figure 4.7.  Figure  4.7 A shows 
HDMEC cells after seeding in the device at time = 0 or start of outside culture with 
continuous recirculation, and  Figure 4.7 B shows the cells after 12 hours of culture 
outside incubator while being heated to a physiological temperature.  This example 
indicates that the evaporation in our hard top-soft bottom devices is significantly lower 
than in all-PDMS devices, as can be expected from the water vapor transmission rates for 
these materials (Table 4.1). 
Figure 4.7: Culture of Human Dermal Microvascular Endothelial cells (HDMECs) 
outside incubator at room temperature humidity in the recirculation loop of the 
device for 12 hours. Scale bar: 100 μm. 
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4.3.5 Oxygen tension in Hard Top Soft Bottom Devices 
We quantified oxygen tension in the hard top-soft bottom devices for three cell lines at 
low flow rates and high cell densities to obtain a lower bound on the dissolved oxygen 
concentration inside these devices.  Real-time measurement of fluorescence signal 
intensity and phase based on Nikon TS-100F microscope with stage for Braille display 
systems was used for measurement of dissolved oxygen measurement in this report.   
 
Table 4.2 shows the lowest oxygen tension recorded in the hard top-soft bottom channels 
with three different cell lines (HepG2, C2C12, and MC3T3-E1) at a low average velocity 
of 5.4 X 10-7 m/sec and high average cell density of 1.54 X 109 cells/m2. The average 
oxygen concentration at 25 0C are evaluated from the differences in the lifetime of the 
dye at normal room oxygen and that at downstream of cells in the devices.  The standard 
deviations for all reported values were less than 5% of the data points. The lowest oxygen 
tensions in the hard top soft bottom devices are significantly different from that in a 
PDMS device for all cell types. Thus, we were able to achieve hypoxic conditions when 
culturing mammalian cells in hard top-soft bottom devices made with PETG, COC and 
PS, and bonded with PU membrane. Such low oxygen tensions are ideal for culture of 
certain embryonic and adult stem cells to control their differentiation capabilities and also 
for the study of ischemia injuries in specific organs (references).  The hard top-soft 
bottom devices offer in vitro model for simulating physiological environments for certain 
cell types as compared to conventional cultures, enabling the studies of how limited 
oxygen can affect cell behavior not only in terms of metabolism but also in cellular 
signaling, gene expression and decision of cell fate. 
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Table 4.2: Dissolved oxygen concentrations in the microfluidic devices in mg/L 







































4.4 Conclusions  
We utilized a hot embossing technique to develop a fast, reliable method for embossing 
microfluidic channels into thermoplastic materials. We were able to imprint channel 
features reproducibly on PETG, COC and PS hard tops with great fidelity. Hot 
embossing enables easy fabrication of these channels, which can be scaled up to suit 
commercial settings. The channel features on hard tops were bonded to elastomeric soft 
membranes to create new microchannels which reduce evaporation problems while still 
taking advantages of Braille pumping. The bonding between dissimilar hard tops and soft 
bottoms was achieved by combination of oxygen and argon plasma. The resulting devices 
had lower evaporation as witnessed by outside incubator heated culture of HDMECS for 
12 hours, lower oxygen tensions as measured by lifetime of oxygen sensitive dye, and 
ability to combine with Braille arrays to enable dynamic pumping and valving without 
 131
leakage. In conclusion, this report describes versatile hard top soft bottom devices which 
can be combined with Braille arrays and used for microfluidic cell culture as well as 
biochemical assays on the chip. These devices can have multiple applications in 
understanding fundamental biology (such as observing the effects of pliable and stiff 
surfaces on cellular behavior), hypoxic cell culture conditions, biochemical analysis, and 
analysis of cellular activities, as well as integrated devices which can perform all these 
functions at the same time. Moreover, the Braille facilitated dynamic pumping and 
valving is useful for creating compartments within the same device to run different 
experiments. Hard top soft bottom devices introduced in this report are low cost, easy to 
fabricate, have high quality channel features, can easily integrate analysis techniques 
(such as electrophoresis), are cell culture ready,  can be used as chemical processing, and 
compatible with key detection technologies. These devices are also resistant to a large 
range of chemicals, organic solvents, and temperature, transparent to allow imaging 
related analysis, not conductive, and offer the possibility of mass-producing disposable 
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CELLULAR OXYGEN UPTAKE 





Compared to conventional culture systems, microfluidic bioreactors offer a closer 
approximation of the in vivo microenvironment for the study of cell biology.  In such 
microbioreactors, the cellular responses are dependent on the operating conditions and 
physical parameters such as cell densities, perfusion rate, inlet nutrient concentrations 
and the device geometry.  One of the key intrinsic cellular characteristics which can be 
different in microfluidic cultures as opposed to conventional culture is the oxygen uptake 
rate (OUR) of cells in culture (Balis et al. 1999; Deshpande et al. 2004; Ducommun et al. 
2000; Guarino et al. 2004; Lai et al. 1982; Ruffieux et al. 1998).  
 
We already have a well characterized experimental method to measure oxygen 
concentration in real time in PDMS microbioreactors as shown in Chapter 3 and 4 (Mehta 
et al. 2007).  In this chapter, we use our oxygen concentration measurement technique of 
mammalian cells and an already established mathematical model (Mehta et al. 2006) 
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along with inference methods to accurately assess the OUR characteristics of various 
cells in microfluidic culture. 
 
The OUR results obtained from these studies  will  specify the different metabolic states 
of mammalian microfluidic cell cultures over different stages of cell growth, which will 
be beneficial in optimizing the microbioreactors for optimal performance (Wagner et al. 
1998; Worboys et al. 1997). 
 
5.2 Experimental Methods 
5.2.1 Microdevice Fabrication 
The microbioreactor comprised of two compartments: channel layer and PDMS-parylene 
C-PDMS membrane. The device was fabricated as previously described in the 
experimental methods of Chapter 3.  Two device designs were used for the parameter 
estimation experiments. The first microdevice was similar to the design as used in 
Chapter 3 (shown in Figure 5.1) and has a ‘X’ geometry at the center of the device. The 
cells are seeded in the X region, which is either 100 or 200 μm high, while rest of 
microchannels are 30 μm high and 300 μm wide. The second microdevice was the new 
design and can be seen in Figure 5.2 and has a single loop with a slanted channel for cell 
culture. The cell region is 100 μm high, while rest of microchannels are 30 μm high and 
300 μm wide.  
 
5.2.2 Cell seeding 
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HepG2, C2C12 and MC3T3-E1 cells were cultured, passaged, and seeded inside the 
device as described in experimental section of Chapter 4.  
 
5.2.3 Oxygen measurement 
Dissolved oxygen concentration in microdevices with different cell types was measured 
in real time using the same optics based lifetime detection technique as outlined in 
Chapter 4. 
 
5.3 Results and Discussion 
5.3.1 Dissolved oxygen tension profiles 
The dissolved oxygen tension profiles in the ‘X’ microdevices (design demonstrated in 




Figure 5.1:  Schematic of the first microdevice design used for oxygen measurement 
in microfluidic cultures of HepG2, C2C12 and MC3T3-E1 cells. 
 
The oxygen tension in the double cross ‘X’ PDMS design varied from 20% to 4% for 
MC3T3-E1 cells, from 20% to 3.7% for C2C12 cells, and 20% to 2.7% for HepG2 cells 
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for the cell density range of 6.7 X 107 to 1.6 X 109 cells/m2 and velocity range of 0.5 to 
28. 5 μ/sec with the cell region channel height of 100 or 200 μm. 
 
As shown in Figure 5.3, HepG2 cells had the steepest oxygen gradients along the length 
of bioreactor of all three cell types, followed by C2C12 and lastly MC3T3-E1. 
Proliferation of HepG2 cells was very rapid compared to other cells and their culture 
requires frequent media changes and passaging as seen from phase contrast microscope 
pictures. A large and varied range of oxygen tension was observed in microfluidic 
cultures of these cells, moreover, from morphological data the cells seem to be healthy 
and growing well under these conditions. Experiments were performed at six perfusion 
velocities using Braille pumping to observe the effect of convection on oxygen 
consumption by the cells. The data also show that when cells are cultured in a 
microchannel with higher liquid height above the cells (300 μm compared to 200 μm), 
the downstream oxygen tension is lower across all flow conditions for a deeper 
microchannel. This might be due to a higher value of resistance to diffusion of oxygen 
from top of device to the cells at the bottom through the liquid column in a 300 μm 
microchannel compared to a 200 μm microchannel. Overall, when data from these 
experiments are compared with  those from a similar device (discussed in Chapter 3), the 
lowest oxygen tension observed here  for C2C12 cells (3.7%) is lower than for the culture 
of same cells in the previous device (4.3%), which may be due to combined effects of 
changes in device geometry, cell densities and perfusion velocities. 
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The oxygen tension axial profile in the ‘single loop’ microdevices (design demonstrated 
in Figure 5.2) with HepG2 cells are shown in Figure 5.4. Oxygen is measured at four 
distinct points along the length of microchannel seeded with cells: from upstream, to 
distance of 1 cm from upstream, to downstream and finally a distance of downstream+0.5 
cm. These four oxygen tensions at the same overall device cell densities and velocities 
are helpful in the measurement of the gas transport through PDMS. The downstream 
oxygen tension in the single loop PDMS design varies from 19% to 2.4% for HepG2 cells 
for the cell density range of 9.8 X 107 to 1.67 X 109 cells/m2 and velocity range of 0.09 to 
31. 5 μ/sec with the cell region channel height of 100 μm.  
 
HepG2 cells were cultures at very high densities in this microbioreactor to get an idea 
about the lowest oxygen tension possible in the gas permeable PDMS device. The cells 
were confluent inside the device at the high density (1.67 X 109 cells/m2), and were 
arranged in a monolayer. The morphology of the microfluidically cultured cells suggested 
normal growth and nutrients were maintained by daily media change. The lowest oxygen 
tension observed in this system was 2.4%, which is still not low enough for the culture of 
certain primary cells, such as hematopoeitic stem cells, which need to be cultured below 
oxygen tension of 1-2% to maintain self-renewal for longer time in vitro. In order to 
further lower the downstream oxygen tension, different polymeric materials could be 
utilized to fabricate microbioreactors with low permeabilities to oxygen and water vapor, 
as discussed in Chapter 4. 
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The data indicated (Figure 5.4) that there is a considerable drop in the oxygen 
concentration as we move downstream of the cell region, which corresponded to the 
uptake of oxygen by cells, and this drop increases with increasing cell density. Media 
flow rate is also seen as an important parameter affecting oxygen tension, and increasing 







Figure 5.2: Schematic of PDMS device for measurement of axial oxygen tension 







Figure 5.3:  Downstream oxygen tensions for a) HepG2, b) C2C12, and c) MC3T3-
E1 cells in double cross ‘X’ PDMS microdevice at three cell densities (high (Hi), 


























































   













































Figure 5.4:  Oxygen Profile in PDMS microdevice at three different cell densities 
high (Hi), medium (Med), low (Lo)) of HepG2 cells at channel height of 100μm. The 






















































































upstream in cell laden channel (x=1), downstream (dwn), and distance of downstream + 
0.5 cm (dwn+0.5).  
 
The increase in oxygen tension at ‘downstream +0.5’ (where there are no cells) compared 
to downstream (see Figure 5.2 and 5.4) provided a direct evidence of oxygen diffusing 
through the PDMS microbiorector. Moreover, the diffusion of oxygen from air through 
the highly permeable PDMS devices, although significant, is not sufficient to avoid 
gradients inside the microchannel, and was demonstrated clearly by our experiments. 
From the experimental and modeling analysis, the overall mass transfer coefficient in the 
PDMS microbioreactor was found to be 1.3 x 10-8 m/s.  Furthermore, the inference of 
cellular oxygen uptake rates and estimation of Vmax and km from these experiments results 




In this chapter we used the oxygen tension data in microfluidic culture of mammalian 
cells to infer OUR and to estimate cellular oxygen consumption coefficients Vmax and Km 
using a continuous partial differential mathematical model. The experimental part of the 
procedure and results were described in this chapter and the model estimated values of 
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PROTEIN LAYER FILMS ON 
MICROFLUIDIC BIOREACTOR 
SURFACES FOR PRIMARY 





The in vivo cellular microenvironment is composed of an intricate blend of extracellular 
matrix proteins, soluble protein factors, immobilized protein factors, proteoglycans, small 
molecule signals, mineralized tissue, and numerous adjacent cell types, all of which may 
vary in space and time. These components present the cells with biochemical signals, and 
the cells are continually faced with sensing these inputs, processing the signals through 
signal transduction and gene regulation networks, and executing cell behavioral or fate 
choices (Jang et al. 2006; Shim et al. 2003). Two of the most important 
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microenvironment components are oxygen concentrations and the extracellular matrix 
(ECM). Recently, we demonstrated that oxygen concentrations can be regulated in 
microfluidic bioreactors made of poly(dimethylsiloxane) (PDMS) (Mehta et al. 2007).  
Here, we focus on modulating the surface chemistry of PDMS bioreactors to create 
advantageous adhesive microenvironments for the culture of bone marrow cells in vitro.  
Although the focus of this paper is mainly the enhancement of bone marrow cell 
attachment, similar ECM engineering strategies will also be useful for other cell types 
and for regulating more complex cellular responses such as intracellular signaling 
(Discher et al. 2005; McBeath et al. 2004) and adhesion-mediated increase in cellular 
secretions (McBeath et al. 2004; Stevens et al. 2005).  
 
Many types of cells that attach well to surfaces such as tissue culture plastic do not attach 
well to an unmodified PDMS surface, even when the PDMS surface is coated with cell-
adhesive proteins(Lee et al. 2004). For example, primary murine bone marrow stromal 
cells do not adhere well to PDMS surfaces even when coated with fibronectin or collagen 
(see section 6.2.5 for details). Various approaches have been used to modify PDMS 
surfaces for particular applications. Modification procedures include exposure to energy 
sources such as plasma, corona discharge, and ultraviolet light, formation of 
polyelectrolyte multilayers (PEMs), radiation induced graft polymerization, silanization, 
atom-transfer radical polymerization, chemical vapor deposition, cerium(IV) catalysis, 
phospholipid bilayer modification, and sol-gel modifications (Hu et al. 2003; Hu et al. 
2002; Lahann et al. 2003; Wang et al. 2005a; Wang et al. 2005b). Most of these 
modifications do not provide long term stability, in part because hydrophobic groups in 
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silicones migrate up to the surface mediating hydrophobic recovery and loss of the effect 
of surface modification (Makamba et al. 2003).  The long-term stability of biomedical 
devices made of PDMS is thus still questionable for applications where long-term cell 
attachment is required.  Improved biofunctionalization methods for PDMS surfaces are 
needed to improve reliability.   
 
A promising way to impart functionality to PDMS surfaces is by layer-by-layer (LBL) 
self assembly of polyelectrolytes and nanocomposites. LBL is a simple method that 
allows creation of nanoscale fuzzy assemblies or structures by alternate adsorption of 
macromolecular substances and most often polyanions and polycations on virtually any 
substrate to produce PEMs, and it has been used extensively for cell culture (Ai et al. 
2003; Brynda et al. 2005; Decher et al. 1991; Haynie et al. 2005; Johansson et al. 2005; 
Kidambi et al. 2004; Ngankam et al. 2004; Tan et al. 2003; Thierry et al. 2003). 
However, most PEM coatings are known to deteriorate in performance with time (Dubas 
et al. 2001; Kharlampieva et al. 2003; Zhang et al. 2002). Many factors, such as the ionic 
strength, type of solvents, temperature, concentration of the solution, and pH of the 
solution (for weak polyelectrolytes) determine the multilayer structure, surface 
functionality, and PEM stability. Moreover, although there have been attempts to make 
the top surface of the PEMs biofunctional to mimic the cell-ECM interaction found in 
living systems and make the PEMs more versatile, more studies are needed to elucidate 
the interactions of the cells with the surfaces, which potentially can influence cellular 
processes and cell fates. Proteins are often adsorbed on PDMS to prime the surface for 
cell adherence; however, there are concerns that the quaternary structure of proteins, 
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which provides them their functionality, might not be optimal when adsorbed onto PDMS 
(Ratner et al. 1996). However, using only synthetic polyelectrolytes will likely not 
produce a biofunctional surface for cell attachment; thus, inclusion of biomolecules and 
inorganic compounds to avoid deterioration of the properties in the cell culture media is 
important. The ability of LBL assembly to produce stratified coatings (Mamedov et al. 
2001; Mamedov et al. 2000) can be particularly useful in this case. 
 
Recently, the Kotov group has shown that organic–inorganic layered composites made 
from montmorillonite clay platelets (clay) and poly(diallydimethylammonium) chloride 
(PDDA) simulate morphological and mechanical properties of nacre and other 
biocomposites(Tang et al. 2003) and has cultured various types of mammalian cells on 
different compositions of PDDA/clay PEMs or PDDA/nanoparticle PEMs, which have 
also been modified with proteins to create cytophilic surfaces (Lee et al. 2006; Podsiadlo 
et al. 2005; Sinani et al. 2003). Some groups have also created LBL coatings inside 
microfluidic devices for applications ranging from improvement of electrosmotic flows in 
PDMS microchannels (Barker et al. 2000a; Barker et al. 2000b; Barker et al. 2001) to 
assembling extracellular matrix (ECM) biopolymers (Tan & Desai 2003;Tan et al. 2004) 
and micropatterning in PDMS channels (Mohammed et al. 2004; Reyes et al. 2004; 
Shchukin et al. 2004). PDMS channels were also used for fast, dynamic sequential LBL 
deposition using PDDA/PAZO[poly(1-4-(3-carboxy-4-
hydroxypheylazo)benzenesulfoamido)-1,2-ethandiyil, sodium salt)] for intended 





Figure 6.1:  Microfluidic bioreactor chip design and set up. a) The bioreactor chip is 
composed of two components. The top component of the microfluidic device contains 
channel features and has punched holes (black circles) acting as reservoirs. The bottom 
component of the microbioreactor chip is a 200 μm thick spincoated PDMS membrane. A 
“horizontal” pump (four orange pins) drives cell culture media from left to right, all other 
channels are valved closed (gray pins are raised to close channels by deformation), and 
rest of the pins are in valve open position and allow fluid to pass (white pins are down), 
b) an actual device filled with red food dye, c) bioreactor chip aligned on Braille pins to 
facilitate pumping and valving.  
 
In this chapter, we use Braille display-actuated microfluidic devices to automatically 
create multiple types of LBL films within a single run on a single bioreactor chip to 
screen for ideal surfaces onto which primary bone marrow stromal cells can be cultured.  
The LBL films tested included PDDA/Clay layers to impart chemical and mechanical 
stability and the two major adhesive protein components of the ECM basement 
membrane of the bone marrow, fibronectin (FN) and collagen (Co), to impart 





primary murine bone marrow cell adhesion, viability, and proliferation over a 15 day 
period.  We embarked on this project because the traditional method of preparing PDMS 
surfaces for cell culture, i.e. adsorption of an ECM protein on the substrate, did not allow 
for long term culture of primary stromal cells (results and Figure J7). 
 
6.2 Experimental Materials and Methods 
6.2.1 Cell Culture  
Unsorted primary bone marrow cells (hence forward called bone marrow stromal cells) 
from femurs and tibias of C57BL/6 mice were cultured in MyeloCult (M5300, StemCell 
Tech.) supplemented with 1% v/v hydrocortisone (07904, StemCell Tech.) and 1% v/v 
antibiotic–antimycotic (15240, Gibco). The 25 cm2 T flasks (3815, Corning) were placed 
in a humidified 5% CO2 cell culture incubator at 33 oC. Cells were allowed to grow for 
two weeks in the plastic dishes in 8 ml of media before plating on PDMS substrates. Half 
of the media in T flasks was replaced every week. 
After 2 weeks, cells were collected by washing in Hank’s Balanced Salt Solution (37250, 
StemCell Tech) and incubated with 0.25% Trypsin/EDTA (07901, StemCell Tech). The 
trypsin solution was neutralized with 25% serum in MyeloCult and spun down for 5 
minutes at 4 oC and 1000 rpm. The supernatant was removed and the pellet was 
resuspended in 200 μl of MyeloCult media, and this suspension was used for seeding 
cells onto the PDMS substrates. The cell suspension was seeded in the outlet of the 
channels from which it was directed into specific areas of the device. 
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6.2.2 Preparation of the microfluidic bioreactor chip 
The chip consisted of two components: a channel top layer and membrane bottom layer, 
as seen in Figure 6.1A. The chips were formed from pre-polymer (Sylgard 184, Dow 
Corning) at a ratio of 10:1 base to curing agent. The top layer was formed using a glass 
wafer mold (soft lithography) (Duffy et al. 1998) to form a layer with negative relief 
channel features ~30 μm in height and 300 μm in width. The positive relief features of 
the mold were composed of SU-8 (Microchem, Newton, MA) formed on a thin glass 
slide (200 μm thick) using backside diffused-light photolithography (Futai et al. 2004). 
The glass slide was silanized with tridecafluoro-(1,1,2,2-tetrahydrooctyl)-1-
trichlorosilane (United Chemical Technologies Inc., Bristol, PA). This channel layer was 
cured overnight at 120 oC and holes were punched (Dermal biopsy puncher, Miltex Inc., 
York, PA) in the channel layer to connect channel features to the bottom layer. The 
bottom layer was a thin membrane of PDMS (200 μm) prepared by spin coating (Cee 100 
Spin Coater, Brewer Science Inc., Rolla, MO) and curing PDMS in an oven at 120 oC 
overnight. The PDMS pieces were bonded by plasma oxidation (Futai et al. 2006; Gu et 
al. 2004; Mehta et al. 2007). 
 
6.2.3 LBL Nanocomposite Fabrication 
For the coating process, the surface of cured PDMS was made reactive by placing it in 
oxygen plasma for 60 s at 300 mTorr.  The peristaltic pumping sequences of Braille pins 
deposited alternate layers of 0.5 wt % poly(diallyldimethylammonium chloride) 
(PDDA)(+) (Mw = 200,000, Sigma, MO) and montmorillonite clay (-) (Aldrich, MO) 
onto the PDMS surface of the microfluidic bioreactor chip. Between each polyelectrolyte 
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deposition sequence, the channels were thoroughly washed with deionized water. Four to 
eight bilayers of PDDA/clay were deposited. To test the charge on the top exposed 
surface, fluorescently labeled charged dyes were used. Sulforhodamine (Sigma, MO) 
detected the negative charge, and 6-Carboxyfluorescein (Sigma-Aldrich, MO) detected 
the positive charge on the surfaces.  
 
LBL deposition was continued by the assembly of bilayers of proteins onto the base 
PDDA/Clay coating. Collagen type IV (lyophilized from human placenta, Sigma, MO), 
positively charged at pH = 4(Sinani et al. 2003), and fibronectin (human plasma, Sigma, 
MO) negatively charged at pH = 7 were deposited on the PDDA/Clay bilayers. One to 
seven bilayers of the biomolecules were deposited on the top of PDDA/Clay bilayers. 
After the LBL coatings were assembled, the bioreactor chip reservoirs were rinsed 
multiple times with DI water, and finally sterile PBS was added to all reservoirs and the 
device was stored in a sealed Petri dish at 4 oC until further use.  When the devices were 
ready for cell culture testing, they were first sterilized under UV light in a bio-safety 
cabinet for 30 minutes. The PBS in the reservoirs was replaced by MyeloCult, and cells 
were seeded from the outlet channels. 
 
Our notation for PEM composition is as follows: (PDDA/Clay)5 refers to deposition of 
five bilayers of PDDA and clay, and the top (exposed) surface is clay. (PDDA/Clay)5.5 
means that 5.5 bilayers of PDDA and clay were deposited, and thus the top (exposed) 
surface is PDDA. (PDDA/Clay)5,6,7,8  means that a device was fabricated with 
composition of (PDDA/Clay)5 in first outlet channel, (PDDA/Clay)6 in second outlet 
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channel, (PDDA/Clay)7 in third outlet channel, and (PDDA/Clay)8 in fourth outlet 
channel. Likewise, Co/FN refers to a PEM built with one layer of positively charged 
collagen overlaid with one layer of negatively charged fibronectin. It is not a mixture of 
two proteins. 
 
6.2.4 LBL Deposition on Flat PDMS Substrates 
PEMs were deposited on flat PDMS substrates using LBL technique (Decher & Hong 
1991; Tang et al. 2003). Six beakers were arranged in series, and PDDA was added to the 
first and clay to the fourth, the rest contained DI water. Two ml of PDMS was dropped in 
35 mm Petri dishes and cured in a 60 C oven for two hours. After plasma oxidation, these 
Petri dishes were dip coated in the beakers described above to create PEMs of different 
compositions. The following PEM composition were created on flat PDMS substrates: 
(PDDA/Clay)5, (PDDA/Clay)5.5,  (PDDA/Clay)7,  (PDDA/Clay)5 (Co/FN)3.   
 
In addition, the following surfaces were also created on flat PDMS substrates: fibronectin 
adsorbed on a flat PDMS substrate, collagen Type IV adsorbed on flat PDMS substrate, 
fibronectin and collagen Type IV (1:1) adsorbed on flat PDMS substrate. A control of 
fibronectin adsorption was also prepared in PDMS microdevice.  
 
6.2.5 Device Cell Seeding 
After sterilization, PBS was replaced with Myelocult media in the reservoir, and the 
bioreactor chip was placed on an array of pin actuators adapted from Braille displays for 
at least one hour to peristaltically pump fluid through the channels(Futai et al. 2006). 
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Bone marrow stromal cells were then seeded into the chip from the outlet channels. The 
cells were manipulated to attach only in the area of the bioreactor chip where 
nanocomposite coatings were earlier formed by using a software program to block out 
other parts of the device. The cells were given 1-2 hours to attach under static (pins up 
and channels valved closed) condition in a humidified incubator (Forma 310 Series 
Direct Heat CO2 Incubator, Thermo electron Corporation, Marietta, OH) maintained at 33 
oC and 5% CO2.  
 
The bioreactor chips were then taken off the pumping hardware and stored in Petri dishes 
inside the incubator. The Petri dishes were further stored in a larger container with DI 
water to prevent evaporation. The cells were grown on the nanocomposite coatings for up 
to 15 days, with media changes every other day. The media was changed every day by 
simple aspiration from the inlet and outlet reservoirs.  Pictures of the cells growing in 
different nanocomposite coatings were taken every day. Cell densities, cell spreading, 
cell proliferation and cell viability were recorded over 15 days. 
 
6.2.6 Fluid Actuation  
An array of 64 pin actuators adapted from a Braille display module (SC9, KGS, Saitama, 
Japan) was used for fluid actuation (Futai et al. 2006). The pin actuator module was 
controlled with a computer via Universal Serial Bus (USB) through a finger-sized stand 
alone custom controller circuit board (Olimex, Plovdiv, Bulgaria). The microfluidic 
bioreactor chip interfaced with the pin actuator module by simply holding the chip in 
place by using some weights such that the channels align with the pins which push 
 154
upward closing the channel, as seen in Figure 6.2. The pin movements for valving and 
pumping were controlled with a custom computer program written in C # (Mehta et al. 
2007).  The average flow rate was controlled by changing the time delay between pin 
motions. The flow rate was kept constant at (8.3 ± 2.3) X 10-2 μL/sec for all experiments.  
 
6.2.7 Cellular Assays for Cell Spreading, Cell Density, Cell Proliferation, and Live-
Dead Assay 
 
The microbioreactor chip was mounted on a glass slide and examined on an inverted 
phase contrast microscope (Nikon TE-300) with a 20X dry objective. Black and white 
images were captured with a CCD camera (Hamamatsu ORCA-100). Simple PCI 
software (Compix Inc; Cranberry Township, PA, ww.cimaging.com) was used for 
capturing and analyzing the images and calculating cell surface area, cell densities and 
cell viability.  For cell viability, LIVE/DEAD Viability/Cytotoxicity Kit (Invitrogen, 
Carlsbad, CA) containing Calcein AM and ethidium bromide was used to quantify 
percentage of cells alive at day 15 of bone marrow stromal cell culture. The controls for 
these experiments were microbioreactor chips without any surface modifications, and the 
variables were chips with varying nanocomposite coatings. Cell proliferation was 
measured as increase in cell density at day 15 compared to day 1. Cell viability was 
measured as percentage of cells alive at day 15.  For all the cellular assays, experiments 
were performed in triplicates, and fifteen images were analyzed to obtain one data point. 
The data were analyzed statistically by ANOVA and Tukey’s test at a 95 percent 
confidence level assuming unequal variances. There were 14 different types of PEMs 
created and tested in microdevices plus 4 different types PEMS created and tested on flat 
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PDMS slabs.  Each PEM substrate was analyzed through micrographs of ten different 
regions to give ten different data points each for cell viability and cell density.  These ten 
data points were collected every day for fifteen days to give a total of fifteen data sets for 
each PEM tested. In addition, all experiments were performed in triplicates. ANOVA was 
performed to find differences between the 14 different PEMs created inside 
microchannels as well as between the 4 PEMs created on flat PDMS and Tukey’s test 
was performed to find differences between specific PEMs within each set of surfaces.  
 
6.3 Results and Discussion 
We grew custom LBL nanocomposite coatings in microfluidic bioreactor chips using 
combinations of different building blocks. Figure 6.1 shows the design and set up of the 
microfluidic bioreactor chip and its alignment with the pin actuator module. The Braille 
peristaltic pumps and valves were used to direct flow in specific channels at different 
times to make LBL coatings with varying composition in four outlet channels as shown 
in Figures 6.2A, 6.2B and 6.2C.  
 
6.3.1 Layered nanocomposite coatings were produced inside PDMS microfluidic 
bioreactor chips 
 
The surface of cured PDMS was made reactive by exposure to oxygen plasma, which 
created a negative charge on the surface.  The bioreactor chips with oxidized PDMS 
channels were aligned on the Braille pumps and the channel inlets were filled with 
PDDA, clay or DI water. PDDA and clay are both strong polyelectrolytes; therefore their 
ionic strength changes little within the pH ranges of interest. The negatively charged 
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PDMS surface was exposed to a PDDA stream for 10-15 minutes (Figure 6.2 A shows 
the process of PDDA adsorption). Subsequently, loosely attached PDDA was removed by 
pumping DI water to rinse the channels for 15 minutes. In the third step, the clay inlet 
was valved open and pumped for 10-15 minutes. Finally, clay inlet was valved off and 
the channels were again washed by flow of DI water. This process created one 
PDDA/Clay bilayers inside the microfluidic bioreactor chip, and was repeated to get the 
desired number of bilayers in different outlet channels. Taking advantage of the 
computerized microfluidic system, all four channels could be patterned at once, or 
alternatively, the composition of the LBL in each channel could be varied by regulating 
the valving and pumping sequences that determine reagent flows. Figure 6.2 B shows 
delivery of clay stream to only second outlet channel, while Figure 6.2 C shows the 
bioreactor chip with four different nanocomposite coatings in the same chip. 
 
In order to create a stratified LBL structure with proteins on top of the PDDA/Clay 
bilayers, inlet reservoirs of PDDA and clay were rinsed with water and protein solutions 
containing fibronectin or type IV collagen were introduced. Processing procedures 
similar to the formation of PDDA/clay multilayers were used to get microchannels with 
varying number of protein patterns in the outlet regions of the bioreactor chip. It should 
be noted that the proteins collagen and fibronectin were added as separate layers in 
sequential steps and not as a mixture. 
 
LBL assembly inside microfluidic devices has been established earlier by multiple groups 
using laminar flow, as discussed in the introduction (Barker et al. 2001; Reyes et al. 
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2004; Shchukin et al. 2004; Tan & Desai 2003). In the current study, however, with the 
use of Braille peristaltic actuation, it was important to not have two streams mixing with 
each other. When the two polyelectrolyte streams mix together due to backflow, solid 
debris is formed (see Appendix J, Figure J1). The backflow problem was countered by 
adding a small step in the software program, i.e. after a particular polyelectrolyte stream 
had completed its run, the water wash streams began flowing, and the polyelectrolyte 
stream was pumped back in the opposite direction to its reservoir for 1 - 1.5 minutes. This 
back-pumping ensured that no polyelectrolyte was left in the mixing region (Figure J2).  
 
 
Figure 6.2: The creation of layered nanocomposite coatings. a) Step 1 of the process: 
PDDA flow and adsorption. The green channels have PDDA flowing from left to right. 
The black channels are valved off to avoid mingling of different streams, b) delivery of 





pump, white are in ‘valve off’ position and grey are ‘valve on’ position. c) Schematic 
representation of the completed multifunctional device with different nanocomposite 
coatings in the four outlet channels (four different colors in outlet channels represent 
different composition of coating). Cell seeding is through the outlet channels. d) 
Fluorescent micrographs of inlet and outlet regions of PDMS bioreactor (all taken with a 
10X dry objective, NA=0.25). The top nanocomposite coating layer is positively charged, 
as shown by pictures on the right, which show a green fluorescence for negative charge 
but no red fluorescence for positive charge.  
 
The resulting coatings were stable, hydrophilic, biofunctional and customizable (Figures 
6.2C and 6.2D). For example, it was possible to create a device with (PDDA/Clay)7 in all 
4 outlet channels, (PDDA/Clay)3 (Co/FN)4 in all 4 outlet channels, or (PDDA/Clay)3 in 
1st outlet channel, (PDDA/Clay)3  (Co/FN)1 in 2nd outlet channel, (PDDA/Clay)3 (Co/FN)2 
in 3rd outlet channel, (PDDA/Clay)3 (Co/FN)3 in 4th outlet channel. Therefore, in a 
multifunctional device, four different compositions of PEMs were simultaneously 
deposited inside one single device. 
 
6.3.2 Microfluidic-made nanocomposite multilayers are homogenous 
Fluorescent images of staining by positively and negatively charged dyes were used to 
verify the charges on the topmost exposed layer, stability of the layers and homogeneity 
of the coatings. The inlet PDDA stream is positively charged, as shown by green 
fluorescence of negatively charged 6-carboxyflourescein, whereas, the inlet clay stream is 
negatively charged as shown by the red fluorescence picture on the bottom left panel 
stained by the positively-charged sulphorhodamine (Figure 6.2D left inlay images). The 
right-side inlay images in Figure 6.2D shows green carboxyfluorescein staining of the 
outlet regions where a nanocomposite coatings of (PDDA/Clay)5.5 with PDDA on the 
outermost layer have been formed confirming the existence of a positive charged surface. 
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When the same outlet is stained for negative charge, no fluorescence was observed. This 
study illustrates that the outlet stream has one charge on its exposed surface, and that the 
nanocomposite coating formed is uniform.  
 
Figure J5 shows the fluorescence intensity of charged dyes after deposition of each layer. 
The fluorescence intensity is very weak in the earlier layers, and increases with layer 
number. At five bilayers, the intensity is very uniform, and well distributed. No change in 
intensity or intensity distribution was seen between five and seven layers. Thus, we 
conclude that five bilayers are sufficient to cover the entire area of the surface under 
investigation and create a homogenous surface.  
 
The topographical similarity of the PEMs deposited ((PDDA/Clay)8) on flat PDMS 
substrate and microfluidic PDMS device is shown in AFM images (Figure J6). The PEMs 
in microfluidic bioreactors were very similar to the ones deposited on flat PDMS in terms 
of morphology, topology and surface roughness. Thus both surfaces are structurally and 
morphologically similar.  These surface characteristics also match well with previously 
reported multilayers formed from these components (Lee et al. 2006; Podsiadlo et al. 
2005; Tang et al. 2003). 
 
6.3.3 Multifunctional LBL Nanocomposite Coating 
To demonstrate the efficient creation of LBL coatings with the capacity to support cells, 
we created four very different LBL coatings in one single bioreactor chip and compared 
their ability to support cell attachment and proliferation.  These four layers were: 
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oxidized PDMS substrate without any LBL coating, a PDDA-topped LBL coating 
((PDDA/Clay)3.5), a clay-topped LBL coating ((PDDA/Clay)4), and a protein-topped 
LBL coating ((PDDA/Clay)4 (Co/FN)5). 
 
 
Figure 6.3:  PDMS microbioreactor chip with multifunctional nanocomposite 
coatings. Four channels with compositions: (a) no coating, (b) (PDDA/Clay)3.5 (PDDA 
topped), (c) (PDDA/Clay)4 coating (clay topped), and (d) (PDDA/Clay)4 (Co/FN)5 were 
made by our process.   
 
The fluorescent micrographs of inlet and outlet regions (all with a 10X objective, gain=2, 
exposure time=0.10 sec) are shown placed on specific points in the schematic of the 
microbioreactor chip to showcase different surface functionalities. For each region (inlet 
or outlet), the pictures are stained to fluoresce for positive charge (PDDA, Co) shown by 
green color and for negative charge (Clay, FN) shown by red color. The PDDA inlet 
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stream has a green fluorescent micrograph and the DI water inlet streams have no green 
or red fluorescence. The clay stream inlet stream has a red fluorescent micrograph. In 
addition, phase contrast images (20X dry objective, all scale bars= 50 μm) compare cell 
cultures at day 15 of culture on the four different surfaces inside the same 




Figures 6.3 shows the results from the microbioreactor chip with multifunctional LBL 
nanocomposite coatings. The fluorescent micrographs of the inlet and outlet regions are 
laid on a schematic of the bioreactor chip and show top surface charge and functionality. 
For each region (inlet or outlet), the pictures are stained to fluoresce green for positive 
charge (PDDA, Co), or red for negative charge (Clay, FN). As seen in Figure 6.2D, the 
fluorescent pictures for the outlet regions in Figure 6.3 also show homogenous coatings 
of a specific charge depending on the nanocomposite coating fabrication steps. Even in 
the case of protein coating, the fluorescence signal (Figure 6.3D outlet channels patterned 
with proteins) is strong and not mixed with the other dye, consistent with the presence of 
a homogenous coating. 
 
Figure 6.3 also shows a comparison of cell spreading and attachment at day 15 of culture 
on the four different multifunctional nanocoated surfaces inside the same microbioreactor 
observed using a 20X dry objective (NA=0.45, plan fluor).  The cells are clearly most 
spread out and covering the entire surface in the last outlet channel (Figure 6.3D), which 
had a nanocomposite coating of the composition (PDDA/Clay)4 (Co/FN)5.  Cell 
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adherence and spreading were reasonable in the third outlet channel (Figure 6.3C) but 
poor on the other two surfaces. Thus by fabricating a single chip with different 
multifunctional nanocomposite coatings, we have compared primary bone marrow 
culture on four surfaces and seen distinct cellular responses. To confirm these results 
independently in more depth and to look at a wider range of surfaces, we performed 




Figure 6.4: Spreading and attachment of bone marrow stromal cells on different 
nanocomposite coatings over 1 to 10 days (all scale bars= 50 μm).  Bone marrow 
stromal cells from femurs and tibias of C57BL/6 mice were cultured on different 
surfaces. Micrographs depict the outlet regions of a microfluidic PDMS bioreactor chip 
where nanocomposite coatings were deposited and bone marrow stromal cells from 
femurs and tibias of C57BL/6 mice were seeded. The pictures are from representative 
samples at day 1 (left column), day 5 (middle column), and day 10 (right column).  The 
cells do not attach on an oxidized PDMS surface on any day (a, b, and c). The cells attach 
first (day 1 and 5) and then lift off from a substrate with PDDA layer exposed to cells (d, 
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e, f, (PDDA/Clay)7.5 , PDDA on top). The cells attach well on clay topped surfaces (g, h, 
i, (PDDA/Clay)7, Clay on top). The cells attach, spread and proliferate best on a 
nanocomposite coating with proteins and larger number of (PDDA/Clay)(Co/FN) 
bilayers (k, l, and m, (PDDA/Clay)4 (Co/FN)6). 
 
 
6.3.4 Number of bilayers and exposed polyelectrolyte affect primary bone marrow 
cells culture on PEMs inside PDMS bioreactors chips 
 
We screened a total of 30 nanocomposite coatings (different numbers of layers and 
combinations of components, all listed in Appendix J) of which we present data for 14 in 
this and the next sections (and Figures 6.4 and 6.5). The 14 different nanocomposite 
coatings were deposited either without protein coating (this section) or with additional 
protein coating (next section) and tested for bone marrow stromal cell attachment. The 
surfaces on which we tested cell culture were either positively or negatively charged; had 
no proteins or had proteins adsorbed on them; and were composed of 3 to 12 bilayers. 
The following are the compositions of the 14 PEMs on which whole bone marrow cell 
culture was tested: (PDDA/Clay)7.5, (PDDA/Clay)7,    (PDDA/Clay)3 (Co/FN)0,1,2,3,  
(PDDA/Clay)4 (Co/FN)0,2,4,6, (PDDA/Clay)5 (Co/FN)0,2,4,7.  We tested three device 
samples per variable, and cultured cells in these devices for more than 15 days. 
 
We first examined the effect of increasing the number of PDDA/Clay bilayers using 4 of 
the 14 different nanocomposite coatings. Figure 6.4 shows bone marrow stromal cells 
growing on different PEMs inside microchannels at day 1, 5 and 10, and quantitative 
measures of spreading, proliferation, and viability are given in Figure 6.5. The cells do 
not attach on an oxidized PDMS surface (Figure 6.4 A, B, and C). Similarly, cells did not 
remain attached on PDMS surfaces with 3-4 bilayers of PDDA and clay (image data not 
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shown).  Among surfaces that do support some degree of cell attachment, cell spreading 
was lowest (520 μm2/cell on day 15, condition A in Figure 6.5 A) when cells were 
cultured on a (PDDA/Clay)3 nanocomposite multilayer, and increased for cells on 
(PDDA/Clay)4  (816 μm2/cell on day 15, condition B in Figure 6.5A) and for cells on 
(PDDA/Clay)5  (1035 μm2/cell on day 15; condition C in Figure 6.5A). On further 
increasing the number of bilayers to (PDDA/Clay)7, cell spreading did not change 
significantly (1021 μm2/cell on day 15, condition E in Figure 6.5A). This may be an 
indication that at least 5 bilayers are needed to get a homogenous nanocomposite 
coverage, as has been illustrated previously for some LBL pairs  although not in 
microfluidic devices (Mendelsohn et al. 2003). 
 
There is some evidence in the literature that cells need a positively charged surface to 
attach well, since all vertebrate cells possess unevenly distributed negative surface 
charges (Freshney 1994). However, bone marrow stromal cells did not attach well to the 
positively charged PDDA-topped surface, initially attaching but later shrinking in size, 
detaching, and dying (Figure 6.4 D, E, F, (PDDA/Clay)7.5 , PDDA on top, condition D in 
Figure 6.5). (PDDA/Clay)7.5 was worse for cell attachment because PDDA is exposed to 
cells, and PDDA has been proven to be unfavorable for primary cell attachment (Fischer 
et al. 2003; Kidambi et al. 2004; Mohammed et al. 2004). Therefore, even though this 
surface had 7.5 bilayers, the chemistry of the top exposed surface affects the cell 
behavior, and when polymers which are cytophobic are exposed to cells, the cells will not 
attach and spread for long periods of time. Other primary cells also do not attach to 
PDDA surfaces (Fischer et al. 2003; Kidambi et al. 2004; Mohammed et al. 2004).  
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In contrast, the same bone marrow stromal cells adhered to a negatively charged clay-
topped surface (Figure 6.4 G, H, I, (PDDA/Clay)7, Clay on top), spreading (1021 
μm2/cell on day 15, condition E in Figure 6.5A) and remaining viable (79.5% cells alive 
on day 15, Figure 6.5C). This might be due to the higher surface area, higher roughness, 
and/or composition (SiO2, AlO4(OH)4, Na+) of the clay. This montmorillonite clay is 
composed of materials that the cells contact in their natural environment, and thus should 
be biocompatible. 
 
As evidenced from Figure J7 as well as results from cell viability and cell density assays 
(data not shown), there are no apparent differences between bone marrow stromal cell 
responses to PEMs created on flat PDMS substrates or PEMs deposited in microfluidic 
devices (see Figure 6.5). However, the physiological ratio of cells to fluids found in 
microfluidic devices is expected to create a more physiological microenvironment, 
compared to conventional cells culture. Such differences will be advantageous for 
enhanced autocrine and paracrine effects, for example, and are expected to affect cell 






































































Figure 6.5: Cell spreading, proliferation and viability on 14 different nanocomposite 
coatings. a) cell spreading at day 15 (x 103 μm2), b) fold increase in cell density at 





(Co/FN)0, B=(PDDA/Clay)4 (Co/FN)0, C=(PDDA/Clay)5 (Co/FN)0, D=(PDDA/Clay)7.5 
(Co/FN)0, E=(PDDA/Clay)7 (Co/FN)0, F=(PDDA/Clay)3 (Co/FN)1, G=(PDDA/Clay)3 
(Co/FN)2, H=(PDDA/Clay)3 (Co/FN)3, I=(PDDA/Clay)4 (Co/FN)2, J=(PDDA/Clay)4 
(Co/FN)4, K=(PDDA/Clay)4 (Co/FN)6, L=(PDDA/Clay)5 (Co/FN)2, M=(PDDA/Clay)5 
(Co/FN)4, N=(PDDA/Clay)5 (Co/FN)7. Surfaces topped with PDDA are not cytophilic for 
primary murine bone marrow cells. 
 
3.5 Protein-topped nanocomposite coatings are better at supporting bone marrow 
stromal cells 
 
The following 10 protein-topped LBL films deposited in microfluidic bioreactors were 
also tested for their ability to support bone marrow stromal cells: (PDDA/Clay)3 
(Co/FN)1,2,3,  (PDDA/Clay)4 (Co/FN)2,4,6,  and (PDDA/Clay)5 (Co/FN)0,2,4,7. Figure 6.4 K, 
L, and M show the bone marrow stromal cells growing on PEMs with protein coating 
((PDDA/Clay)4 (Co/FN)6) at day 1, 5 and 10. As compared to cells on (PDDA/Clay)7.5 or 
(PDDA/Clay)7 surfaces, the cells appear more spread. 
 
On adding 2, 5 or 7 bilayers of Co/FN to (PDDA/Clay)5,  the cell spreading on day 15 
increased from 1035 (no Co/FN)  to 2039, 2053, and 2085 μm2/cell respectively (Figure 
6.5A, condition C, L, M, N). The cell density increased from 2.35 x 109 cells/m2 (no 
Co/FN) to 2.61 x 109 cells/m2 (Figure 6.5B, condition C, L, M, N), and the percentage of 
live cells increased from 80% (no Co/FN) to 98% (Figure 6.5C, condition C, L, M, N), 
when two to seven bilayers of Co/FN were added to five bilayers of PDDA/Clay. 
Differences between 2, 5, and 7 bilayers of Co/FN were not statistically significant, 
suggesting that two layers of Co/Fn were sufficient to coat the PDDA/Clay surface 
completely and provide sufficient adhesive ligands on the exposed surface.  There may be 
a synergistic contribution of having both (PDDA/Clay) and (Co/FN) layers, as the stiff 
mechanical properties of (PDDA/Clay) (E(P/C)1= 0.11 GPa (Tang et al. 2003)) compared 
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to the relatively soft PDMS (EPDMS=2 MPa(Lee et al. 2004)) are also known to be 
beneficial for cellular adhesion (Lee et al. 2006; Sinani et al. 2003). 
 
For comparison with PEMs that have PDDA/Clay coatings, bone marrow stromal cells 
were also cultured on flat PDMS substrates on which either Co, or FN or a 1:1 mixture of 
Co and FN was adsorbed for 30 minutes. On these surfaces, the stromal cells detached 
after only a few days of seeding. The FN adsorption control was also performed in a 
microfluidic device surface, and the same result was found. Lack of cell spreading on 
these surfaces at day 15 is shown in Figure J7. 
 
The composition of the multilayers affects cell behavior as evidenced by cell spreading, 
attachment, proliferation and viability on biofunctional nanocomposite coatings. The cell 
sizes became larger with time on these cytophilic coatings. The bone marrow stromal 
cells achieved 80% confluence by day 3 of culturing in these nanocomposite coatings. 
These nanocomposite coatings had the most spreading, proliferation and density, and the 
largest number of live cells. Among the biofunctional nanocomposite coatings, the best 
ones for culture of bone marrow stromal cells were (PDDA/Clay)5(Co/FN)2, 4, 7. These 
results are consistent with our earlier observation about the effect of composition of 
nanocomposite coating on its ability to support primary bone marrow culture. 
 
The ECM combination we used in the current study is rather unique as FN has a Co 
binding domain (Williams et al. 1982). In fact, FN and Co are often used together for cell 
culture studies(BD Biosciences BD BioCoat™ Cell Culture Inserts). Moreover, 
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fibronectin and type IV collagen are both important members of the extracellular matrix 
of the bone marrow microenvironment (Tavassoli 1989). Both positively and negatively 
charged proteins adsorb to some extent on multilayer surfaces regardless of the surface 
charge because proteins bear on their surfaces domains with both positive and negative 
surface excess charges. Not surprisingly, adsorbed amounts and the protein layer 
thicknesses are larger when the proteins and the terminating polyelectrolyte layer are 
oppositely charged compared to protein adsorption onto films terminating with a 
similarly charged polyelectrolyte layer (Ladam et al. 2001). Proteins might denature and 
change conformation once adsorbed on the surface (Ratner et al. 1996), which may affect 
biological responses and confound the data.  The dominant charge of proteins depends on 
the pH, and pH was carefully monitored during our experiments. It is believed that other 
interactions, such as van der Waals and hydrophobic attraction are also likely to 
contribute to protein layer formation and stability (Decher & Hong 1991; Tang et al. 
2003).   
 
Our results compare well with other specific reports of culture of bone marrow cells and 
other primitive cells (Brynda et al. 2005; Garza et al. 2005). More broadly, PDMS 
substrates are widely used in medical research and in a variety of clinical devices 
(Makamba et al. 2005). Control of the polymer surface chemistry is a crucial aspect of 
such devices which rely heavily on cell-biomaterial interface. PDMS substrates are 
intrinsically hydrophobic due to the low surface energy backbone (Makamba et al. 2005; 
Makamba et al. 2003; Sia et al. 2003) and require a biofunctional hydrophilic film on the 
surface in order to promote cell attachment and interaction with substrate. The 
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biofunctional nanocomposite coating described in this report is specifically useful for 
making PDMS and other substrates conducive to culture of primary bone marrow cells.  
Our results with stratified LBL assembled films for primary murine bone marrow culture 
also corroborate studies with a variety of other cells types that demonstrate the broad 
usefulness of biofunctional LBLs on PDMS substrates (Ai et al. 2003; Forry et al. 2006; 
Mohammed et al. 2004; Reyes et al. 2004; Thierry et al. 2003).  Thus, the computerized 
microfluidic LBL methods described should also be more broadly applicable to a wide 
range of cell types and with many complimentary advantages over traditional LBL film 
formation methods, such as computerized pumps and valves for greater flow control, 
automatic processing using programmable software, customized creation of different 
coating compositions in different microchannels in one experiment, and reduced use of 
polymer and protein solutions.  Although this manuscripts describes these concepts using 
a relatively simple channel system with relatively low number and density of channels, 
the methods and devices are compatible for scale up to enable simultaneous preparation 
and testing of a much larger number of variables (Gu et al. 2007; Gu et al. 2004). 
 
6.4 Conclusion 
In this chapter, we have made the surface of microfluidic PDMS bioreactor chips 
hydrophilic, stable and cytophilic for an extended time by control of surface chemistry. 
This is achieved by the growth of stable biofunctional nanocomposite coatings on the 
PDMS surface, so that the primary murine bone marrow stromal cells can attach and 
spread on the substrate and mimic ECM-cell interactions ex vivo. The nanocomposite 
coatings were made utilizing computerized microfluidic perfusion systems and various 
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polyelectrolytes PDDA, clay, type IV collagen and fibronectin to optimize the PDMS 
channel surface for successful culture of primary murine bone marrow cells in ex vivo 
cultures. The adherent cells of marrow attached and spread on nanocoated PDMS 
microchannel surfaces for more than two weeks. The protein-topped nanocomposite 
coatings ((PDDA/Clay)5 (Co/FN)2,4,7) were best to achieve maximum cell spreading, 
proliferation and viability for these cells. Although this paper focused on optimizing 
attachment of bone marrow stromal cells, the process should be useful for creating 
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Hematopoeitic stem cells (HSCs) are a type of adult stem cell that give rise to all cells in 
the blood lineage. In adult mammals, they reside in the spongy bone marrow of the long 
bones. Long term HSCs (LT-HSCs), the most primitive HSCs, can both self-renew and 
differentiate into daughter progenies. These cells provide the constant supply of myeloid 
and lymphoid cells in the marrow as well as the circulatory system. 
 
Blood is the most commonly transplanted tissue in clinical settings, which makes HSCs 
an important candidate in establishing better treatments for hematological malignancies. 
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HSCs, however, when isolated and then cultured in vitro, quickly lose the expression of 
key antigens on their cell surface (Zhang et al. 2005). They undergo differentiation as the 
time in culture increases. Many research groups have come up with innovative solutions 
to prolong the self-renewal capacity or ‘stemness’ of HSCs in vitro cultures, such as co-
culturing with different support cells, exposing to a media rich in cytokines found in the 
bone marrow, growing HSCs in different extracellular substrates, using serum free media, 
changing metabolic parameters, non-contact co-cultures and changing gene expression 
(overexpression, deletion, forced expression of a certain gene) either in HSCs or support 
cells (Bellantuono 2004; Cheung et al. 2006; Kirouac et al. 2006; Madlambayan et al. 
2001; Mikkola et al. 2006; Sauvageau et al. 2004; Sharma et al. 2006; Sorrentino 2004; 
Takagi 2005; Uher et al. 2003; Jung et al. 2005). Even with all these ways to elongate the 
self renewal capacity of HSCs in vitro, the current state-of-the-art HSCs true expansion is 
at 5.2 fold (initial cell number X 5.2)  (Madlambayan et al. 2005). This number is much 
different form the in vivo capacity of expansion of HSCs which is 8400 fold (Sauvageau 
et al. 2004). We hypothesize that the in vitro expansion capability of true HSCs is 
unlikely to change significantly unless dramatic measures are taken to simulate the in 
vivo HSC niche. We aim to use microfluidic tools to create engineered niches for HSCs 
which will help us understand and control HSC proliferation and self renewal, and even 
study the biological role of HSCs in the niche using the optimized microbioreactor.  
 
In microfluidic poly(dimethylsiloxane) (PDMS) bioreactors, a few HSCs and primary 
bone marrow cells (~100s of cells) can be cultured in nanoliter volumes of fluids under 
defined microenvironments. The nanoliter scale microfluidic bioreactors have an 
advantage over conventional bioreactors or other macroscopic culture systems in that the 
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small volume allows even one or a few HSCs to condition the culture environment 
significantly. An important feature of the bone marrow HSC niche or any in vivo HSC 
niche is that the cells are arranged in a three-dimensional structure. In fact, three 
dimensional cultures of HSCs have been reported to increase the expansion of HSCs in 
vitro (Bagley et al. 1999; Banu et al. 2001; Braccini et al. 2005; Kim et al. 2003; Li et al. 
2001; Rookmaaker et al. 2005; Rosenzweig et al. 1997; Takagi 2005; Tun et al. 2000; 
Wang et al. 1995). Some of these studies include culturing HSCs on collagen beads, with 
capillaries of endothelial cells,  in porous hydroxyapatite disks, on silk fiber matrices, in 
porous biomatrix Cellfoam,  on collagen coated porous polyvinyl formal resin, on 
tantalum-coated porous biomaterial, porous bovine collagen microspheres, and three 
dimensional bone marrow spheroids. 
 
Another salient feature of the in vivo HSC niches are that HSCs are surrounded by a 
heterogeneous population of supporting cells, which provide soluble and adhesive signals 
to HSCs, and typically, HSCs are very rare. For example, in the mouse bone marrow 
there is one HSC per 30,000 bone marrow cells. In order to export these features to our 
microfluidic bioreactors, we started with co-culture of hematopoeitic progenitor cells 
(HPCs) and different types of support cells either as cell lines or primary cells. In vitro 
co-culture of HSCs with support cells is very common in the literature (Taichman 2005). 
HSCs have been co-cultured with various types of cells including but not limited to: 
osteoblasts, brain endothelial cells, fibroblasts, bone marrow stromal cells, mesenchymal 
stem cells, bone marrow endothelial cells, and cell lines of stromal and osteoblastic cells 
such as MS-5 and OP-9.    
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The literature also supports the idea that primitive quiescent HSCs are located in the 
regions of very low oxygen tension (close to 1%) and the more differentiated progenitors 
are found at higher oxygen levels (Levesque et al. 2007; Parmar et al. 2007; Sipkins et al. 
2005).  Therefore, we conducted our experiments at two oxygen levels: 20% O2 in a 
standard incubator and 1.5% O2 in a hypoxia chamber. 
 
The stem cell activity of hematopoeitic stem and progenitor cells co-cultures in our 
microfluidic system was detected by colony formation unit (CFU) assay. Among the in 
vitro assays for HSC activity, CFU is an established and popular assay.  The numbers and 
types of colonies formed in CFU assay indicate the stage of differentiation of the HSCs 
or HPCs in culture. Other in vitro assays for HSC activity are long term culture initiation 
assay (LT-IC), cobblestone area formation assay (CFAC), immunostaining for surface 
antigens present on HSCs (sca-1, c-kit, CD150 for mouse HSCs). Apart from the in vitro 
assays, the ‘gold standard’ assay for quantifying HSC activity is in vivo competitive 
repopulation assay (CRU), where the ‘test’ cells are injected into a lethally irradiated 
animals and the transplantation of these cells and their repopulation of the marrow are 
evaluated from 4 weeks for up to 16 weeks.  
 
For the microfluidic co-culture of hematopoeitic cells, we chose a bioreactor with gravity 
–driven flow as it allows culture of small number of non-adherent pure HSCs without 
shearing or washing away, inclusion of different supporting cell types that can provide 
adequate cues for HSCs, 3-D environment created by support cells in micro-
compartments, gentle replacement of media from bottom channel by convection and 
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diffusion, and finally, easy removal of cells for CFU assays by cutting open the top 
microchannel containing cells. These experiments are our first step towards using 
microfluidically cultured HSCs for long term in vivo reconstitution assays. 
 
In Chapter 8, we generated erythrocytes for 15 days in a similar semi-porous membrane 
based PDMS microbioreactor from unsorted bone marrow mononuclear cells. Generation 
of erythrocytes required differentiation of hematopoietic stem, progenitor and erythroid 
cells without major emphasis on stem cell self-renewal in a media formulation containing 
differentiation and expansion factors. In the present chapter, we focus on co-culture of 
hematopoietic cells with supporting cells for self-renewal, expansion and maintenance of 
stem and progenitor cells.  
 
7.2 Experimental Methods 
7.2.1 General Cell Culture 
The cell lines used in this work were: EMLC1, K562 and Meg01; while the primary cells 
used were: primary murine bone marrow stromal cells (BMSC), human micro vascular 
endothelial cells (EC) and Lin- c-kit+ Sca-1+ primary mouse marrow hematopoeitic 
progenitor cells (HPC).  
The EMLC1 cell line was obtained from a male BDF1 mice bone marrow retrovirally 
infected with LRARalpha403SN. This cell line is non-adherent SCF-dependent lympho-
hematopoietic progenitor cell line and can differentiate to B-lymphocyte, erythrocyte, 
neutrophil, macrophage, mast cell, megakaryocyte lineages. We chose this cell line as a 
model for HPCs and HSCs. The K-562 cell line is a non-adherent human erythroleukemia 
line from chronic myelogenous leukemia in terminal blast crises, highly undifferentiated 
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multipotential, hematopoietic malignant cells. These cells are of granulocytic series and 
differentiate to erythrocytic, granulocytic and monocytic lineages. The Meg-01 is a non-
adherent human megakaryocyte line from megakaryoblastic crisis of chronic 
myelogenous lymphoma (CML). K-562 and Meg-01 cells were chosen as models for 
hematopoietic progenitor cells. 
 
Cell Lines 
EML C1 cells (CRL-11691, ATCC) were propagated in ATCC complete growth medium 
(30-2005, Iscove's modified Dulbecco's medium with 4 mM L-glutamine adjusted to 
contain 1.5 g/L sodium bicarbonate), supplemented with 200 ng/ml mouse stem cell 
factor,  20% heat-inactivated fetal bovine serum and 1% antibacterial/antimycotic at 37 C 
in a humidified 95% air + 5% carbon dioxide incubator.   
 
K-562 cells (CCL-243, ATCC) were cultured in ATCC complete growth medium (30-
2005) with 10% fetal bovine serum and 1% antibacterial/antimycotic at 37 C in a 
humidified 95% air + 5% carbon dioxide incubator.   
 
Meg01 cells (CRL-2021, ATCC)  were propagated in ATCC complete growth 
medium(30-2001, RPMI-1640 medium) supplemented with 10% fetal bovine serum and 
1% antibacterial/antimycotic at 37 C in a humidified 95% air + 5% carbon dioxide 




Primary murine bone marrow stromal cells (BMSC) were isolated from adult wild type 
C57BL/6 mice in MyeloCult (M5300, StemCell Tech.) supplemented with 1% v/v 
antibiotic–antimycotic (Mehta et al. 2007a). BMSCs were the adherent cells of the bone 
marrow present in the culture flasks after two weeks of growth, and were propagated in 
MyeloCult supplemented with 1% hydrocortisone and 1% antibacterial/antimycotic.  
 
Primary human dermal microvascular endothelial cells (EC) were cultured in EGM-2MV 
(EGM-2MV Microvascular Endothelial Cell Medium, CC-3202, Lonza) media 
supplemented with 1% v/v antibiotic–antimicotic. 
 
Murine hematopoietic progenitor cells were isolated from adult (6- to 8-week-old) 
C57BL/Ka-CD45.2:Thy-1.1 mice by the following process. The bone marrow cells from 
femurs and tibias were flushed out and stained with Sca-1-APC (E13-161.7, BD 
Pharmingen; 1:400), c-kit-biotin (2B8, BD Pharmingen; 1:400), FITC-conjugated lineage 
antibodies (such as Ter119, CD2, Gr-1 or B220, BD Pharmingen; 1:800) as described 
earlier (Kiel et al. 2005). Briefly, after primary and secondary antibody incubation (StAv-
APCCy7 (1:400), anti-FITC microbeads (Miltenyi Biotec Inc.; 1:10)), the cell suspension 
was  depleted of lineage positive cells were by using the autoMACS Pro Separator 
(Miltenyi Biotec Inc.), and the enriched cells were sorted by flow cytometry to get c-kit+ 
Sca-1+ cells. These cells (Lin- Sca-1+ c-kit+) were used in devices within a few hours of 
cell sorting and not cultured in dishes at all.   
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7.2.2 Hematopoeitic Co-Culture Microfluidic Device Fabrication 
The microfluidic devices consisted of two layers of microchannels separated by a 
polyester semi-porous membrane (0.4 micron polyester membrane (Corning 3452) 
(Figure 7.1)  Details about fabrication of silicon molds can be found elsewhere (Torisawa 
et al. 2007). The upper channel was designed with a dead-end to facilitate cell capture 
whereas the lower channel was continuous to allow medium perfusion (Torisawa et al. 
2007). Mortar made of PDMS and toluene (Chueh et al. 2007) was used to bond the two 
pieces of microchannels along with the membrane. The device was plasma oxidized to 
make it hydrophilic and fibronectin was adsorbed on it for 30 minutes. The device was 
then sterilized by exposure to UV for 30 minutes. Three devices were used for each set of 
experiments.  Experiments were repeated three times. 
 
7.2.4 Cell Seeding 
The T-25 culture flasks were placed in a humidified 5% CO2 cell culture incubator. 
Unless otherwise mentioned, at 70-80 % confluence, the cells were passaged by washing 
in PBS, and incubating with 0.25% Trypsin/EDTA (Invitrogen, Carlsbad, CA). The 
Trypsin solution was neutralized with 15% FBS in DMEM and spun down with a 
centrifuge (ThermoForma, Marietta, OH) for 2 minutes at  4 oC and 1000 RPM. The 
supernatant was removed and the pellet was resuspended in DMEM media. The pellet 
was reconstituted in 4 ml of cell specific media, and 1 ml of this suspension was used for 
creating a new plate of respective cells. The cells were passaged every third day.   
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When the cells were to be cultured in the PDMS microbioreactors, the pellet was 
reconstituted in 70-100 μL of respective cell specific media. The cells were counted as 
number of cells per ml of media, and the final cell suspension was created by aliquoting 
calculated volumes of cells according to the combination and ratio of cells desired for a 
particular co-culture (for eg. BMSC + EC + HPC (2:2:1) for one such co-culture). The 
co-culture combinations were:  BMSC + HPC (4:1), BMSC + EC + HPC (2:2:1), EC + 
HPC (4:1), EC + MEG 01 + HPC (6:4:1), EC + K562 + HPC (6:4:1), and BMSC + EC + 
EMLC1 (2:2:1). 
 
Cells (~5000 total per device) were seeded in the device by gravity-driven flow, by 
creating a height difference of 6 inches between the inlet of one channel layer, through 
the semi-porous membrane layer between channel layers, and the outlet reservoirs of the 
other channel layer. Once cells were seeded, media levels in the reservoirs were adjusted 
to same media volumes, and the devices were incubated at 37oC and 5% CO2 in a 
humidified cell culture incubator. Fresh media was pipetted into the inlet of the media 
transporting channel (bottom channel layer) every day and old media was removed from 
the outlet.  Duplicate control experiments were performed in tissue culture plastic dishes. 
 
7.2.6 Hypoxia Chamber 
The co-culture of hematopoietic and support cells were performed at two oxygen 
tensions: 20% oxygen (in a conventional cell incubator with 5% CO2) and 1.5% oxygen 
(hypoxia). A hypoxia chamber (Stem Cell Technologies) was used for keeping the 
microdevices containing cells at 1.5% oxygen for the duration of co-culture. The hypoxia 
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chamber was gassed daily with a premixed cylinder of nitrogen, carbon dioxide and 
oxygen with a gas composition of 93% N2, 1% O2 6% CO2 (Cryogenic Gases, Metro 
Welding Supply Corporation, Detroit, MI) to achieve 1.5% oxygen after exchange of 
media in the microdevices. The oxygen tension inside the hypoxia chamber was set to 
1.5% by measuring gas exiting the chamber for oxygen content using a KE-25 galvanic 
cell type oxygen sensor (Figaro Engineering Inc, Japan) with accuracy of ±1% within full 
oxygen range (0-100%). A calibration of the sensor output (mV) with respect to oxygen 
concentration provided by the manufacturer was used to find out the oxygen 
concentration.  
 
7.2.7 Removal of Cells and CFU Assay 
After seven days of co-culture, the cells were removed from microdevices to be assayed 
for colony forming activity. The devices were cut, washed multiple times with media to 
collect the removed cells. The cells were then plated in 1:9 solution of IMDM with 2% 
FBS and M3334 Methocult (M3434, Stem Cell Tech) in sterile non-cell culture treated 35 
mm Petri dishes. The dishes were incubated for 12 days at 37°C with 5% CO2 and ≥95% 
humidity and the resulting colonies were identified and count colonies according to 
established protocol. The CFU assay was performed in the same way for the control co-
cultures performed in tissue culture plastic dishes. The colonies identified and counted 
were: Colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte(CFU-
GEMM), Colony-forming unit-granulocyte macrophage(CFU-GM), Colony-forming 







Figure 7.1: Microfluidic bioreactors used for co-culture of hematopoietic cells with 






7.3 Results and Discussion 
The microfluidic devices used for co-culture of hematopoeitic cells studies are shown in 
Figure 7.1. In these devices, the cells were seeded in the upper channel which had only 
one inlet and no outlet. The bottom channel with one inlet and one outlet were used for 
refreshing the media and delivering it to cells through a semi-permeable membrane (pore 
size 400 nm) between the top and bottom channel by gravity-driven flow.  
 
7.3.1 Three dimensional co-culture of HPCs and cell lines with different support 
cells 
 
The preliminary investigation of the feasibility of hematopoeitic cell culture in 
microfluidic bioreactors was performed for seven days. The co-cultures performed in 
different ratios were: primary murine bone marrow stromal cells (BMSC) + Human 
micro vascular endothelial cells (EC) + EMLC1 (2:2:1), BMSC + EC + HPC (Lin- c-kit+ 
Sca-1+ primary mouse marrow cells) (2:2:1), BMSC + HPC (4:1), EC + HPC (4:1), EC + 
MEG 01 + HPC (6:4:1), and EC + K562 + HPC (6:4:1). Pictures taken after 24 hours of 
co-culture at these different cellular compositions are shown in Figure 7.2 A. The co-
cultures of hematopoeitic and support cells in one micro-compartment of the top channel 
can be seen in this figure. The cells are in close contact with each other and even seem to 
form three dimensional spheroid like structures reminiscent of embryoid bodies in some 











Figure 7.2:  A) Pictures of microniche compartments of the top cell loaded channels after 
24 hours of co-culture for all six different cell combinations tested. Each micro-
compartment is 300 μm wide and long and 100 μm high. B) CFU data for hematopoeitic 
& support cell co-cultures in microfluidic bioreactors represented as number of colony 




After seven days of co-culture in microbioreactors, the cells were removed from the devices and plated in 
methylcellulose gel supplemented with cytokines and antibacterial/mycotic. The numbers and types of 
colonies were quantified for each co-culture after 12 days. Figure 7.2 B shows the number of CFCs per 
1000 HPCs (or EMLC1) for all six co-cultures tested. We observed a maximum number of CFCs for the 
co-culture of BMSCs + HPCs, followed by BMSC + EC + HPC, and others as seen in Figure 7.2 B. As 
expected, when using EMLC1 cell line along with EC and BMSC, we obtained minimal number of 
colonies. When comparing co-culture of HPCs with either BMSCs or ECs alone, more colonies were found 
when HPCs were with BMSCs. This may be because BMSCs consist of all heterogeneous adherent cell 
types in the bone marrow and can recreate the in vivo bone marrow microenvironment, compared to ECs 
which were from a completely different microenvironment (human dermal endothelium). The types of 
colonies observed here were CFU-G, CFU-M, CFU-E, BFU-E, CFU-GM, and a few CFU-GEMM. The 
types of colonies and distribution of colonies are the same for all 6 cases, and were found to be not 
significant statistically when tested by ANOVA. The differences in the number of CFCs between colonies 
formed in the six co-cultures were statistically significant at α=0.001 as tested by ANOVA. 
 
These results indicated that it is possible to co-culture hematopoeitic cells in microfluidic 
bioreactors and isolate the cells to perform in vitro CFU assay on them. The 3-D co-





Figure 7.3: CFU data for hematopoeitic & support cell co-cultures in microfluidic 
bioreactors. A) Number of colony forming cells per 1000 HPCs for different ratios of 
HPCs to BMSCs ranging from 0:1 to 1:1000 for co-cultures performed at two oxygen 
tensions (20% and 1.5%), B) Distribution of colony types (as percentage of all colonies) 
at two different oxygen tensions for all ratios of HPCs to BMSCs. 
 
7.3.2 Ratio of BMSCs to HPCs for maximum number of colony formation 
From the Figure 7.2B we obtained maximum number of colonies when culturing BMSCs 




what ratios of cells needed to be cultured to get the maximum number of colonies. Figure 
7.3A shows the number of CFCs per 1000 HPCs for co-cultures of HPCs and BMSCs at 
different ratios from 0:1, 1:0, 1:1, 1:2, 1:4, 1:8, 1:10, 1:20, 1:40, 1:60, 1:80, 1:100, 1:150, 
1:200, 1:300, to 1:1000. As a negative control, when only BMSCs are cultured, there was 
no colony formation. However, when only HPCs were cultured in microfluidic 
bioreactors, there were ~55 CFCs per 1000 HPCs. This number kept increasing as more 
BMSCs were cultured with HPCs all the way up to the ratio of 1:100 and 1:150, when it 
becomes constant. After further increase in the number of BMSCs, the colony formation 
activity actually decreased from 1:300 all the way up to 1:1000. Thus, the optimal ratio 
for co-culturing HPCs and BMSCs to get the maximum number of colony formation was 
found to be 1:100, and this ratio was used for future co-cultures of HPCs and BMSCs. 
Although HSCs and HPCs have been co-cultured with different support cells or feeder 
layers in the past 50 years of HSC research, there was never an attempt to optimize the 
number of support cells needed to maintain HSCs in a self-renewing state in vitro. In the 
literature, HSCs are typically cultured over a confluent layer of feeder/support cells 
treated with radiation or biochemicals (such as Mitomycin C) to prevent further cell 
division of support cells. In such systems, the ratio of HSCs  to support cells can be 
greater than 1:1000, which as we just saw above, is not optimal for maximal colony 
formation, and consequently for maintaining the stemness of HSCs in vitro. 
 
Another trend emerging from this result is that fewer colonies were formed at 1.5% 
oxygen as compared to 20% oxygen at all ratios. This is intuitive because not all 
progenitors may survive and thrive at lower oxygen tension. When the same experiment 
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was carried out in conventional in vitro culture (tissue culture plastics) at the ratio of 
1:100 HPCs to BMSCs, there are 80 CFCs/1000 at 1.5% oxygen and 100 CFCs/1000 at 
20% oxygen.  The values reported in literature for similar hematopoietic cultures at 1:100 
or higher ratio of HPCs to BMSCs match those from our experiments (Fei et al. 2007; 
Nakayama et al. 2006).  
 
The differences between number of colonies formed at all ratios were statistically 
significant at α=0.001 as tested by ANOVA. Furthermore, the colony formation (number 
of CFCs) at two oxygen tensions colonies were statistically significant at α=0.001 as 
tested by ANOVA. Additionally, when comparing microfluidic co-cultures and TCPS 
controls, the higher number of CFCs in microbioreactor cultures was statistically 
significant at both oxygen levels as evaluated by Student’s t test. 
 
7.3.3 Distribution of colonies at different oxygen levels 
Figure 7.3 B shows the distribution of colony types at two different oxygen tensions for 
all ratios of HPCs to BMSCs.  At 20% oxygen, ~10% colonies are the most primitive 
CFU-GEMM, while at 1.5% oxygen, double the number (~21%) colonies are the most 
primitive CFU-GEMM. The progenitor colonies CFU-GM, CFU-G, CFU-M are higher at 
20% oxygen as compared to 1.5% oxygen. Furthermore, more BFU-E are observed at 
1.5% oxygen (~5%) than at 20% oxygen (~2%), which is expected because hypoxia 
induces EPO production by progenitors, which enhances number of BFU-E colonies 
(Cipolleschi et al. 1997). For the tissue culture plastics control of the same experiment at 
the ratio of 1 HPCs to 100 BMSCs (1:100), 14% of colonies were CFU-GEMM at 1.5% 
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oxygen and 5% of colonies were CFU-GEMM at 20% oxygen tension. The values 
reported in literature for similar hematopoietic cultures at different oxygen levels follow a 
similar trend as seen in our experiments (Cipolleschi et al. 1993; Cipolleschi et al. 2000; 
Ivanovic et al. 2000; Ivanovic et al. 2004).  
 
The differences between number of CFU-GEMM and BFU-E colonies at both oxygen 
tensions were statistically significant at α=0.001 as tested by ANOVA. Furthermore, 
when comparing microfluidic co-cultures and TCPS controls, the higher number of CFU-
GEMM and BFU-E in microbioreactor cultures was statistically significant at both 
oxygen levels as evaluated by Student’s t test.  
 
Overall, we observe that microfluidic co-culture produced higher number of colonies, 
with more primitive colonies as compared to TCPS control, which suggests that bone 




In this chapter, we performed 3-D co-culture of hematopoeitic cells in microbioreactors 
for 7 days and looked at the colony forming ability of the cells after co-culture with 
different support cells in various ratios. We found that of all the combinations that we 
tried, maximum number of colonies was observed in a co-culture of HPCs and BMSCs. 
Further, ratio of 1:100 for HPC to BMSC was found to be optimal for number of colonies 
in CFU assay in the present study. Lower oxygen tension (1.5%) better at maintaining 
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primitive colonies in culture compared to 20% oxygen. Future microfluidic 
hematopoeitic cultures will be performed using 1:100 HSCs to BMSCs in order to test the 
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CHAPTER 8  
 
CAPTURE AND EXPANSION OF 
SMALL NUMBERS OF NON-
ADHERENT PRECURSOR 
CELLS IN MICRONICHES WITH 
EMBEDDED SEMI-POROUS 





Hematopoiesis is the process by which hematopoietic stem cells (HSCs) in the bone 
marrow, spleen and liver develop into mature blood cells.  According to the 
monophyletic theory, a single type of stem cell gives rise to all mature blood cells in the 
body (Klinken 2002).  Hematopoietic tissue proper includes a range of maturing 
hematopoietic cells originating from the proliferation, commitment, and differentiation of 
blood-born HSCs and progenitors, which seed the marrow (Morrison et al., 1995). 
Enucleated erythrocytes are one of the progenies of HSCs formed by differentiation of 
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erythroid progenitors, and are turned over every 21 days over the entire lifetime of 
humans. 
 
There is great interest in establishing in vitro erythropoiesis to supply clinical blood 
needs and also in new research using blood as a therapeutic biodistribution vector 
because enucleated erythrocytes have systemic circulation and no progression of DNA 
into new generations of erythrocytes (Douay and Andreu, 2007, Ropars et al., 1985). In 
addition, small scale in vitro production of erythrocytes would provide a platform for 
physiological assays to detect toxic and mutagenic compounds (Shuga et al. 2007) as well 
as an assay system to identify crucial autocrine/paracrine factors. 
 
Microfluidic devices enable greater control of the in vitro cell microenvironment than 
conventional culture systems. For example, the small ratio of fluid to cell volumes 
enhances autocrine and paracrine effects over what would be seen with static Petri dish 
culture, and active convective fluid flow in the device can regulate the chemical as well 
as the mechanical environment (Mehta et al. 2008, Shim et al. 2003, Walker et al. 2004). 
Therefore, our goal in this chapter is to use these devices to create a model of 
erythropoiesis-on-a-chip.   
 
Most microfluidic devices that utilize small numbers of cells employ adherent cells 
because of the need to retain cells inside microchannels.  However, many biologically 
important cells, such as hematopoietic precursor and stem cells, are non-adherent. 
Microfluidic devices that can mechanically capture non-adherent cells using weir-like 
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structures have been described but often require large numbers of cells and capture only a 
small percent of cells that are introduced (Lee et al. 2005 and 2006, Neville 2007).  
Microdevices using wells for capturing cells have also been developed (Khademhosseini 
et al. 2004 and 2005, Gutierrez and A. Groisman, 2007, Deutsch et al. 2006, Di Carlo et 
al. 2006, Sinclair and Salem 2006, Lee et al. 2006, Deutsch et al. 2006, Lee et al. 2005, 
Carlo, Wu and Lee 2006, Wu et al. 2007, Neville et al. 2007). There are few if any 
reports of performing small scale microfluidic culture of non-adherent precursor cells for 
extended periods of time.  Trapping cells (adherent or non-adherent) within microfluidic 
channels is attractive for various cell studies. However, the capture efficiency of cells 
within microchannels (calculated as cells captured in microdevice divided by total cells 
input as cell suspension is not high (often below 1%) for various studies in the literature 
(see Table 8.1). These numbers indicate that new designs of microdevices are needed to 
increase cell trapping efficiency.  By incorporating semiporous membrane to create small 
chambers for spatial confinement of cells in our microdevices, we demonstrate here a 
simple way to retain ~80% of non-adherent cells.  
 
The utility of our system is demonstrated by production of erythrocytes from 
hematopoietic progenitor cells.   In addition to the challenges of handling small numbers 
of non-adherent cells, small scale in vitro production of erythrocytes from progenitors 
can be difficult as multiple steps of culture, including co-culture on feeder layers and 
changes and replacements of media, are required.  The porous membrane sandwich 
design allows not only efficeint capture of progenitor cells, but also gentle refreshment 
and exchange of media needed for expansion as well as differentiation of cells without 
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worry of washout.  Additionally, by using a media containing both expansion and 
differentiation factors, we show that erythrocytes can be produced even without stepwise 
changes in the media composition.  Overall, these experiments create first steps towards 
hematopoieis-on-a-chip.  
 











(%) † Reference 
              
Straight 
Channel 0  0 1000000 0 _ 
         
Cell Docking* 
in microwell 500 10 5000 20000000 0.025 
Khademhosseini 
et al. 2004  
Cell Docking 
in microwell 857 7 6000 20000000 0.030 
Khademhosseini 
et al. 2004  
Cell Docking 
in microwell 688 8 5500 20000000 0.028 
Khademhosseini 
et al. 2004  
         
Cell Docking 
in microwell 340 25 8500 30000000 0.028 
Khademhosseini 
et al. 2005  
         
Dynamic 
Array‡ 1 576 576 1000000 0.058 
 Carlo, Wu and 
Lee 2006 
         
Dynamic 
Array 29 64 1856 1000000 0.186 Lee et al. 2006 
         
Dynamic 
Array 10 184 1840 1000000.00 0.18 Wu et al. 2007 
         
Dynamic 
Array 50000 6 300000 3020000.00 9.93 
Neville et al. 
2007 
          
Side 
Compartments 95 21 2000 2500 80 Present work 
*Cell Docking: Microchannels sealed with a substrate with microwells. Some of the cells 
rest in microwell grooves when cell suspension flows though the channel. 
‡Dynamic Array: Mechanical structures designed to trap cells, with multiple number of 
repeating arrays. 
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†Capture efficiency calculated as: total cells captured divided by cells in suspension 




8.2.1 Microdevice Fabrication 
Microfluidic devices consisted of two layers of microchannels separated by a polyester 
semi-porous membrane (3 micron polyester membrane (Corning 3452).  Details about 
fabrication of silicon molds can be found elsewhere (Torisawa et al. 2007). The upper 
channel was designed with a dead-end to facilitate cell capture whereas the lower channel 
was continuous to allow medium perfusion (Torisawa et al. 2007). Mortar made of 
PDMS and toluene (Chueh et al. 2007) was used to bond the two pieces of microchannels 
along with the membrane. The device was plasma oxidized to make it hydrophilic and 
fibronectin was adsorbed on it for 30 minutes. The device was then sterilized by exposure 
to UV for 30 minutes. Three devices were used for each set of experiments.  All 
experiments were repeated 3-4 times. A device schematic and photograph are shown in 
Figure 8.1.  
 
8.2.2 Cell seeding in microdevice  
Primary murine bone marrow cells were isolated from adult wild type C57BL/6 mice in 
MyeloCult (M5300, StemCell Tech.) supplemented with 1% v/v antibiotic–antimycotic 
(Mehta et al. 2007). The cell suspension was then placed on a ficoll (Stem Cell Tech) 
column and after 30 minutes of centrifugation the band of mature erythrocytes was 
removed.  The resulting cell suspension was composed of bone marrow mononuclear 
cells (BMMNCs), which contain a small fraction of HSCs (less than 0.5%; Kiel et al. 
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2006). These cells were centrifuged again to form a pellet and then resuspended in 80 μl 
of either expansion media or the combined expansion + differentiation media.  
 
Cells (~2000 per device) were seeded in the device by gravity-driven flow, by creating a 
height difference of 6 inches between the inlet of one channel layer, through the semi-
porous membrane layer between channel layers, and the outlet reservoirs of the other 
channel layer. Once cells were seeded, media levels in the reservoirs were adjusted to 
similar fluid levels, and the devices were incubated at 37oC and 5% CO2 in a humidified 
cell culture incubator. Fresh media was added via the inlet of the media transporting 




Figure 8.1: Schematic of microdevice for generation of erythrocytes. The top view of the 
device is shown in (a). A semi-porous membrane separates the side compartment 
microniches containing top channel from the straight bottom channel. An actual 
microdevice with a penny for scale is shown in (b). Orange colored food dye fills the top 
channel while a green colored food dye covers the bottom channel. Transparent semi-
porous membrane is barely visible in (b). 
 
8.2.3 Media formulation for Erythrocyte Generation  
Various media compositions to support erythropoiesis have been reported (Bridell et al. 
1997, Kie et al 2003, Kim et al. 2002, Neildez-Nguyen et al. 2002, Giarratana et al. 2005, 
Microniche
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Miharada et al. 2006, Papayannopoulou et al. 1996, Wojchowski et al. 2006, Miller and 
Klein 1996, Rahman et al. 2000, Nagler et al. 1994, Pick  et al. 2002, von Lindern et al. 
1999, Szilvassy et al. 1996, Muench et al. 1993). The common ingredient in all of these 
cocktails is erythropoietin (Epo), a major regulator of erythropoiesis. Other cytokines 
which help enable differentiation of erythroid progenitors to erythrocytes are IGF-II and 
Tpo. 
 
In this work, we use a medium to support erythropoiesis which contains both expansion 
(Zhang and Lodish, 2005) and differentiation (Neildez-Nguyen et al. 2002) factors and is 
well-suited to the heterogeneous starting populations of cells used.  The composition of 
the media used for generating erythrocytes was as follows: StemSpan serum-free medium 
(StemCell Tech, Vancouver, CA) was supplemented with 10 μg/mL heparin (Sigma, St 
Louis, MO), 10 ng/mL mouse SCF, 20 ng/mL mouse Tpo, 20 ng/mL mouse IGF-2 (all 
from R&D Systems, Minneapolis, MN), 10 ng/mL human FGF-1 (Invitrogen, Carlsbad, 
CA) (Zhang and Lodish, 2005) and 1% v/v antibiotic–antimycotic (15240, Gibco); this 
we term the hematopoeitic ‘expansion media’. Alternatively, 1% deionized BSA, 5 ng/ml 
mouse IL-3 (Peprotech), 10-6 M hydrocortisone (StemCell Tech), 6 IU/ml human Epo 
(Epogen), 100 μg/ml human Insulin, 90 μg/ml Ferric Nitrate, 900 μg/ml Ferric Sulfate, 
150 μg/ml iron saturated Holo-Human Transferrrin (all from Sigma) were added to the 
serum-free media (Neildez-Nguyen et al. 2002, Giarratana et al. 2005); this we term the 
erythroid ‘differentiation media’. Lastly, 1% v/v antibiotic–antimycotic (15240, Gibco) 
was also added to the (expansion, differentiation or both) media and the combined media 
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was sterile filtered (0.22 μm). We refer the hematopoeitic expansion media and erythroid 
differentiation media mixed together in 1:1 ratio as ‘expansion + differentiation media’. 
 
8.2.4 Quantification of erythrocytes 
Microdevices were observed every day for 15 days from the start of cell seeding using a 
Nikon (TE-300) microscope. Color images were recorded with a Nikon Coolpix digital 
camera. The number of erythrocytes (seen as red cells) was counted over the entire length 
of the cell culture channel. The generation of these red cells was calculated by 
enumerating cell counts on a specific day (e.g. on day 0 there were no erythrocytes). 
May-Grunwald-Giemsa staining was performed inside devices to verify existence of 
erythrocytes as pink cells and nucleated cells as blue or purple. Giemsa staining was also 
performed on the cells after removing them from the microniches. The cells were 
removed from microniches by cutting the device open and washing the cells out. A smear 
of removed cells was created on a clean glass coverslip and observed with a microscope. 
 
8.2.5 Mathematical model 
 
A schematic of the pathway for progenitor cell differentiation through erythrocyte (RBC) 
production (hematopoiesis) is shown in Figure 8.3A and based on the literature (Aubin et 
al., Yoshida et al., 2004). We develop an ordinary differential equation model for the 
process by using a balance equation for each cell type (M, CFU-M, BFU, CFC, and RBC; 





−= −− 11  
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where rate constants ki describe the differentiation process from state i to state i+1 (k5 = 
0.) For the myeloid progenitor equation there is an additional term kr x1 to incorporate the 
ability of the progenitor to self-renew. This simple model ignores cell death and also the 
dynamics of influence of external growth factors, and is more phenomological than 
mechanistic. The initial values of the model were chosen based on information from 
previous experimental results and were equal to M = 100, CFU-M = 800, BFU = 300, 
CFU–E = 30 and RBC = 0.  Parameters (kr and k1 to k4) were estimated from our data 
using non-linear least square optimization and the objective function defined as 
  f (k) = [xexp,i − x(k)pred ,i]∑
2
 
where xexp,i and x(k)pred,i are the measured and predicted cell numbers, respectively, and k 
refers collectively to the rate constants k.  Rate constants were constrained to be positive. 
Statistics of the fit along with the correlation matrix of parameters were calculated as per 
the usual regression procedure (Seber and Wild, 2003) using MATLAB. 
 
8.3 Results 
8.3.1 Capture and Retention of Non-Adherent Primary Cells 
 
Capture efficiency (cells captured/cells input) of BMMNCs in the microdevice (Figure 8.1) used in the 
present work is 80%, which is significantly higher than other microdevices used for trapping cells 
(Supplementary Table S1). Cells residing in microniches received fresh media daily by removal of old 
media from the outlet of the bottom channel and pipetting new media into the inlet of the bottom channel. 
This ensured gentle exchange of media for cells in the microniches. As quantified from microscope images, 
no cells were lost during the media exchange, maintaining all progenitor cells inside the microdevice for 





Figure 8.2: Comparison of a microfluidic side compartment microniche (See Figure 8.1 
for location) on Day 0 (a and d) and Day 15 (b and e) of culture (Scale bar: 300 μm). 
There are no red cells on day 0 (a and d) when using either expansion media or expansion 
+ differentiation media. However, erythrocytes can be prominently observed on day 15 
(b) when the combined media is used, but there are no red cells when using just the 
expansion media (e). Giemsa-stained cells after removal from the microniches after 15 
days (c and f, Scale bar: 100 μm). Cells in c) were cultured in combined media, while 
cells in f) were in expansion media. Black arrows show erythrocytes in panel c) and black 
arrow heads show nucleated cells in panel f). 
 
8.3.2 Differentiation of Bone Marrow Progenitors to Produce Erythrocytes 
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With an initial cell seeding density of 1950 ± 78 cells (no erythrocytes) per microdevice, 
we produced 2048 ± 183 erythrocytes per microdevice using the expansion + 
differentiation media and a 15 day culture (Figure 8.2). There were no red cells on day 0 
when using either expansion media or expansion + differentiation media, as seen by the 
purple color of cells after May-Grunwald-Giemsa staining (Figure 8.2 A and D). 
However, erythrocytes can be prominently observed on day 15 when the expansion + 
differentiation media is used as seen by the pink color after the Giemsa stain (Figure 8.2 
B and C).  
 
The phenotypic, morphological, genetic and functional analysis of erythrocytes generated 
in vitro is reported in detail in the literature (Giarratana et al. 2005, Cheung et al. 2007, 
von Lindern et al. 1999, Kie et al. 2003, Szilvassy et al. 1996, Muench et al. 1993). We 
further evaluated the cells produced in the microniches by removing cells from the 
devices and making smears on glass slides. The distribution of bone marrow cells in the 
microniches at day 15 can be seen in Figure 8.2 C and F. There are a mix of nucleated 
blue or purple cells (black arrowheads) and pink stained erythrocytes (black arrows).  
These bone marrow-derived and microdevice-cultured cells were compared with Giemsa 
stained cells from peripheral blood (not shown), in which more erythrocytes are 
observed.  
 
If only expansion media was used, no erythrocytes were seen over a 7 day period.  Once 
the media was replaced with the combined differentiation and expansion media, however, 
erythrocytes could be observed from day 8 to day 15. This result shows that change of 
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media can be performed efficiently and used to trigger cell differentiation on-demand. 
Moreover, seven days of culture in just the expansion media is enough to expand or 
maintain progenitor cells.  
 
For comparison, we also cultured cells in 24 well conventional plate using the same 
(expansion + differentiation) media composition and an initial population of 1x104 
cells/well (data not shown).  Both the conventional culture and our microdevice gave 
similar numbers of erythrocytes.  However, when using a microfluidic device, we were 
able to get the same level of expansion (5 fold expansion) with a smaller number of 
starting cells. One challenge when using 24 well dishes to perform media changes is that 
some cells are forced out of the well by the pipette every time; however, in the 
microdevice, the cells are not removed during media changes.  
 
The production of erythrocytes, computed by enumerating the number of erythrocytes on 
each day of the culture, is seen in Figure 8.3 B and follows the common logarithmic 
pattern (Neildez-Nguyen et al. 2002, Giarratana et al. 2005). The distribution of 
erythrocytes compared to nucleated cells was also quantified by calculating the 
percentage of erythrocytes of all total cells on a particular day. By the end of 15 days of 
microfluidic culture, there are about 30% erythrocytes in the total cell population. The 
generation of erythrocytes inside microdevice hints at the presence of progenitor cells in 
the microniches that give rise to erythrocytes. Autocrine or paracrine factors secreted 
within the microniches may aid in retaining progenitor cells as well as in inducing the 
formation of more differentiated cells.  
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8.3.3 Comparison between the experiments and the model 
The experimental data on erythrocyte production are in agreement with the model 
structure (Figure 8.3B) and the parameters of the model give information on the rates of 
differentiation and self renewal of cells in the culture. The non-linear nature of the model 
and the high correlation of the parameters in the model makes it difficult to ascertain 
global minimum, and hence there can be multiple sets of parameter values which can 
minimize the objective function, and hence the absolute values of rate constants cannot 
be determined accurately. However, all fit sets of parameters with high R2 demonstrate 
that the rate of self renewal of the progenitor cell (M) (kr,) was slower than the rate of 
differentiation (k1). This is indicative of the fact that this microfluidic culture is incapable 
of sustaining the self renewing cells, and hence eventually will run out of self-renewing 
cells resulting in the decline in production of cells, as indicated by the difficulty in 
sustaining such cultures over a long period of time. In this particular system, the primitive 
HSCs will be depleted from the culture in approximately 4 weeks, and an evidence for 
this is seen in Figure 8.3B where number of erythrocytes plateaus off during the later part 
of the microfluidic culture. However, these results compare very well with other 
conventional in vitro cultures for the generation of erythrocytes suggesting that the 
microbioreactors studied here are functioning much like the macro scale bioreactors in 
the literature.  Moreover, in our microfluidic culture systems, the optimal conditions for 
maximizing the yield of erythrocytes can now be established using high throughput 
methods. Another highly efficient method to dramatically increase the number of 
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erythrocytes produced in these microbioreactors would be to start with a population of 
bone marrow cells that are highly enriched in hematopoietic stem cells. 
 
 
Figure 8.3: a) Schematic of the hematopoiesis pathway relevant for erythrocyte (RBC) 
production: M=Myleloid progenitor, CFU-M=Colony forming unit-Myeloid, BFU=Burst 
forming unit-erythrocytes, CFU-E=Colony forming unit-Erythroid, RBC=Erythrocytes b) 
Counts of erythrocytes from day 0 to day 15 per microdevice with ‘expansion + 
differentiation media’ (from all cell compartments) for all devices (10) are shown as 
points with standard deviations.  Fit of the pathway model to the data from all devices is 
shown as a smooth curve. The five parameters were estimated to be k1,sr = 6.3671, k2 = 
6.5895, k3 = 0.9185 , k3 =  0.3783, k4 =  0.0945. The R2 for the fit was 99%. The highest 
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8.4 Conclusions 
In this chapter, we describe semi-porous membrane separated PDMS microbioreactors 
which are highly advantageous for culture of small number of non-adherent cells.  
Because of the upper microchannel not having an outlet and not being open to 
atmosphere, the cells could not flow out anywhere, and thus important autocrine and 
paracrine factors were likely preserved. These results pave the way for the next wave of 
research with precious cells in microfluidic devices. Bone marrow mononuclear cells 
were moderately expanded with an expansion + differentiation media in these 
microbioreactors with a goal of generating erythrocytes. In the beginning of the 
microfluidic culture, there were no red cells visible in the microniches; however, from 
day 2 onwards, we started to see red cells. The red cells consistently increased in number 
from this point onwards until the end of experiment at day 15. Our results also confirm 
that we had some hematopoeitic progenitor cells in our population, which then produced 
the erythrocytes. Additionally, this report shows that erythrocytes can be differentiated 
from precursor cells in the microfluidic devices. These microbioreactors can further be 
optimized to ultimately maximize the yield of erythrocytes for culture of small number of 
any non-adherent cells using a high throughput format. Comparison with a mathematical 
model also shows the kinetics of generation of erythrocytes inside microdevice from 
precursor cells. Our next goal is to recreate entire hematopoeisis on a microfluidic device 
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Often in our darkness 
we forget to see the light: 
The sun is constant, 
even behind the clouds, 
The river’s current 
washes away the debris. 
Let the wind on your cheeks 
help you remember 
there is more - 
There is more for you. 
-Ruth Gilmore Langs, Ann Arbor Artist, 2006 
 
 9.1 Summary 
In this thesis, we set out to create in vitro microfluidic niches for HSCs which simulate 
the features of in vivo bone marrow microenvironment (see Figure 9.1A). We have been 
able to construct develop new tools for studying biology of niches by controlling oxygen 
tension in microbioreactors, by enhancing optimal attachment and growth of HSC 
supporting stromal cells, and create three dimensional cultures of hematopoeitic and 
support cells. 
 
As a part of our first aim to control oxygen tension in gas-permeable PDMS microfluidic 
bioreactors, we developed experimental techniques to quantify dissolved oxygen 
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concentrations in the microchannels in real time using fluorescence intensity and lifetime 
imaging of an oxygen sensitive dye, ruthenium tris(2,2’-dipyridyl) dichloride 
hexahydrate (RTDP). Combining such experiments with a mathematical model enabled a 
more quantitative understanding and better control of the physical-chemical mechanisms 
underlying cell biological events in such PDMS bioreactors. The data indicated that 
despite oxygen diffusion through PDMS, uptake of oxygen by cells inside the perfused 
PDMS microchannels induces an axial oxygen concentration gradient, with lower levels 
recorded in downstream regions ranging from 20% to 4.3%. The oxygen concentration 
gradient generated by a balance of cellular uptake, convective transport by media flow, 
and permeation through PDMS in our devices ranged from 0.0003 (mg/l)/mm to 0.7 
(mg/l)/mm. The existence of such steep gradients induced by cellular uptake can have 
important biological consequences. Results are consistent with our mathematical model 
and give insight into the conditions under which flux of oxygen through PDMS into the 
microchannels will or will not contribute significantly to oxygen delivery to cells and 
also provide a design tool to manipulate and control oxygen for cell culture and device 
engineering. The combination of computerized microfluidics, in situ oxygen sensing, and 
mathematical models opened new windows for microphysiologic studies utilizing oxygen 
gradients and low oxygen tensions. 
 
Many primary cells, especially adult HSCs need to be at a much lower oxygen tension 
(close to 1%) to remain in a self-renewing state for a longer time in vitro. In order to 
further lower the oxygen tension in microbioreactors below 4.3%, we developed new 
microfluidic devices made of thermoplastic and elastomeric polymers. These 
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microdevices offered three distinct advantages:  1) generation of low oxygen tensions 
with mammalian cell culture (20% to 1%), 2) lower evaporation of aqueous solutions 
compared to PDMS devices, and 3) perfusion using Braille actuation. Channel features 
were created on rigid polymers such as PETG, COC and PS by hot embossing. These 
‘hard tops’ were bonded to elastomeric ‘soft bottoms’ to create devices that can be used 
for microfluidic cell culture as well as biochemical analysis.  
 






We applied our well-characterized oxygen measurement system and the mathematical 
model to establish cellular oxygen uptake rate parameters for different mammalian cells 
in PDMS microbioreactors.  We estimated cell intrinsic parameters, Vmax and Km, for 
each cell type in microfluidic culture by utilizing the model and experiments together, 
and thereby developed a method to measure uptake rates of other nutrients / measure 
ligand/drug responses in microfluidic bioreactors. 
 
HSCs need supporting cells to provide adhesive and soluble signals and to mediate 
cellular processes such as proliferation, differentiation, mobilization, homing and 
apoptosis. Primary murine bone marrow cells do not successfully grow on PDMS 
substrates due to the weak attachment of cells to the PDMS surface even with adsorption 
of cell adhesive proteins such as collagen or fibronectin. Therefore, for our second aim, 
we modified the surface of PDMS with biofunctional multilayer coatings to promote 
marrow cell attachment and spreading.  We utilized an automated microfluidic perfusion 
system to create multiple types of polyelectrolyte nanoscale coatings simultaneously in 
multiple channels based on layer-by-layer deposition of PDDA (poly(diallyldimethyl 
ammonium chloride)), clay, type IV collagen and fibronectin. Adherent primary bone 
marrow cells attached and spread best on a surface with composition of (PDDA/clay)5 
(Collagen/Fibronectin)2  with negatively charged fibronectin exposed on the top, 
remaining well spread and proliferating for at least two weeks.  Compared to traditional 
more macroscopic layer-by-layer methods, this microfluidic nanocomposite process 
offered advantages of greater flow control, automatic processing, multiplexed fabrication, 
and use of lesser amounts of polymers and protein solutions. Thus, we utilized PDMS 
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microbioreactors with computerized perfusion controls for engineering the bone marrow 
microenvironment. 
 
For our third aim, we established three dimensional in vitro cultures of hematopoeitic 
stem, progenitor and support cells for seven days in semi-porous membrane separated 
PDMS microfluidic bioreactors. The microdevice consists of a top channel with side 
compartment microniches separated from a bottom channel by a semi-porous membrane. 
We assayed the ability of different supporting cell combinations to maintain in vitro HSC 
colonies, and observed that of all combinations, the CFU activity was highest when bone 
marrow stromal cells were co-cultured with HPCs. Further, in the BMSC-HPC co-culture 
system, we optimized the ratio of hematopoeitic cell to support cells needed for 
maximizing the number of colony formation, and found it to be 1:100 HPCs to BMSCs. 
Experiments performed at two oxygen tensions (20% and 1.5%) confirmed that lower 
oxygen tension was better at maintaining primitive colonies in culture. 
 
We have established erythropoiesis-on-a-chip in semi-porous membrane based PDMS 
microdevices using small numbers of non-adherent unsorted primary bone marrow cells 
to generate erythrocytes over a 15 day period. Culture of non-adherent cells in side 
chamber microniches of the microdevice allowed efficient change of media from the 
bottom microchannel as well as entrapment of cells. Primary mononuclear bone marrow 
cells were grown in the side compartment microniches in medium containing either 
expansion factors or expansion and differentiation factors. Only in the presence of 
differentiation factors were erythrocytes observed in microdevices. The experimental 
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results were also found to be consistent to mathematical model describing the growth and 
differentiation of the progenitor cells based on the known hematopoeisis model.  
 
In summary, we used different microfluidic tools to recreate ex vivo models for HSC 
niches (as seen in Figure 9.1B), which can be helpful for the microenvironmental studies 
with other stem cell niches. Microbioreactors also allow additional functionality to 
control autocrine/paracrine factors, local nutrient/mitogenic gradients, continuous 
perfusion, micrometer control of topology and composition of substrate, and easy 
integration with sensing and analysis tools. Results from this thesis will contribute to 
development of engineered bony organs in microbioreactors (Figure 9.2) and 
hematopoiesis-on-a-chip.  These hybrid bony organs containing mineralized tissue, 
marrow and microcirculatory compartments could possibly be used as biosensors and 
tissue replacements. Understanding the roles of the biomolecules studied in our artificial 
niches, and their involvement in the bone marrow-HSC continuum will catalyze further 
studies at the molecular level.  Thus results take us closer to the goal of creating 





Figure 9.2: Functional bony organs on-a-chip 
 
9.2 Future Directions 
Although we have made substantial progress towards in vitro HSC niches that mimic 
features of the in vivo bone marrow, we are still far away from the goal of artificial bone 
marrow niches that are just as functional and effective as their physiological counterparts. 
There have been many technical and practical limitations in our work, which in retrospect 
may be rectified with the following measures: 
 
High throughput screening: In the bone marrow HSC niches, a heterogeneous population 
of cells (support cells and HSCs) cohabitate in a hierarchical and structurally functional 
manner to maintain bone marrow as a complex organ. The definition of 
microenvironment and mimicking the in vivo marrow processes are not straightforward 
FACS
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tasks due to the highly transient processes and the largely undefined heterogeneous 
environment. Therefore, high throughput screening technologies are needed to test 
various parameters that might have an effect on ex vivo true long term (LT) HSC 
expansion.  
 
The variables that need to be considered for such experiments include: 
 
1) Primary murine cell types isolated from bone marrow such as mesenchymal stem 
cells, endothelial cells, osteoblasts, megakaryocytes, pericytes, reticulocytes, 
adipocytes, fibroblasts, osteoclasts, osteocytes, cells of all MSC lineage,  
hematopoeitic cells which are CD48+ and/or CD41+, heterogeneous BMSC. 
2) Primary support cell types also need to combined together in various ratios and 
compositions to the synergistic effects of different combinations of cells 
3) Genetic manipulations also need to be applied to the primary support cells to 
maximize the ex vivo expansion of HSCs. Some examples are overexpression of 
HOXB4, WNT proteins, Notch-1, Sonic hedgehog, GATA2, AML1, p18, MPL, 
STAT5 and p21. 
4) Cytokines which are known to have any effect on the entire murine system (not 
just the ones expressed in the bone marrow) also need to be systematically probed 
at various concentrations and in different combinations to determine the effects 
(extent of survival, proliferation, and differentiation) they can impart on LT-HSC 
expansion.  
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5) Extracellular matrices also play a major role in how HSCs sense their 
environment, and also known to regulate various HSC functions. The entire range 
of ECM proteins found in the murine system again need to be tested alone and in 
all possible combinations possible to single out the particular combinations that 
dramatically raise LT-HSC ex vivo expansion. 
6) In vitro physiochemical culture parameters, such as pH, osmolarity, dissolved 
oxygen tension, dissolved carbon dioxide tensions, and temperature, as well as 
metabolite concentrations (glucose, glutamine, glutamate, lactate and ammonia) 
also need to be monitored and optimized for the maximal HSC expansion. 
7) Three dimensional cultures must be a necessary condition for in vitro culture of 
LT-HSCs. In addition to the 3-D cultures mentioned in this work, scaffolds of  
biopolymers, proteins or amino acids must be utilized to provide a conducive 
environment for HSCs. 
 
When all the permutations and combinations of the above mentioned variables are added 
together, we get thousands of possible experiments to exhaust all possible culture 
conditions that may lead to high ex vivo LT-HSC expansion, which closely follows in 
vivo self renewal in the bone marrow. In order to narrow down the list of experiments 
that need to be performed, a mathematical approach is required to create a careful and 
intelligent design of experiments. Moreover, the high throughput experiments also need 
to be combined with appropriate monitoring tools to get an overall view of optimization 
of the ex vivo LT-HSC expansion. 
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Design of experiments (DOE): The process control of the in vitro HSC cultures has been 
difficult to achieve due to the complexity and interactions of the cells involved. The 
variability of cell type, transient kinetics, high sensitivity and specificity to extrinsic 
factors, and interaction of a multitude of these factors affecting cellular behavior pose 
significant challenges to process characterization. This lack of characterization and 
control is highly undesirable and can result in low quality, yield, and purity of the final 
LT-HSC produced in culture.  Full factorial designs will be essential in the future studies 
to screen out a large number of parameters and experimental conditions which do not 
allow drastic increase in LT-HSC expansion. In order for such a design of experiments to 
be successful and insightful, the interactions between all variables must also be accounted 
for. Kinetic models of LT-HSC expansion might also be necessary in conjunction with 
DOE for predictive analysis. 
 
Real-time process monitoring: Real time and on-line monitoring of key process 
parameters will provide vital information for making decisions about the optimized 
culture conditions.  The current monitoring techniques for cell bioprocesses will have to 
be applied to the microfluidic LT-HSC cultures. The simultaneous monitoring of key 
process variables is limited to only certain parameters:  a) pH,  dissolved oxygen tension, 
carbon dioxide tension, and  temperature; b) nutrients and metabolites; c) growth  factors; 
and d) cell viability and concentration. 
 
Measurement of paracrine secretion: The small amounts of paracrine factors secreted by 
support cells for use by HSCs need to be better characterized. Microfluidic HSC niches 
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can be integrated with in situ immunoassays to quantify the concentrations and identity of 
precious paracrine factors, which might also be present in a gradient in specific niches. 
 
Mice experiments:  The efficacy of the artificial microfluidic HSC niches needs to be 
evaluated by the ‘gold standard’ bone marrow in vivo long term competitive 
reconstitution assays.  We performed some preliminary studies in this context where after 
7 day co-culture of HSCs and support cells in microdevices we tested the reconstitution 
ability of microfluidically cultured HSCs by injecting cells into lethally irradiated mice of 
a differing strain. The different co-culture conditions that we tried in these experiments 
were: HSCs control, HSCs + post-natal day1 liver endothelial cells, HSCs + osteoblasts, 
HSCs + megakaryocytes, HSCs + MSCs, and HSCs + megakaryocytes + endothelial 
cells. In these experiments, 25 to 40 HSCs were loaded into the devices with 100 times 
that number of support cells. When we looked at the peripheral blood of the injected mice 
after four weeks, we did not observe any significant myeloid, B and T cells originating 
from HSCs cultured in microfluidic niches. For these experiments, we had a positive 
control of non-cultured FACS sorted HSCs, which when immediately injected into 
recipient mice were able to reconstitute the bone marrow of the host. This leads us to 
believe that some variables that might be affecting the culture of FACS purified HSCs in 
our devices. There may be elements in the device itself, handling of cells, removal of 
cells, small numbers of pure HSCs used for culture, loading of cells, media configuration, 




More experiments are needed with significantly higher number of starting HSCs, for 
example, 5000 or more per device instead of 25-100.  Furthermore, we performed 
positive control experiments to verify the mechanics of microfluidic cell manipulations 
and survivability of HSCs in our device. In these experiments, FACS purified HSCs were 
cultured in microfluidic bioreactors for either 5 minutes or 24 hours and then used for 
reconstitution assays, we found that 5 minute culture in microdevice gives rise to myeloid 
and lymphoid cells from the test HSCs. These experiments tell us that handling of cells in 
and out of device for a 5 minute culture allows reconstitution. Cells are removed from the 
device by pippetting, washing with a buffer, and incubating with an enzyme free 
dissociation media for 15 minutes. However, this protocol might be inflicting physical 
injury onto the fragile HSCs when they are in culture for longer than 5 minutes. These 
results lead us to believe that for successful in vitro experiments we need to use a higher 
number of HSCs since HSCs are either dormant, or apoptosing, or differentiating or 
depleting in our cultures. 
 
Biological questions: The bone marrow niche is one of the most well known 
microenvironments for adult hematopoeitic stem cells. Although it has been established 
that osteoblasts and other stroma supporting cells (including endothelial cells, adipocytes, 
fibroblasts) play a central role in hematopoiesis, and produce many factors essential for 
the survival, renewal and maturation of hematopoeitic stem cells, it still needs to be 
determined whether HSCs play a role in establishing an inductive microenvironment. 
Bone marrow studies typically look at the effect of a particular object (cytokine, ECM 
protein, etc.) under evaluation on HSC proliferation, differentiation, homing, quiescence 
 231
and migration. Thus, it is important to identify the roles HSCs play in the niche and how 
they influence marrow cells (MSCs, osteoblasts and endothelial cells) to create an 
inductive microenvironment, and to study how their function is altered in abnormal or 
diseased marrows. It is very difficult and resource straining to perform this type of study 
in animal models. Therefore, in vitro studies can be formulated to find out the influence 
HSCs can have on mesenchymal stem cells (MSCs) and stromal cells of the marrow 
niche, including endothelial cells and osteoblasts. In such studies, different variations of 
abnormal HSCs in microbioreactor cultures can be configured where small populations of 
HSCs and stromal cells can be easily studied in simulated microenvironments.  
 
Some of the examples of abnormal HSCs that can be explored are: 
 
1) HSCs with reduced proliferative capacity by RNAi silencing of homeobox 
transcription factors, HOXB3 and HOXB4. Overexpression of HOXB4 strongly 
enhances hematopoeitic stem cell regeneration, and mice deficient in both Hoxb3 and 
Hoxb4 have defects in endogenous hematopoiesis and diminished number of 
hematopoeitic progenitors due to insufficient expansion of HSCs.  
 
2) HSCs in an environment of high oxidative stress. It has been shown that elevated 
reactive oxygen species causes progressive bone marrow failure resulting from a defect in 
HSC function in mice.  
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3) HSCs with under-expressed and over-expressed Notch 1 and Tie 2 receptors,  which 
are believed to be instrumental in the homing and quiescence of the HSCs respectively.  
 
Other biological questions that remain unanswered in the context of the HSC bone 
marrow niche are: 
• Role of osteoblasts in getting pre-HSCs and HSCs to differentiate 
• Role of osteoblasts (and other BMSCs) in leukemic HSCs 
• Operational structure of bone marrow microenvironment (and how it is different 
from leukemic bone marrow) 
• Interaction between cell associated growth factors (provided by osteoblasts) and 
growth factor receptors (on HSCs) important for: 
 Proliferation of HSCs (eg. G-CSF, GM-CSF, etc.) 
 Niche localization or homing of HSCs (eg. ICAMs, Jagged1, CD 164 etc.) 
 Survival and quiescence of HSCs (eg. VCAM-1, N-Cadherin, Ang-1etc.) 
• Important signaling mechanisms which have not yet been established for HSCs 
(eg. signaling by PECAM-1). 
 
Furthermore, microfluidic culture systems described herein can be applied towards 
development of physiological in vitro drug toxicity assays, where cells on axial gradient 
of oxygen or any nutrient are exposed to drugs.  
 
Overall, this work has the potential to provide major insights into bone marrow stem cell 
biology.  Future studies in this field will lead to establishment of new protocols to 
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successfully expand HSCs in vitro without losing their multipotency. Using the in vitro 
model systems developed here, functions of HSCs in the bone marrow niche could be 
discerned, which will have important implications for new treatment options for 
hematologic and bone marrow disorders. It could lead directly to: a) improved 
understanding of the molecular pathways involved in hematopoiesis, b) identification of 
functions of other niche components, c) understanding of other adult stem cell niches, 






Calculation of Oxygen Fluxes for PDMS Microbioreactor used in Oxygen Tension 
Experiments 
 
This appendix shows calculation of oxygen flux through the top surface of PDMS 
microbioreactor for materials presented in Chapter 3. 
 
J= (P * Δp) / t 
 
J = (D* ΔC) / t 
 
P = D * S 
where,  J = Flux 
P = permeability 
Δp = pressure drop 
t = thickness 
D = diffusivity 
ΔC = concentration gradient 
S = solubility 
 
Flux through media layer 
D O2/Water = 10-5  cm2/sec (Fleischer et al. 1981) 
ΔC = solubility of oxygen in media at 25 C = 8.5 mg/l (Fleischer et al. 1981) = 2.67 X 10-
7 mol/cm3 
t= 30 microns (channel height) = 30 X 10-4 cm 
 
J= 10-9 mol/cm3 sec 
 
Flux through parylene C bottom layer 
P O2/parylene C = 3.4 X 10-11 (cm3 (STP) cm)/(cm2 sec atm) (Yeh et al. 1990) 
D O2/parylene C = 10-8 cm2/sec (Yeh et al. 1990) 
ΔC = solubility of oxygen in parylene C at 25 C = 10-3 (from P= D*S) 
 
t = 2.5 microns (thickness of parylene layer) = 2.5 X 10-4 cm 
 
J= 10-7 mol/cm3 sec 
 
Flux through PDMS top layer  
P O2/PDMS = 5.88 X 10-6 (cm3 (STP) cm)/(cm2 sec atm) (Mercel et al. 2000) 
D O2/PDMS = 10-5 cm2/sec (Mercel et al. 2000) 
ΔC = solubility of oxygen in PDMS at 25 C = 10-1 (from P= D*S, [0.18 cm3 STP/ cm3 
atm] Mercel et al. 2000)) 
 
t = 1 cm (height of PDMS above channel features)  




PDMS Microfluidic Cell Culture Literature 
 
Table B1: Research work citing biological studies in microfluidic devices (Chapter 
2) 
 
Cell type Material  Perfusion Results Reference 








140 um high 
Static culture 5 day culture, 
Cells grew slower in 







Mouse embryo PDMS Static culture Growth rate similar 
to in vivo 




Mouse embryo silicon, 
PDMS, 
borosilicate 



















Upto 107 cells 




















































3 day culture, 
differentiation of 
C2C12 















13 day culture, 
uniform cell growth 
in 3 D device, flow 
characterization, 
ALP staining for 
cellular activity 














E Coli, chicken 
erythrocytes, 
BCE cells  
PDMS Gravity flow Use of laminar flow 
to pattern cell 
culture substrate, 





C2C12 PDMS  HOMR Zhu et al 
(2004) 
Analyst 








Song et al 
(2005) Anal 
Chem 
HepG2 PDMS  Single cell analysis, 
separation of  ROS 
and GSH by on-chip 
electrophoresis 
















C2C12 PDMS  Reconfigurable 
protein matrices 
























Syringe pump NanoLiter 
BioReactor, 14 days, 
pH, glucose, 













cancer cells,  
PDMS Syringe pump Multiphenotype cell 
docking 
Khademhoss












Table B2: Device technologies (Chapter 2) 
 
Material Technology Results 
 
Reference




PDMS Bending planar sheets of 
channels for pseudo-3D 
channels, “plug-in and 
mold” for true 3-D 
channels 
Complex 3D microchannels Wu et al. 
(2003) 
JACS 
PDMS UV grafting of co-mixed 
monomers (neutral and 
charged) 










PDMS Applying voltage breaks 
the 20 um PDMS 
separating disconnected 
Configurable microfluidic 
device: connections can be 










Table B3: PDMS based reviews (Chapter 2) 
 




Single and multilayer systems, intergrated 
componenets including chaotic mixer, 
elastomeric switch, magnet filter, embedded 
membranes, flouresecence detection system 





PDMS containing different amount of 
crosslinker  analyzed by gravimetry, contact 
angle, mechanical testing, XPS, SEM, FTIR, and 
nanoindentation 














Oxygen Profiles in COC-PU and PS-PU Microbioreactors 
 
The four points of oxygen detection in the microchannel are: upstream (ups), 1 cm from 
upstream in cell laden channel (x=1), downstream (dwn), and distance of downstream + 
0.5 cm (dwn+0.5).  
Figure C1: Oxygen profile at four distinct regions in COC-PU microdevice at high (hi 
dens) cell density of HepG2 cells and channel height of 100μm.  
 
Figure C2: Oxygen profile at four distinct regions in COC-PU microdevice at 


























































Figure C3: Oxygen profile at four distinct regions in COC-PU microdevice at low (low 
dens) cell densities of HepG2 cells and channel height of 100μm 
 
Figure C4: Oxygen profile at four distinct regions in PS-PU microdevice at high (hi 


























































Figure C5: Oxygen profile at four distinct regions in PS-PU microdevice at medium 
(med dens) cell densities of HepG2 cells and channel height of 100μm 
 
Figure C6: Oxygen profile at four distinct regions in COC-PU microdevice at low  (lo 




























































Hematopoietic Stem Cell Staining using SLAM-Family Markers 
 
Used in Chapter 7 [From Mark Kiel (Sean J. Morrison Laboratory)] 
 
1. Extract bone marrow from each hind limb (and humerus). Sacrifice the mice by 
cervical dislocation and then extract bone marrow from each according to the following 
procedure. 
 
2. Fix the animal to the surgery pad by inserting needles through each paw. Wet pelt with 
70% EtOH. 
 
3. Cut the skin at the ankle and up along the side to expose the muscles of the hindlimb. 
Cut away as much muscle and fascia from the femur and tibia as possible. 
 
4. Using forceps and scissors, pinch the femur and gently pull laterally to dislocate the 
hip; cut attached muscle and ligament using scissors. 
 
5. Cut the bone at the ankle and remove from animal. Repeat this procedure for each 
hindlimb. 
 
6. Clean both femur and tibia of muscle by passing through a Kimwipe. Separate femur 
and tibia by hyperextension at the knee joint. Place the clean bones into a petri dish 
containing 2 ml of ice-cold staining medium. 
 
7. Cut away both ends of all bones to gain access to the marrow cavity. 
 
8. Using a 3 ml syringe containing ice-cold staining media (2% heat-inactivated calf 
serum in Hank’s Buffered Salt Solution) and 25G needle, separate the contents of the 
marrow from the bone by flushing the marrow cavity with staining medium. This may be 
repeated several times for each bone to ensure all marrow has been removed. 
 
9. After flushing all the marrow from the bones, dissociate the marrow by gently 
pipetting up and down. 
 
10. Filter marrow through nylon mesh into a clean 15ml centrifuge or 5ml FACS tube. 
 
11. Allocate the cell sample into appropriately labeled tubes for subsequent staining. 
 
12. Centrifuge cell suspension for 5 min at 500g. While sample/s is/are being centrifuged, 
begin to prepare the antibody solutions for subsequent staining steps as below. 
 
13. Aspirate supernatant using a vacuum flask and resuspend the cell pellet in 400 μl of 
staining media  (for 1-2 mice, 800 μl for 3 mice) containing the following antibodies at 
the specified dilutions: 
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CD150-PE (TCF15-12F12.2, Biolegend; 1:100),  
CD48-FITC (HM48-1, BD Pharmingen; 1:100),  
CD41-FITC (MWReg30, BD Pharmingen; 1:100),  
Sca-1-APC (E13-161.7, BD Pharmingen; 1:400),  
c-kit-biotin (2B8, BD Pharmingen; 1:400), 
Ter119- FITC-conjugated lineage antibody (BD Pharmingen; 1:800), 
CD2- FITC-conjugated lineage antibody (BD Pharmingen; 1:800), 
Gr-1- FITC-conjugated lineage antibody (BD Pharmingen; 1:800), 
B220- FITC-conjugated lineage antibody (BD Pharmingen; 1:800), 
 
Inclusion of lineage antibodies in this staining step to enhance the discrimination of true 
CD150+CD48-CD41- HSCs from background levels of florescence. 
 
14. Incubate cells in antibody solution for 20 min on ice, resuspending the suspension 
every 5-10 minutes. After 20 min, dilute cell suspension in 15 ml of staining media and 
centrifuge as above. 
 
15. Aspirate the supernatant and resuspend cell pellet in 400ul of staining media 
containing the following second step reagents at the specified dilutions: StAv-APCCy7 
(1:400). To enrich HSCs, pre-select using MACS, include in this staining step anti-biotin 
microbeads (Miltenyi Biotec Inc.; 1:10) and select according to manufacturer’s 
instructions after completing step 17 below. 
 
16. Incubate cells in antibody solution for 20 min on ice, resuspending the suspension 
every 5-10 minutes. After 20 min, dilute cell suspension in 15 ml of staining media and 
centrifuge as above. 
 
17. Aspirate the supernatant and resuspend pellet in 1 ml of staining media containing 7- 
AAD (1:500 of 1mg/ml stock). Filter through nylon mesh into a clean 5 ml FACS tube. 
 
18. HSCs are identified as CD150+CD48-CD41-(lineage-) in addition to being 7- AAD-
FSCmidSSCmid. Gating on this population of cells should reveal a 90-95% Sca-1+c-kit+ 
double-positive population. The representative FACS plots of first and second sort are 
shown in Figure D1 and D2. 
 
19. For color compensation, create the following FACS tubes with bone marrow cells: 
blank (no color), PE (CD48), FITC (CD48), APC (Sca-1), Biotin-Streptavidin or PHAR 













Stem Cell Tech EasySep  Lineage- and Sca-1+ / c-kit+ Selection from Mouse Bone 
Marrow Cells 
Used in Chapter 7 for removing Lin- cells from bone marrow and selecting c-kit+ cells. 
 
For Lineage- Selection:  
 
1. Prepare single nucleated cell suspension at a concentration of 1 x 108 cells/mL in 
recommended mediumcontaining 5% Normal Rat Serum and 2 mM EDTA. Cells must 
be placed in a 5 mL (12 x 75 mm) polystyrene tube to properly fit into the purple 
EasySep® Magnet. Do not exceed a volume of 2.0 mL (i.e. 2 x 108 cells) per 5 mL 
tube or 8.5 mL (i.e. 8.5 x 108 cells) per 14 mL tube. 
Falcon™ 5 mL (Becton Dickinson Catalog #352058) or 14 mL (Catalog #352057) 
Polystyrene Round-Bottom Tubes are recommended. 
 
2. Centrifuge the tube of EasySep® Mouse Hematopoietic Progenitor Enrichment 
Cocktail before use to ensure recovery of entire contents. Add cocktail at 50 μL/mL of 
cells (e.g. for 2 mL of cells, add 100 μL of cocktail). Mix well and incubate in 
refrigerator (4-8°C) for 15 minutes. 
 
3. Wash cells and resuspend at 1 x 108 cells/mL in recommended medium. Centrifuge 
cells. 
 
4. Add EasySep®Biotin Selection Cocktail at 100 μL/mL of cells (e.g. for 2 mL of cells, 
add 200 μL of selection cocktail). Mix well and incubate in refrigerator (4-8°C) for 15 
minutes. 
 
5. Vortex EasySep® Mouse Progenitor (M Prog) Magnetic Microparticles to ensure that 
they are in a uniform suspension. Add the microparticles at 100 μL/mL of cells (e.g. for 
2 mL of cells, add 200 μL of microparticles). Mix well and incubate in refrigerator (4-
8°C) for 10 minutes. 
 
6. Bring the cell suspension to a total volume of 2.5 mL by adding recommended 
medium (Normal Rat Serum is not required at this stage). Mix the cells in the tube by 
gently pipetting up and down 2 - 3 times. Place the tube (without cap) into the magnet. 
Set aside for three minutes. 
 
7. Pick up the EasySep® Magnet, and in one continuous motion invert the magnet and 
tube, pouring off the desired fraction into a new polystyrene tube. The magnetically 
labeled unwanted cells will remain bound inside the original tube, held by the magnetic 
field of the magnet. Leave the magnet and the tube in inverted position for 2-3 seconds, 
then return to upright position. Do not shake or blot off any drops that may remain 
hanging from the mouth of the tube. 
The enriched cells in the new tube are now ready for use. 
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8. After this step place the new tube with the desired fraction back in the magnet and 
incubate for ten minutes. 
 
9. Then perform another pour of as per the instructions in step 7.  Once again your 
desired cells are in the pour off. 
 




For Sca-1+ or c-kit+ Selection: 
 
1. This procedure is used for processing up to 2 x 108 cells per preparation. Prepare a 
single cell suspension at a concentration of 1 x 108 cells/mL in recommended medium. 
For samples containing 107 cells or fewer, resuspend in 100 μL. At this point, cell 
suspension must be in a 12 x 75 mm polystyrene tube to properly fit into the EasySep® 
Magnet. 
Falcon™ 5 mL Polystyrene Round-Bottom Tubes (Becton Dickinson, Catalog #352058) 
are recommended. 
 
2. Add CD117 (cKit) PE Labeling Reagent at 50 μL/mL of cells (e.g. for 2 mL of cells, 
add 100 μL of labeling reagent). Mix well and incubate at room temperature for 15 
minutes. 
 
3. Add EasySep® PE Selection Cocktail at 70 μL/mL cells (e.g. for 2 mL of cells, add 
140 μL of cocktail). Mix well and incubate at room temperature for 15 minutes. Note: PE 
Selection Cocktail is supplied in excess and may be discarded when CD117 (cKit) PE 
Labeling Reagent vial is empty. 
 
4. Mix EasySep® Magnetic Nanoparticles to ensure that they are in a uniform suspension 
by pipetting vigorously up and down 5 times. Add the nanoparticles at 50 μL/mL of cells 
(e.g. for 2 mL of cells, add 100 μL of nanoparticles). Mix well and incubate at room 
temperature for 10 minutes. 
 
5. Bring the cell suspension to a total volume of 2.5 mL by adding recommended 
medium. Mix the cells in the tube by gently pipetting up and down 2-3 times. Place the 
tube (without cap) into the magnet. Set aside for five minutes. 
 
6. Pick up the magnet, and in one continuous motion invert the magnet and tube, pouring 
off the supernatant fraction. The magnetically labeled cells will remain inside the tube, 
held by the magnetic field of the EasySep® Magnet. Hold the magnet and tube in 
inverted position for 2-3 seconds, then return to upright position. Do not shake or blot off 
any drops that may remain hanging from the mouth of the tube. 
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7. Remove the tube from the magnet and add 2.5 mL of recommended medium. Mix the 
cell suspension by gently pipetting up and down 2-3 times. Place the tube back in the 
magnet and set aside for five minutes. 
 
8. Repeat Steps 6 and 7 two times, and then Step 6 once more, for a total of four 5-minute 
separations in the magnet. Remove tube from magnet and resuspend cells in an 




CFC assay using MethoCult 
Summary of % recovery and fold enrichment of CFC from mouse bone marrow enriched 
for CD117+(c-kit) or Sca-1+ cells using EasySep™ positive selection 
Positive selection only 
















Unseparated 12 3.4 + 1.0 - 12 3.4 + 1.0 - 
    2x separated*   4x separated* 
c-kit+ 6 32 + 15 77 + 15 9 + 4 11 70 + 18 57 + 17 26 + 12 
Sca-1+ 6 23 + 7 54 + 18 6 + 3 11 29 + 9 35 + 14 10 + 6 
Values are means ± 1 sd; n= no. of expt´s. 
* 2 or 4 rounds of separation 
 Positive selection followed by lineage depletion with SpinSepTM 
 
Values are means ± 1 sd 
target cell n number of CFC/1000 cells total CFC % recovery Fold enrichment
c-kit+ -> lin depletion 3 95 + 4 26 + 11 59 + 28 
Sca-1+ -> lin 
depletion 3 
57 + 22 8 + 4 33 + 16 
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APPENDIX F 
Blood and Bone Marrow Cells 
Background information for Chapter 8 
 
PERIPHERAL BLOOD SMEARS: 
- only contains mature cells (no precursors) 
- cell types: 
 erythrocytes (RBCs) 
 platelets 
 leukocytes (WBCs) 
 granulocytes: neutrophils, basophils, eosinophils 
 agranulocytes: lymphocytes, monocytes (macrophages) 
 
PERIPHERAL BLOOD SMEARS 
1. erythrocyte 
- largest proportion of cells in the blood 
- biconcave discs (7-8 μm) 
- lack nucleus and cellular organelles 
- cotains hemoglobin (carries O2 and CO2) 
2. neutrophil (polymorphonuclear leukocyte, PMN) 
- 50-70% of WBCs in peripheral blood 
- diameter = 10-12 μm (larger than RBC) 
- 3-5 lobed nucleus stains deep purple 
- pale cytoplasm 
- small, light purple granules 
 few azurophilic (1°) granules (myeloperoxidase, lysosomal enzymes) 
 many specific (2°) granules (lysozyme, collagenase) 
- function: acute inflammation (exit circulation to site of injury, phagocytose 
pathogen, granules fuse with phagosome to destroy pathogen) 
3. basophil 
- rare, hard to find (less than 1% of WBCs) 
- diameter = 8-14 μm 
- lobulated nucleus, obscured by granules 
- dark blue specific granules of varying sizes 
 contain hydrolytic enzymes, heparin sulfate, histamine, slow reacting 
substance, SRS 
- act like tissue mast cells, bind antigen specific IgE, exposure to antigen releases 
vasoactive substances from granules, leads to inflammation 
4. eosinophil 
- 2-4% of WBCs 
- diameter 10-14 μm 
- bilobed nucleus 
- bright pink eosinophilic granules of uniform sizes 
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 contain arginine rich major basic protein, peroxidase, histaminase, arylr-
sulfatase 
- important in allergic reactions, parasitic infections, and phagocytosis of antibody-
antigen complexes 
5. monocytes 
- 3-8% of WBCs 
- diameter 9-18 μm (usually larger than PMN’s) 
- kidney shaped nucleus, less compact nucleus than PMN 
- pale, basophilic cytoplasm without specific granules, but do contain azurophilic 
lysosomes 
- exit circulation to tissues, differentiate into phagocytes (macrophage, osteoclast, 
alveolar macrophage, etc) 
- differentiated monocytes function in phagocytosis & antigen presentation to 
lymphocytes 
6. lymphocytes 
- 20-40% of WBCs 
- diameter = 6-12 μm 
- intensely staining, round to oval nucleus; may be slightly indented 
- thin, pale blue rim of cytoplasm WITHOUT granules 
- B cells & T cells are indistinguishable 
 B cells: function in antibody production, carry Ig on plasma membrane which 
recognize antigen 
 T cells: function in cell mediated immunity, destroy virally infected cells, 





 PROERYTHROBLAST                                                                                                            
- relatively large cell 12-15μm in diameter 
- large, central, spherical nucleus with one or two nucleoli 
- cytoplasm: moderately basophilic (blue) due to ribosomes 
- look for an unstained region of cytoplasm=Golgi ghost 
 
BASOPHILIC ERYTHROBLAST 
- smaller than proerythroblast 
- checkerboard nucleus (heterochromatic and smaller) 
- intense basophilia (blue) due to lots of free ribosomes 
 
POLYCHROMATOPHILIC ERYTHROBLAST 
- smaller than basophilic erythroblast 
- smaller intensely heterochromatic nucleus 
- purple/lilac cytoplasm due to combo of basophilia from ribosomes and 
eosinophilia from increasing amount of hemoglobin 




- smaller than polychromatophilic erythroblast 
- small, compact, intensely staining nucleus; getting ready to extrude the 
nucleus 
- eosinophilic cytoplasm (abundant hemoglobin); NOTE: the color of a 
normoblast is close to the normal pinkish color of the mature erythrocyte 
 
RETICULOCYTE 
- immature erythrocyte that still retains some basophilia due to the presence of 
RNA 
- only seen with a special (supravital) stain on the peripheral smear 
- increased # seen with anemia 
 
ERYTHROCYTE 
- smallest (7-8 μm) 
- NO NUCLEUS 




Immature  Mature 
Basophilic  Eosinophilic 







- 15-20 μm 
- large, euchromatic, spherical nucleus (>3nucleoli) 
- basophilic cytoplasm with no granules 
- prominent nucleoli 
- can be seen in peripheral blood with certain leukemias 
 
PROMYELOCYTE 
- 18-24 μm 
- Large nucleus 
- **Golgi ghost** 
- **azurophilic granules (purple) ** 
- CANNOT tell which type of granulocyte it will develop into 
 
MYELOCYTE (Neutrophilic, Basophilic, or Eosinophilic)  
- smaller 
- eccentric, spherical nucleus 
- ** granules specific to N,B,E appear** 
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- LAST MITOSIS 
 
METAMYELOCYTE 
- **indented, heart-shaped nucleus** 
- many cell-specific granules 
 
BAND CELL 
- immature granulocyte 
- U-shaped nucleus just prior to segmentation 
- increased # seen with acute infections (a left shift) 
 
MATURE GRANULOCYTE 
- Neutrophil, Eosinophil, or Basophil 




Immature  Mature 
Large cell  Small cell 
No granules  Azurophilic (non-specific) granules  Cell-specific granules 






MEGAKARYOCYTE   
- HUGE compared to other cells 
- Contain multi-lobed nucleus (as opposed to osteoclasts which are 
multinucleated) 
- Platelets are formed by invaginations of the plasma membrane that fuse to 






Efficacy of Microfluidic In Vitro HSC Niches tested by In Vivo Experiments 
 
Device preparation for HSC Co-culture 
 
• Device assembly: PDMS mortar 3:2 Toulene: PDMS  
• Desiccated to remove all air + O2 for 24 - 48 hours 
• Put in hypoxia chamber at 1% N2 for 24 - 48 hours 
• Plasma oxidized for 2-3 minutes 
• FN (0.4 mg/ml) coating for  30 minutes 
• UV sterilization for  30 minutes 
• Myelocult media (containing 25% serum, horse + bovine 1:1) in devices 




• Donor HSCs: adult (6- to 8-week-old) C57BL/Ka-CD45.2:Thy-1.1 mice 
• Donor supporting cells: adult C57BL/Ka-CD45.1:Thy-1.2 mice 
• Recipient mice in reconstitution assays: adult C57BL/Ka-CD45.1:Thy-1.2 mice 
 
• Microfluidic culture groups:  
– HSC control (1:0) 
– HSC - osteoblast co-culture (1:100) 
– HSC - mesenchymal stem cell co-culture (1:100) 
– HSC - megakaryocytes co-culture (1:100) 
– HSC - endothelial cells co-culture (1:100) 
– HSC - megakaryocytes- endothelial cells co-culture (1:50:50) 
– HSC - megakaryocytes- endothelial cells- mesenchymal stem cell co-
culture (1:34:33:33) 
– HSC - mixed culture with all above supporting cells (1:25:25:25:25) 
– HSCs (5 minute culture) 
– HSCs (24 hour culture) 
 
• 3-9 devices for each condition (total 85)  
• Devices seeded with support cells 24-48 hours before adding HSCs 
• 7 day culture experiments in microdevices at 1 % O2  
• 42 - 50 HSCs in each device 
• HSCs: CD 150+ CD 48- CD41- Lin- Sca-1+ c-kit + FACS double sorted  
• Devices in hypoxia chamber filled with 1% O2 + 6% CO2 + 93% N2 for 2-3 
minutes 
• Control experiments: All experimental groups in 96 well plates 
• Megakaryocyte progenitors (FACS double sorted) 
• Megakaryocyte progenitors and HSCs also placed in Methylcellulose gel for CFU 
• Media replaced daily in devices for 7 days 
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• Time for devices to equilibrate to 1 % oxygen after going back into 
incubator 
• Removal of cells from devices- efficiency of removal 
• Cells removed using enzyme free cell dissociation buffer 





• Primary mouse osteoblasts  
– Alpha-MEM (without AA) + 10% FBS + 1% antibacterial/mycotic 
– Bone specific media: Alpha-MEM (without AA) + 10% FBS + 10-8 M 
DMSO + 10 mM β-glycerophosphate + 50 mg/L L- ascorbic acid- 2-
phosphate + 1% antibacterial/mycotic  
 
• Primary mouse mesenchymal stem cells  
– Alpha-MEM (without AA)  + 10% FBS + 1% antibacterial-antimycotic 
 
• Primary mouse endothelial cells  
• EGM-2MV (Lonza) media supplemented with endothelial growth factors  
 
• Primary mouse megakaryocytes (megakaryocyte progenitors FACS isolated, to be 
expanded in culture) 
– Media: IMDM + 10% FBS + 1% antibacterial-antimycotic + 2 mM 
GlutaMax-1  + 0.1mM non-essential amino acid + 1 mM sodiumpyruvate 
+ 50 mM 2-mercaptoethanol +  SCF (25 ng/ml) + Flt3 ligand (25 ng/ml) + 
IL-11 (25 ng/ml) + IL-3 (10 ng/ml) + Tpo (25 ng/ml) + Epo (2.5 U/ml) 
+GM-CSF (10 ng/ml) 
 
• HSC expansion media: StemSpam (StemCell Tech) + 10 micro g/mL heparin + 
10 ng/mL mouse SCF + 20 ng/mL mouse TPO + 20 ng/mL mouse IGF-2  + 10 
ng/mL human FGF-1 + 5 ng/ml IL-3 + 6 U/ml human EPO +100 ugm/ml human 
insulin + 1 % deionized BSA 
 
 
Mouse Mature Megakaryocytes Isolation 
 
• Isolate marrow as usual (2 mice) 
• Have one of the centrifuges left open to warm to RT (leave a note to others that it 
should be left open) 
• Stain the cells with CD41-FITC (1:200) for 20 min on ice 
• Dilute and centrifuge as usual 
• Resuspend in anti-FITC MACS beads (1:10) for 20 min on ice 
• Dilute and centrifuge as usual 
• Resuspend pellet in 6 ml of staining media 
• Aliquot 3 ml of FICOLL medium into two 15 ml tubes 
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• Carefully pipet 3 ml of cells onto each FICOLL tube ensuring that the separation 
between layers is preserved 
• Centifuge at 800 RCF for 15 min at RT 
• A leukocyte band should appear in the middle of the liquid column- the megs (and 
erythroid cells) are in the pellet 
• Resuspend the pellets in 3 ml total and select once (for recovery) or twice (for 
purity) using the autoMACS 
• Examine the end result under the inverted microscope to document purity- 
Megakaryocytes are substantially larger than other leukocytes 
 
 
Mouse Pups Liver and Spleen Endothelial Cells Isolation 
 
Livers and spleens from BA pups (less than 5 days old) 
 
Need:  
2% FBS + HBSS (Ca, Mg free) 
Collagenase IV  
37 C shaking water bath 
 
• 3 pups 
• 3 days old 
• Isoflurane in mouse room 
• Anaesthized 
• Brought up to lab and chopped heads off 
• Opened the body cavity (working media: 2% FBS + HBSS free) 
 
 
• Took off viscera 
• Below diaphragm 
• Red tissues are liver and spleen 
• Three-four lobes of liver 
• Spleen just behind the stomach (like a red cylinder) 
• Stomachs white-filled with milk 
• Pinch off livers like a bud from behind don't chop off from front or will lose 
tissue 
• 5 min 1500 rpm 
• Remove the supernatant 
• Sterile filter 10% FBS+ HBSS+ 1% Collagenase IV 
• 18 gage needle 
• Triturate 5-6 times 
• 37 C shaking water bath 1.5 hours 
• After 20 minutes, each 20 minutes, triturate with a 25 gauge needle 
 
• FACS (Flow Cytometry) 
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• Working media: RPMI 1640 
• Isotype control (CD 31 only, CD 105 only, Sca-1 only) 
• Live dead stain (7AAD or DAPI)  
• All staining on ice 
• CD 31 (PE) 1:100 
• CD 105 (biotin) 1:100 
• Sca-1 (FITC) 1:400 
• Streptavidin (APC Cy5) 1:400 (for biotin) 
 
 
Microfluidic Device Design for Co-culture of HSCs and Support Cells 
 
• Small number of cells 
• Different supporting cells 
• Gentle replacement of media from bottom channel by convective diffusion 
 
Figure G1:  Semi porous membrane based microfluidic device for co-culture of FACS 







Figure G2: Hypoxia chamber for maintaining 1% oxygen in microfluidic cultures of 
HSCs and support cells 
 
 
Figure G3: Osteoblasts, mesenchymal stem cells and megakaryocytes used as supporting 




















Figure G6: Cell suspension containing bone marrow cells from two mice enriched in 
Lin- c-kit+ cells using aMACS 
 
 
Figure G7: FACS tubes containing Lin- c-kit+ enriched cell suspension (far right) and 








Figure G8: Aliquoted 400 μl of HSC expansion media for collecting FACS sorted HSCs 
 
Efficacy of In Vitro HSC Niche 
 
• After removal from microfluidic devices, ‘test’ cells prepared for in vivo injection 
in lethally irradiated Ly 5.2 mice (500 cGy for 5 minutes) 
• 300,000 radio protective bone marrow cells (RPD) from BA mice  
• Injection of RPD + test cells through retro orbital sinus after anaesthetizing mice 
with isoflurane 
• Mice given antibiotic water for first 3 days after injection 
• Four weeks after injection, peripheral blood of host mice analyzed for cells from 
donor mice 
• Subsequent peripheral blood analysis at 8, 12, and 16 weeks 
 
Peripheral Blood Analysis 
• Peripheral blood from mice tail 
• Cells from donor CD 45.2 mice 
• FITC-conjugated anti-CD45.2 antibody (clone A20) 
• B220: B Cells  
• Mac-1: Myeloid cells 
• Gr-1: Granulocytes 
• CD 3: T cells 








Figure G9: Representative FACS plot of myeloid, B and T cells against CD45.2 
antibody 
 

















Reasons for No In Vivo Engraftment 
• Ineffective cell removal 
• Cell death 
• Not enough HSCs in microdevices 
 
Adding/Removing Small Number of Cells from Microdevices 
• Counted number of cells in microbioreactor 
• Kept for 2 hours in incubator 
• Removed cells by triturating and washing 








Figure G12: Cells in microdevice funnel region at 10X magnification 
 
 





Figure G14: Microdevice after removal of cells at 10X magnification (Note: the grainy 





Cell Seeding in PDMS Microbioreactor for Real Time Oxygen Measurements 
 
(Supplementary for Chapter 3) 
 
 




Figure H2: Flow direction (solid green arrows) and valve (valve-up: gray with black 




LabVIEW Graphic User Interface for Measurement of Changes in Florescent 
Lifetime of Ruthenium based Oxygen sensitive Dye 
 










Polyelectrolyte Multilayers inside Microfluidic Bioreactors 
 
(Supplementary for Chapter 6) 
 
Description of 30 PEMs created inside PDMS microfluidic bioreactors: 
PEMs (14 out of total 30) which are discussed in the manuscript: (PDDA/Clay)3 
(Co/FN)0, (PDDA/Clay)4(Co/FN)0, (PDDA/Clay)5(Co/FN)0, (PDDA/Clay)7.5(Co/FN)0, 
(PDDA/Clay)7(Co/FN)0, (PDDA/Clay)3(Co/FN)1, (PDDA/Clay)3(Co/FN)2, 
(PDDA/Clay)3(Co/FN)3, (PDDA/Clay)4(Co/FN)2, (PDDA/Clay)4(Co/FN)4, 
(PDDA/Clay)4(Co/FN)6, (PDDA/Clay)5(Co/FN)2, (PDDA/Clay)5(Co/FN)4  and 
(PDDA/Clay)5(Co/FN)7.  
 
The rest of 16 PEMs which are not discussed in the manuscript: 
(PDDA/Clay)4.5(Co/FN)0, (PDDA/Clay)5.5(Co/FN)0, (PDDA/Clay)6(Co/FN)0, 
(PDDA/Clay)6.5(Co/FN)0, (PDDA/Clay)8(Co/FN)0, (PDDA/Clay)10(Co/FN)0, 
(PDDA/Clay)12(Co/FN)0, (PDDA/Clay)15(Co/FN)0, (PDDA/Clay)5(Co/FN)8, 
(PDDA/Clay)5(Co/FN)9, (PDDA/Clay)7(Co/FN)1, (PDDA/Clay)7(Co/FN)2, 












Figure J2: Mixing of clay and PDDA is avoided by returning the polyelectrolyte 





Figure J3: Fluorescent micrographs of inlet streams and multifunctional 
nanocomposite coatings created in outlet channels inside PDMS microbioreactor 
chips (images taken with a 10X objective). The pictured from (a) to (d) represent the 
inlet streams, while those from (e) to (h) represent the outlet streams. For each region 
(inlet or outlet), the green pictures are stained to fluoresce for positive charge (PDDA, 
Co), while red are stained for negative charge (Clay, FN). The picture (a) shows the 
PDDA inlet stream; (b) and (c) illustrate the DI water streams; and (d) shows the clay 
stream. The picture (d) represents the first outlet channel which has no nanocomposite 
coating on PDMS surface; (e) shows the second channel with the composition 
(PDDA/Clay)3.5 coating (PDDA topped); (f) illustrates the third outlet channel with 
(PDDA/Clay)4 coating (clay topped), DI water stream; and (g) shows the last outlet 





Figure J4: Cell spreading on nanocomposite coatings microfluidic bioreactors at day 
1, 5, 10 and 15 (x 103 μm2). Legend: A=(PDDA/Clay)7.5(Co/FN)0, 
B=(PDDA/Clay)7(Co/FN)0, C=(PDDA/Clay)3 (Co/FN)0, D=(PDDA/Clay)3 (Co/FN)1, 
E=(PDDA/Clay)3 (Co/FN)2, F=(PDDA/Clay)3 (Co/FN)3, G=(PDDA/Clay)4 (Co/FN)0, 
H=(PDDA/Clay)4 (Co/FN)2, I=(PDDA/Clay)4 (Co/FN)4, J=(PDDA/Clay)4 (Co/FN)6, 
K=(PDDA/Clay)5 (Co/FN)0, L=(PDDA/Clay)5 (Co/FN)2, M=(PDDA/Clay)5 (Co/FN)4, 







Figure J5: Comparison of fluorescence intensity of charged dyes after deposition of 
each bilayer. The fluorescence of a PEM with 3 bilayers is shown in a), and b) shows the 
change in intensity with increasing number of bilayers. The fluorescent intensities were 
analyzed using SimplePCI on a Nikon TE-300 microscope with a Hamamatsu-ORCA 
100 camera. The bin size of 2 was used for all images, with a gain of 2 and exposure time 
of 1 second. The fluorescent image shows uneven intensity inside the channel after 






Figure J6: AFM images of PEMs deposited on flat PDMS substrate and microfluidic 
device. PEMs of composition (PDDA/Clay)8  were scanned with AFM in the tapping 
mode. The images are 50 μm in both dimensions, a) is an AFM scan for PEM on flat 
PDMS substrate, and b) is the counterpart inside PDMS microfluidic bioreactors. The 
mean roughness (Rms) of both images is similar (~70 nm). 
 
 
Figure J7: Cell spreading at Day 15 on surface modified flat PDMS substrate (μm2).  
Legend: A=(PDDA/Clay)5 on flat PDMS substrate, B=(PDDA/Clay)5.5 on flat PDMS 
substrate,  C=(PDDA/Clay)7 on flat PDMS substrate,  D=(PDDA/Clay)5 (Co/Fn)3 on flat 
PDMS substrate,  E=Fibronectin adsorption on flat PDMS substrate, F=Collagen Type IV 
adsorption on flat PDMS substrate, G=Fibronectin and Collagen Type IV (1:1) 
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